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Abstract 
 
Objective:  
The diagnosis and management of normal pressure hydrocephalus (NPH) remains 
controversial.  The aim of this prospective study was to assess the usefulness of clinical and 
radiological criteria together with supplemental neuropsychological and gait tests, cerebrospinal 
fluid (CSF) hydrodynamic studies and external lumbar drainage (ELD) in identifying those who 
may respond to a shunt and to compare the outcomes with the non-shunted patients at one year.   
Method:  
Forty patients with a clinical diagnosis of NPH were prospectively studied according to a 
fixed management protocol. Resistance to CSF (Rcsf) was measured using a lumbar infusion 
study and an ELD was used to determine improvement in neuropsychological and gait tests 
following CSF drainage. Based on specific criteria those who showed improvement were 
shunted. Clinical and radiological outcomes were assessed at one year in all patients.  
Results:  
Twenty three (57.5%) patients were shunted. Improvement was observed in 74% of 
shunted patients, while 17% did not improve and 9% deteriorated following surgery. Age, 
etiology, presentation, duration of symptoms and presence of co-morbid factors were unrelated to 
outcome. Improvement was found in 63% of shunted patients with RCSF of 12 mmHg/ml/min or 
higher. The sensitivity was 64% with a positive predictive value of 68%. Both Rcsf testing and 
ELD enhanced the positive predictive outcome of shunt operation. Using the non-shunted 
4 
 
patients as controls, the mean difference between the two groups over time differed significantly 
in all the neuropsychological tests and some gait test.  
Conclusions: 
No single test was able to predict overall success with shunting but the results showed 
that a high percentage of improvement could be achieved by using continuous ELD and a 
rigorous protocol. Greater improvements were observed in cognitive and gait function than in 
sphincter control. An Rcsf of 12mmHg/ml/min or more was related to better outcomes. 
Consideration was given to the significant limitations in the study design and outcome measures. 
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Chapter 1: Introduction  
 
1.1. Introduction 
There are few dilemmas for the clinician in the management of acute non-communicating 
hydrocephalus, in which the urgent need to bypass an obstruction to cerebrospinal fluid (CSF) 
flow, is self-evident.  The core pathophysiological process is the elevation of intracranial pressure 
above cerebral perfusion pressure and consequent tissue hypoxia and ischemia.  The diagnosis is 
usually clear from the clinical features.  There is usually a preceding history, which includes 
headache and an evolution through nausea, and vomiting, confusion and coma in association with 
appropriate clinical signs on examination.  In addition there are confirmatory investigation 
results, which usually include sophisticated neuroimaging techniques.  Chronic communicating 
hydrocephalus (CCH), in stark contrast, challenges the clinician with both diagnostic and 
management dilemmas.  This is primarily because the diseases processes underlying these 
conditions are poorly understood but they probably also involve an interaction between tissue 
perfusion and intracranial pressure.  In addition, the onset of these conditions is insidious; the 
differential diagnosis is wider than for acute onset hydrocephalus and the results of surgical 
intervention are unpredictable leading to a spectrum of outcomes ranging from possible 
significant recovery to potentially hazardous complications. 
Normal pressure hydrocephalus is a syndrome of gait disturbance, dementia and urinary 
symptoms in the presence of ventricular enlargement and normal intracranial pressure. Hakim 
and Adams first described this condition in 1965. It can occur in people of any age, but it is most 
common in the elderly population above the age of 65 years. NPH is rare, estimated to account 
for 0.4% of cases of dementia (Vanneste, 1994). The likelihood is that it represents the final 
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common pathway of a number of different pathologies and symptoms are likely to be due to a 
combination of mechanisms rather than a single cause.  Half of the cases are idiopathic (iNPH) 
and half are secondary NPH (sNPH) cases following head injury (HI), subarachnoid haemorrhage 
(SAH), meningitis or neurosurgery (Vanneste, 1994. Ojemann, Fisher, Adams et al, 1969). 
Idiopathic normal pressure hydrocephalus (iNPH) accounts for a significant proportion of 
cases of CCH.  It is already recognised as an important cause of cognitive impairment because it 
has for decades been thought to be reversible by surgical means.  As our population continues to 
age, the social and economic importance of this condition is likely to grow and yet there are no 
reliable clinical or neuroimaging criteria to distinguish it from other chronic encephalopathies 
such as diffuse small vessel cerebrovascular disease, which can have very similar clinical and 
imaging features.  Amongst the many causes of cognitive and motor dysfunction in the elderly, 
NPH is almost unique in that ventriculo-peritoneal shunting may result in marked recovery. This 
procedure involves diversion of CSF from the ventricles into the peritoneal cavity via shunt 
tubing. Shunting, particularly in elderly patients, is associated with a significant incidence of both 
acute and cumulative longer-term complication. Not all subjects respond to shunting, however, 
an acute complication rates of between 30-40% with rates of serious complications occurring at 
about 5-8%  have been quoted following surgery (Vanneste, Augustijn, Dirven et al, 1992).     
In CCH the decision to insert a ventriculo-peritoneal shunt which may be in situ for years 
and can arrest the disease process or even result in dramatic recovery, has to be balanced against 
the risk of acute and chronic complications some of which are life threatening. There are no 
robust criteria to predict outcome from this surgery in patients with NPH and even the decision to 
operate in the non-NPH CCH can be difficult because patients rarely present with raised 
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intracranial pressure (ICP) (Kirkpatrick, Engleman, Minns, 1989) and ventricular size does not 
correlate with ICP (Hanlo, Gooskens, van Schooneveld et al, 1997. van der Knaap, Valk, Bakker 
et al, 1991).  The concern about these complication rates associated with an otherwise curative 
treatment of cognitive and gait decline has contributed to the drive to investigate the underlying 
processes in this disease. This is required to develop reliable non-invasive techniques to measure 
disease activity, which can then be used to guide management decisions such as whether, and 
when to operate. The bulk of the literature on this condition has been aimed at the development 
of reliable techniques for predicting outcome from surgery in order to better target this invasive 
form of therapy. In this systematic prospective clinical study we have tried to identify some 
reliable factors that can be used to predict those who are most likely to respond to a shunt than 
the others suspected to have a similar presentation.  
1.2. History of Normal Pressure Hydrocephalus 
The term ―Normal Pressure Hydrocephalus‖ was introduced by Solomon Hakim in his 
thesis Some Observations on CSF Pressure: Hydrocephalic syndrome in Adults with “Normal” 
CSF Pressure in March 1964, Colombia. Adams and colleagues published the first article in the 
New England Journal of Medicine in 1965. During the same year Hakim and Adams in the 
Journal of Neurological Science (Hakim and Adams 1965) described the “Classical triad” of 
gait disturbance, incontinence and dementia characterized by normal opening pressures at lumbar 
puncture (LP) and improved on removal of CSF. He discussed three cases, two posttraumatic and 
one idiopathic hydrocephalus. In the last four decades since it was first described considerable 
controversy has evolved as to the appropriate diagnosis, investigation and management of the 
NPH patients. There are more than 1850 papers in the English literature between 1965 and 2008 
that have looked into this condition. Of these, several studies have focused on identifying those 
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who will respond to a shunt surgery.  Despite the advances and a slightly better knowledge of the 
disease the postoperative results of shunt implantation has not improved significantly. Only a few 
studies report an extended follow-up of patients and the value of the predicting factors in the long 
term. 
1.3. Clinical features 
A review of the clinical features of NPH may be helpful in determining the site and nature 
of the pathophysiology.  Idiopathic form of NPH tends to present in the
 
elderly above 65 years 
whereas patients with secondary form of NPH
 
tend to present at an earlier age.  
The original concept of Hakim and Adam‘s triad of symptoms (Hakim and Adams, 1965), 
namely impaired consciousness and reduced responsiveness in combination with locomotor and 
sphincteric difficulties in two patients with secondary and one patient with iNPH has evolved.  At 
one stage the cardinal features were dementia, ―apraxic‖ gait (Sudarsky and Ronthal, 1983) and 
urinary incontinence but even this has been refined further.   
When six patients (4 with iNPH) were subjected to detailed neurological examination and 
gait analysis (Estanol, 1981) the gait impairment was found to be part of a subtle constellation of 
motor deficits, including failure of postural righting reflexes, a feature commonly seen in diseases 
of the basal ganglia such as Parkinson‘s disease.  Interestingly, the term ―apraxic‖ has been used 
to describe the gait.  The problem, however, may not be just in the programming of the 
movement where the individual elements are adequately performed but not put together to 
complete the task.  Rather the gait difficulty may be manifest only when weight is put on the legs.  
It has been suggested that this is due to release of positive proprioceptive supporting reactions or 
put another way a defect of supraspinal modulation of locomotion (Estanol, 1981). Interestingly 
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none of the patients studied had signs of idiomatic or ideational apraxia or agnosia.  Grasp, snout 
and sucking reflexes are observed which are commonly seen with diffuse frontal lesions.  
Abnormal smooth pursuit, a feature of occipital disease and failed suppression of vestibulo-
ocular reflexes seen in brainstem disease are also observed (Estanol, 1981).  Difficulties with gait 
are an early feature, and have been described variously as, ―shuffling‖ (Estanol, 1981), 
―magnetic‖ gait,  ―ignition failure‖, ―bradykinetic‖, ―glue-footed‖, ―short-stepped‖, ―apractic‖, 
and ―lower body Parkinsonism‖ all of which are more in keeping with a disorder of higher order 
regulation of gait rather than a simple disorder of the pyramidal system.  Gait is characterised by 
perseveration of posture (a frontal lobe feature), wide base, and slow, small steps with reduced 
range of foot-floor clearance.  The presence of increased tone with brisk tendon reflexes in the 
lower limb and the absence of weakness or in-coordination (Estanol, 1981), suggest disruption of 
accessory circuits involved in the higher order production of gait.  The plantar responses may be 
flexor or extensor, unilaterally or bilaterally.  An early hypothesis suggesting that enlarged 
ventricles in NPH led to the compression and deformation of upper motor neuron fibers, passing 
through the corona radiate, is not supported by a recent study using motor evoked responses 
(Bech-Azeddine, Walder, Knudsen et al, 2001). Electromyographic evidence reveals contraction 
of antagonistic muscles and abnormally increased activity in the antigravity muscles acting on 
hips and knee joints (Bench, Waldemar, Gjerris et al, 1999, Boon, Tans, Delwel et al, 1997). This 
disturbance in the phased activation of muscle groups suggests a subcortical motor control 
problem and clearly suggests that pyramidal tracts are not necessarily involved in the disease 
process. Fisher, 1982 noted that hand tremor; writing disturbances and fine motor activity can 
also be affected in NPH. Impaired input from the sensorimotor cortex, the superior
 
frontal cortex, 
and the anterior cingulate gyrus to the reticular
 
formation in the tegmentum of the brain stem may 
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also contribute
 
to the gait and stance disorder (Nutt, Marsden and Thompson 1993). Gait is 
known to be the earliest symptom noticed by the patient followed by cognitive and urinary 
symptoms and the first one to resolve following
 
successful VP shunting (Graff-Radford and 
Godersky, 1987). Patients who have a lesser duration of symptoms are known to have a better 
outcome with shunting.  
Boon, Tans, Delwel et al, 1997, in the Dutch normal pressure hydrocephalus study 
proposed that sub cortical dementia is mild to moderate. These patients had memory deficits, 
diminished visuospatial abilities, inertia, and psychomotor slowing. Similarly to Thomsen, 
Borgesen, Bruhn et al, 1986, patients were classified into groups according to their scores on the 
psychometric tests. An analysis of the duration of the illness found no relationship between 
length and the severity of NPH. The symptom duration ranged from 4 months up to 10 years. 
Twelve of those were diagnosed with NPH due to neurological conditions whereas the remaining 
89 were idiopathic. The results, supporting previous findings, found that the dementia caused by 
NPH varied from mild cognitive problems through to severe impairment and an inability to even 
complete psychometric tests. In contrast to previous findings, this study indicated that length of 
illness did not correlate with extent of dementia, although reasons for this are unclear. It suggests 
however, that the dementia in NPH is not progressive. Meier, Zeilinger, and Kintzel, 1996, found 
higher rates of improvement following shunt surgery, of 65% at short term follow up. A mild 
regression was noted at long term follow up as only 54% remained improved (Thomas, McGirt, 
Woodworth et al, 2005).  
In the initial stages incontinence may be due to gait disturbances when the patient cannot 
physically get to the toilet within the necessary time. In the more advanced stage the urinary 
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features are initially of urgency and later frank disinhibition suggestive of a frontal lobe element 
to the disease (Vanneste, 2000). It is suggested that the bladder disturbance is due to the 
distending of the periventricular nerve fibres and ensuing (partial) 'loss of inhibition of bladder 
contractions', (Vanneste, 2000). This impairment in bladder control often results in the patient 
feeling a strong, immediate sensation of a need to urinate (every one to two hours). In some cases 
there is a complete loss of bladder control, and although rare, cases of double incontinence have 
been reported. Bowel incontinence is usually present in more advanced stage. Some patients 
however never develop bladder dysfunction. Meier, Zeilinger and Kintzel, 1999 found urinary 
incontinence to be present in 24% of those in the early stages of NPH and 54% of those in the 
late stages. This supports previous findings that incontinence is not always a predominant 
symptom. The bladder `hyperactivity' can be temporarily alleviated by removal of 50mls of CSF 
through a lumbar drain and shunt insertion improves incontinence problems in this group of 
patients.  Ahlberg, Norlen, Blomstrand et al, 1988 noted this improvement in all NPH patients 
following CSF drainage, but not in those with Alzheimer's disease or multi-infarct dementia. 
They suggest that urodynamic testing may be of benefit in differentiating between NPH and other 
causes of incontinence.  
The characteristic which links these features is that these symptoms can be localised 
predominantly to the sub cortical white matter, the brain tissue in close proximity to the 
ventricles and this suggests that investigation of the cortex is unlikely to be fruitful and that 
investigation should be directed at the periventricular tissues.   
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1.4. Radiological diagnosis 
1.4.1. Introduction 
As mentioned previously the diagnosis of NPH is based on clinical symptoms and 
radiological confirmation of communicating hydrocephalus. Radiological confirmation is either 
by computed Tomography (CT) scan and or Magnetic Resonance Imaging (MRI) scan. The 
prognostic value of CT and MRI on their own is limited and other supplementary tests are 
necessary to increase the prognostic accuracy of identifying NPH responders to shunting.  
  1.4.2. Computerised tomography techniques (C.T) 
CT scan not only helps in diagnosis along with the clinical symptoms, but it also helps to 
differentiate from other conditions that may mimic NPH (Table 1.1). In the normal population the 
mean ventricular size, as a percentage of the intracranial area, was 5.2% between ages 50-59, 
6.4% from age 60-69, 11.4% from 70-79 and increased further to 14.1% between ages 80-89 
years (Barron, 1976) These normal ventricular enlargements need to be noted when analysing CT 
scans in these patients. In NPH there is no significant cerebral atrophy compared to others causes 
of dementia.
 
It is important to differentiate the ventriculomegaly
 of NPH from the ‗hydrocephalus 
ex vacuo‘ of advanced Alzheimer‘s disease. Peri-hippocampal fissures (PHFs) are normal or only 
minimally
 
dilated in NPH, and typically markedly dilated in Alzheimer‘s disease. Figure 1.1 
shows a CT scan of a patient with NPH. 
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Figure 1.1: CT scan slices of a patient with NPH.
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Figure 1.2: CT scan showing the calculation of Evans‘ index 
 
 
 
 
 
Evans‘ index = A / B 
 
The Evans‘ Index (EI) or Frontal Horn Index (FHI), which is determined by the largest 
diameter of the frontal horns divided by the diameter of the internal skull at the level of the 
frontal horns, if above 0.3 indicates ventriculomegaly, may possibly be the only finding 
obligatory for establishing the diagnosis of NPH (Figure 1.2). All the other imaging findings, i.e. 
large temporal horns, dilated third ventricle, enlarged peri-sylvian fissures or both focal dilation 
and obliteration of cortical sulci, cortical and subcortial atrophy and the "so-called" 
periventricular oedema have never been consistently reported in larger patient‘s series (Mori, 
Handa, Murata, et al., 1980, Wikkelso, Andersson, Blomstrand et al., 1989). Frontal Horn Index 
A 
B 
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(FHI) of 0.4 was also noted as a sign of ventriculomegaly in a series of 151 patients by 
(Marmarou, Young, Aygok et al.  2005). No study in the literature has shown evidence of a 
positive association with any of the imaging criteria with clinical improvement except a recent 
study by Marmarou, Young, Aygok et al. 2005. FHI in patients whose condition had improved 
after drainage and shunt placement, and who had follow-up CT studies from within 6 months to 1 
year of surgery showed a reduction in ventricular size and was statistically significant (p<0.001). 
The number of patients who did not improve after External Lumbar Drain (ELD) and shunt 
placement together with a follow up was small. Some of the findings have been suggested to 
relate to NPH pathophysiology by comparison made in the pre-shunting CT, e.g. focal sulcal 
dilation, which has been ―misinterpreted‖ as cortical atrophy in the previous times and therefore 
even been used as a criterion to exclude patients from undergoing a shunting procedure 
(Holodny, George, de Leon et al. 1998).  Takeuchi et al studied patients with severe cerebral 
atrophy and found good improvement in 48% following shunting, providing evidence that 
cortical atrophy does not correlate with outcome. In a study of five cases of patients who 
presented with focal dilation of cortical fissures and sulci, in three of the cases, there was a 
paradoxical decrease in the size of the dilated fissures and sulci that paralleled the decrease in the 
size of the lateral ventricles following successful shunting. The authors concluded that focal 
fissural and sulcal dilation may represent ―atypical‖ reservoirs of cerebrospinal fluid analogous to 
the ventricular system (Holodny, George, de Leon et al, 1998). Hydrostatic valves (Dual-Switch-
Valves) were implanted in 80 patients with NPH and one year postoperatively Evans-Index was 
measured. 80% of the patients who showed no postoperative change in ventricular volume had 
59% good to excellent clinical improvements, 17% satisfactory clinical improvement, and 24% 
no improvement. Of the 14% of those who showed moderate reduction in ventricular size 36% 
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experienced a good to excellent clinical improvement, 28% a satisfactory improvement, and 36% 
unsatisfactory improvement. A marked reduction in ventricular size was observed in 6% of the 
patients, of whom, 60% demonstrated good to excellent outcomes, whereas 40% had 
unsatisfactory outcomes. Favourable outcomes following the implantation of a shunt in patients 
with NPH did not correlate with decreased ventricular volume 1 year after surgery. In fact, better 
clinical outcomes were observed in patients with little or no alteration in ventricular size, 
compared with those in patients with marked decrease in ventricular size (Meier and Mutze, 
2004). The same authors reported a similar conclusion in 2003 (Meier, Paris, Grawe, et al. 2003). 
Most crucial, however, is the accurate selection of those patients, which may benefit from 
shunting based on both the clinical and imaging findings.  
1.4.3. Magnetic resonance techniques (M.R.I) 
Multimodal Magnetic Resonance protocols are ideal for investigating the vascular 
contribution to human brain disease because of the uniquely high resolution, the safety profile 
and the ability to study subjects longitudinally.  Furthermore the ability to co-register high 
resolution anatomical data with physiological (haemodynamic) and biochemical (lactate and high 
energy phosphate metabolites) data in the same study provides an unparalleled tool to relate 
vascular compromise with the metabolic consequences of ischaemia in specific areas of brain.   
Current clinical imaging detects areas of ischemic damage both acutely and in the 
chronic period.  T2 weighted changes have been reported as soon as 2 hours after infarction 
(Mintorovitch, Moseley, Chileuitt, et al. 1991) and are visible years after the infarct has 
matured.  Diffusion weighted imaging has found a use in the early detection of ischemic tissue 
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which is clearly delineated from unaffected tissue, in the face of unchanged conventional 
imaging.   
1.5. Diagnostic dilemmas 
The differential diagnosis of iNPH includes a large number that are relatively 
commonplace in the elderly (Pickard, 1984). Table 1.1 (page 40) outlines the differential 
diagnosis for NPH classified by their symptoms. Gait being the commonest and earliest symptom 
can be put down by most patients as a slowing down process of aging. If they have associated 
neck and back pain they could have been investigated for spondylotic changes. Only in the later 
stages when they start developing cognitive impairment with or without urinary symptoms does it 
raise a suspicion of NPH. As well as gait disturbances, Fisher CM, in 1982 noted that hand 
tremor; writing disturbances and fine motor activity can also be affected in NPH. These 
symptoms of tremor could make it difficult to distinguish from Parkinson‘s disease (PD). 
Parkinson‘s disease, even without the tremor and other disorders such as chronic alcoholism and 
progressive supranuclear palsy (Vanneste, 2000) may display symptoms of NPH, with gait 
disturbance, urinary incontinence and subcortical mental deterioration. The number of disorders 
which have similar symptoms to NPH highlights the fact the appropriate clinical evaluation is 
required to make a diagnosis and also that the classical triad is not unique to NPH.  
Deficits associated with NPH tend to be mild to moderate subcortical dementia which are 
best differentiated from cortical dementia by the absence of aphasia (disturbance in the 
comprehension or production of speech) apraxia (inability to perform voluntary actions) and 
agnosia (inability to recognize the form and/or function of objects & people) (Boon, Tans, 
Delwel et al, 1997). The
 
dementia may also be caused or exacerbated by a number of factors,
 
including ischaemia, frank infarction and relative CSF stasis
 
with decreased clearance of various 
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macromolecules (Klinge, Samii, Muhlendyck et al, 2003. Silverberg, Mayo, Saul et al, 2003. 
Tullberg, Hultin, Ekholm et al, 2002.) There have been a number of studies, which have 
attempted to differentiate the dementia of NPH and Alzheimer's. The dementia in AD is cortical 
and characterised by impairment in language executive functions, constructional and visuospatial 
abilities. Impairment of memory, especially for recent events, is the most prominent feature of 
Alzheimer‘s. As can be seen these features of Alzheimer's are very similar to those found in 
NPH. As has previously been reported, evidence of aphasia, is a poor prognostic factor for 
surgical success and subsequent improvement of the symptoms of NPH (Graff-Radford, 1999). It 
could therefore be surmised that evidence of aphasia is indicative of AD rather than NPH. To 
enable clinicians to distinguish NPH from other dementias a number of studies have aimed to 
assess the nature of the cognitive decline in NPH. Batteries of tests have been used to 
differentiate the types of dementia as shown in Table 3.4, in section 3.4.1. These tests are 
designed to assess for dementia, which is subcortical. The prevalence of AD in patients with 
normal pressure hydrocephalus was found to be related to the severity of dementia. Golomb, 
Wisoff, Miller et al in 2000 found that those who scored lower on neuropsychological tests and 
had increased gait disturbance and urinary incontinence; were more likely to have Alzheimer‘s 
concomitant with NPH. Following shunt surgery there were no significant differences found in 
the extent of improvement between those with NPH who had concomitant Alzheimer's and those 
with NPH only. Both groups were found to significantly improve with regard to gait and 
incontinence. In accordance with previous findings cognitive impairment was not found to have 
improved significantly following shunt surgery. This study suggests that improvements in the 
physical symptoms of NPH can be improved even when the patient also has AD. Several 
researchers have suggested that those with Alzheimer's should not be selected for surgery. 
40 
 
However, if the shunt alleviates these physical problems caused by NPH, this might reduce the 
pressure on the families of the patient, even if the dementia were still present. Some authors 
suggest that AD is quite prevalent in NPH, more so than they conservatively estimated and 
propose that a dual diagnosis such as this should not prevent the patient from receiving a shunt.
 
Silverberg, Mayo, Saul et al, 2003 postulate a new entity of CSF circulatory failure, with features 
of AD and NPH. NPH–AD syndrome may cover an important subset of patients who carry the 
diagnosis of either AD or NPH.  
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Table 1.1: Differential Diagnosis for Normal Pressure Hydrocephalus classified by their 
symptoms. 
Cognitive and behavioural 
manifestations 
Neurodegenerative disorders: 
Alzheimer‘s disease 
Parkinson‘s disease 
Lewy body disease 
Huntingtons disease 
Frontotemporal dementia 
Amyotrophic lateral sclerosis 
Spongiform encephalopathy 
HIV and Syphilis 
 
Vascular dementia: 
Cerebrovascular disease 
Stroke 
Multi infarct dementia 
Binswanger‘s disease 
Vertebro-basilar insufficiency 
Cerebral autosomal dominant 
arteriopathy 
 
Gait and balance disturbances 
Structural lesion of brain or spine: 
Tumours 
Stroke 
Vascular malformations 
Spinal stenosis 
Rheumatoid arthritis 
Craniocervical abnormalities 
 
Neurodegenerative disorders: 
 Idiopathic Parkinson‘s disease 
Amyotrophic lateral sclerosis 
Others 
Peripheral neuropathy 
 
Urinary disorders 
Urinary tract infection 
Bladder and prostate enlargement 
Benign prostatic enlargement 
 
 
Other hydrocephalus disorders: 
Aqueductal stenosis 
Arrested hydrocephalus 
Long standing overt ventriculomegaly 
syndrome 
Non-communicating hydrocephalus. 
 
Miscellaneous: 
Collagen vascular disease 
Epilepsy 
Depression 
Traumatic brain injury 
Chiari malformation 
Wernicke‘s encephalopathy 
B12 deficiency 
Carcinomatous meningitis 
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The main differences between NPH, Alzheimer‘s and Parkinson‘s are that the postural 
instability starts early in Parkinson‘s where as it can be a late presentation in NPH. Patients with 
Parkinson‘s have rigidity, tremors and bradykinesia which can also be present in NPH but not as 
a prominent early feature and rarely seen in AD. Most patients with AD have early onset of 
memory symptoms, difficulty performing familiar tasks and behavioural changes, whereas these 
present late or partly in NPH and PD.  
1.6. Summary  
Historically there has been considerable variation of the results in pathophysiological 
studies of NPH and in the results of studies attempting to determine the utility of tools to predict 
outcome from surgery in this condition.  This is likely to be related to the range of aetiological 
factors operative in NPH and therefore heterogeneous patient selection.  In addition, partly 
because NPH is rare, most of the studies in the literature are small and it is difficult to justify the 
application of the results from small studies into clinical practice. At the same time technological 
advances mean that different methods have been used to assess the same parameter.  This makes 
comparison between studies more difficult.  Additionally, studies that diagnose NPH on the basis 
of recovery from shunting will inevitably exclude patients with advanced or irreversible disease 
and may unnecessarily restrict selection of patients to those earlier in the disease course.  These 
studies also ignore the fact that technical factors in shunting contribute greatly to outcome.  
There is therefore a potential for excluding data from patients who have NPH but who were not 
adequately treated.  If investigators used widely accepted standards in methodology and patient 
selection, results could be more easily interpreted.  Not withstanding these problems, there is 
evidence that NPH is the consequence of multifactorial processes and there are arterial, venous 
and CSF hydrodynamic contributions to the disease process. The aetiology of NPH remains 
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uncertain but the clinical deterioration is probably the result of a combination of both 
cerebrovascular and pressure effects on the periventricular white matter and deep grey matter 
structures.   
In order to limit the heterogeneity of potential aetiologies biasing results and because the 
NPH group represents the largest single group of patients with CCH patients with NPH were 
chosen as a group to study.  We have included both iNPH and sNPH in our study.  
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Chapter 2: Pathophysiological hypotheses 
 
2.1. Histopathology of normal pressure hydrocephalus 
There have been very few human studies looking at the periventricular tissues in NPH 
(Del Bigio, 1993).  An early study of two patients with clinical and radiologic criteria for NPH 
who came to autopsy demonstrated extensive hypertensive cerebrovascular disease in the deep 
white matter (Earnest, Fahn, Karp, 1974).  The meninges and the arachnoid villi were normal in 
these cases.  Another shunt responsive case that came to autopsy was characterized by severe 
hypertensive vasculopathy with multiple infarcts, which were distributed mainly throughout the 
periventricular white matter and the basal ganglia (Koto, Rosenberg, Zingesser et al, 1977). 
A mixed study of 7 patients with the clinical features of both idiopathic (2 cases) and 
secondary (5 cases) NPH, demonstrated marked microvascular involvement of the 
periventricular tissues (Akai, Uchigasaki, Tanaka et al, 1987). There was moderate to severe 
arteriosclerosis in both periventricular and deep white matter tissues.  Demyelination, similar to 
the ischaemic demyelination of SAE (Binswanger‘s disease) was present in all cases and 
microinfarction of the periventricular tissues was commonly found.  In addition, there was focal 
leptomeningeal fibrosis and a reduction in the arachnoid granulations, the structures responsible 
for re-absorption of CSF into the venous system.  One of these cases designated ―idiopathic‖, 
was young, had a significant history of alcohol abuse and psychiatric disease and may have been 
more appropriately considered chronic alcoholic encephalopathy.  There wasn‘t enough clinical 
data given to explore this.  He had a poor response to shunting and had the mildest white matter 
demyelination of the group.     
Interestingly, the subependymal tissue in all of these cases was associated with oedema 
and spongiosis.  The ependymal layer was thinned and focal disruption was evident.  There was 
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widespread demyelination within the periventricular white matter with sparing of the arcuate 
fibres.  Focal ballooning of myelin sheaths was seen and axonal loss was observed which was 
less marked than the demyelination.  Despite widespread demyelination there were few 
macrophages containing fat and myelin debris and astrocytic proliferation was limited.  This 
suggests that the demyelination is not primarily inflammatory in nature.  There was variable 
gliosis and in all but the 16-year-old case, the arteries and arterioles demonstrated marked 
intimal fibrosis and marked hyalinization of the media.  The veins also demonstrated marked 
fibrosis of the wall and perivascular spaces suggesting that vascular disease in this condition may 
be a combination of arterial and venous origin.  
2.2. Pathophysiological hypotheses 
The current understanding of mechanisms responsible for the symptoms in NPH is 
reviewed below.  Although the pathological mechanisms underlying NPH are not fully 
understood, changes in the perfusion of the periventricular white matter resulting from abnormal 
CSF hydrodynamics are thought to be important in the genesis of symptoms.  Indeed, one view is 
that a reversible form of ischaemia is the underlying haemodynamic contribution to the disease 
process (Bateman, 2000). Invasive lumbar infusion studies have demonstrated abnormal CSF 
hydrodynamic properties in these patients (Vanneste, 2000). In addition, whilst the ICP is normal 
during the day and hence at LP, invasive monitoring has shown those NPH patients have 
characteristic repeated, short-lived, nocturnal elevations of pressure, B-waves (Symon, Dorsch 
and Stephens, 1972. Crockard, Hanlon, Duda et al, 1977. Pickard, Teasdale, Matheson et al, 
1980). A further view is that the periventricular tissues are subject to toxic substances in the CSF 
which is forced into the white matter in the form of transependymal flow (Silverberg, 2004). 
These putative mechanisms are reviewed below. 
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2.2.1 CSF hydrodynamic factors and mechanical factors 
Hakim and Adams (1973) in their original description of NPH hypothesised that previous 
pathology was essential in causing an increase in ventricular pressure which in turn leads to 
ventricular dilatation. This theory states that ventricular pressure and dilatation eventually 
equilibrate to leave the chronic syndrome we know as secondary NPH.  This does not however 
explain the mechanism in idiopathic NPH.  Neither does this theory account for the continuing 
ventricular dilatation of untreated patients with clinical diagnoses of NPH.  The authors also 
invoked Pascal‘s Law in explaining the pathophysiology of their newly described condition.  
This law states ―the pressure applied to an enclosed fluid is transmitted undiminished to every 
portion of the fluid and to the walls of the containing vessel‖ (Hakim and Adams, 1965).   
Mathematically this is expressed as:  
Force = pressure x area. 
More explicitly, the force applied to the ventricular wall varies with ventricular area, so 
that patients with normal ventricular area and a normal range opening pressure of 18 cm of water 
will have a given force acting at their ventricular walls.  If the area is doubled the force required 
to keep CSF pressure at 18 cm of water will also have to double.  In other words, the pressure is 
not a good indicator of force actively compressing the periventricular tissues unless the area of 
the ventricle is known and the larger the ventricles the larger the forces active at any given 
opening pressure. Fig 2.1 shows the normal intracranial CSF pathways. 
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Fig: 2.1 Normal intracranial CSF pathways. (www.lifenph.com/about.asp. Webpage accessed on 
20.10.2007)  
An analysis of this ―total force‖ hypothesis, however, shows that it does not take into 
consideration the tensile properties of the wall of the container (Geschwind, 1968). This 
―container,‖ the brain (and its coverings), is complex and consists of vascular structures and 
other tissues and the tensile properties of the ventricular wall determine its behaviour in the face 
of changes in pressure.  Any theory regarding the pressure and differential volume changes in the 
ventricles needs to take into consideration the properties of the ventricular walls (Geschwind, 
1968). 
Other authors have proposed that the primary pathology in the CSF circulatory system is 
coeternal (Lying-Tunell, 1977) or supra-Sylvian (Kitagaki, Mori, Ishii et al, 1998) block to the 
outflow of CSF leading to a pressure gradient between the ventricle and the convexity or a 
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transmantle gradient (Conner, Foley, Black et al 1984). Supra- Sylvian block was inferred from 
Magnetic Resonance Imaging (MRI) analysis of the pattern of focal dilatations of sulci in 11 
patients with iNPH compared to 11 patients with AD.  No pressure measurements, however, 
were taken (Kitagaki, Mori, Ishii et al, 1998).  The transmantle gradient has only been 
demonstrated in 7 cats with kaolin induced hydrocephalus (Conner, Foley, Black et al 1984) and 
has not been replicated in humans.   
According to this line of thought the gradient between ventricle and convexity may be 
constant, with pressures within normal ranges, or intermittent (Geschwind, 1968) and leads to 
dilatation of the ventricles.  This then in turn causes stretching of neural or vascular structures 
and therefore symptoms.  Neural structures suggested include primary motor, supplementary 
motor, sensorimotor integration loops, ascending and descending pathways, extra pyramidal 
centres or autonomic centres.  The postulated effect may either be diffuse, affecting sensorimotor 
integration or via specific pathways such as the medial fibres of the corona radiata (Fisher, 1982. 
Hennerici, Oster, Cohen et al, 1994) which when damaged lead to the ―magnetic gait‖ 
disturbance seen in this and other conditions. Impaired input from sensorimotor, anterior 
cingulate and superior frontal cortex to the brainstem reticular formation may contribute to the 
impaired initiation and maintenance of gait and the stance disorder (Nutt, Marsden and 
Thompson. 1993), which characterises the gait in NPH.  Pressure on the deep grey matter 
structures, and the interconnections between the basal ganglia and the motor and supplementary 
motor areas have also been thought to result in the Parkinsonian features sometimes seen in this 
condition (Thompson and Marsden. 1987) Psychomotor retardation may be the result of pressure 
effects on the fibres of the frontal corona radiata; specifically, the longitudinal fibres of the 
superior frontal gyrus (Fisher, 1982) 
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Impaired ability to absorb CSF or increased resistance to CSF outflow (Rout) is likely to 
contribute to the pathophysiology of NPH.  In a study of 15 patients with NPH, 8 of who were 
considered idiopathic the Rout was measured using a constant flow and pressure lumbo-
ventricular study (Borgesen, Gjerris and Srensen, 1978).  Interestingly, the patients with an 
identifiable cause for their NPH tended to have higher resistance to outflow than the apparently 
idiopathic group.  This suggests that patients with secondary NPH are likely to have a primary 
difficulty with CSF re-absorption as a consequence of their original illness.  
An inability to clear potentially toxic metabolic products,
 
such as amyloid ß-peptides tau
 
protein, could lead to an increase in their concentration
 
in brain interstitial fluid, creating a 
potentially decrease neuronal function and survival.
 
In NPH and in normal ageing, there is 
evidence for both a decrease
 
in CSF production and an increase in the resistance to CSF 
absorption
 
(Czosnyka, Whitehouse, Smielewski et al., 1996, Silverberg, Huhn, Jaffe et al, 2002). 
Both events lead to a decrease in CSF
 
turnover and, in turn, a decreased clearance of amyloid ß-
peptides tau proteins is suggested by the higher than expected coincidence of Alzheimer‘s 
disease pathology in cortical biopsies taken from NPH patients
 
at the time of shunt implantation. 
From 30 to 50% of NPH patients
 will exhibit plaques and tangles consistent with Alzheimer‘s 
disease, and, in the severely demented NPH patients, 75% will
 show Alzheimer‘s disease 
(Silverberg, May, Saul et al, 2003).  In the Dutch NPH study, increased Rout correlated with a 
good outcome from shunting with a positive predictive value of 92% for patients with an Rout of 
greater than 18 mmHg/ml/minute (Boon, Tans, Delwel et al, 1997)  
The CSF circulatory system is subject to senescence (Rubenstein, 1998) and Rout is 
known to increase with age (Albeck, Skak, Nielsen et al 1998).  How Rout is related to 
ventricular dilatation and the genesis of symptoms in NPH is still not clear.  It is likely that these 
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senescent changes may be exaggerated in some patients with iNPH and contributes to both the 
increased Rout and to intermittently raised ICP.  Intermittent peaks of ICP commonly in the form 
of nocturnal B waves have been demonstrated in NPH (Symon, Dorsch, Stephens, 1972), but are 
also seen in normal physiology (Martin, 1978).  B-waves occur at 0.5 to 2 per minute and are of 
variable height from just discernible to 50 mmHg (Martin, 1978).  Frequent B waves predict a 
good outcome from shunting (Crockard, Hanlon, Duda et al, 1977. Pickard, Teasdale, Matheson 
et al, 1980. Symon, Dorsch, 1975). In one study 8 patients with NPH exhibited resting ICP of 
11.7+/-6.7 mmHg with ICP waves of 17.1+/-8.9mmHg 41.5% of the time studied (Crockard, 
Hanlon, Duda et al, 1977).  In another study of 26 patients with NPH, 8 of whom where 
idiopathic, the mean ICP in shunt responders was 12.5+/- 6mmHg and 7.5+/- 2mmHg in non-
responders (Pickard, Teasdale, Matheson, et al. 1980).  Other workers have found that good 
outcome was associated with other measurable changes in B-waves such as higher amplitude B 
waves.  This was demonstrated in a study of 23 shunted patients with iNPH in which the 
amplitude was greater than 9 mmHg (Raftopoulos, Deleval, Chaskis, 1994)   
Intermittent peaks of ICP may have a pathological effect by other means than dilatation.  
Pathological activity may also be mediated through pulse waves or the water-hammer effects 
(Bering, 1955. Bering, 1962).  This was first identified as a possible mechanism by Bering who 
noted asymmetric ventricular dilatation following unilateral choroid plexotomy in an 
experimental model (Bering, 1955).  The contralateral lateral ventricle dilated to a larger extent 
than the ipsilateral lateral ventricle when hydrocephalus was induced by kaolin injection.  In 
addition, the systolic wave of ICP, which is a consequence of the systolic wave of blood entering 
the brain, may be responsible for ventricular dilatation by producing endoventricular pressure 
pulses (Di Rocco, 1984).  In a series of experiments on lambs, Di Rocco demonstrated the effect 
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of endoventricular CSF pressure pulses on ventricular dilatation.  One group of animals were 
subject to intermittent peaks of CSF pressure mediated by a unilateral intraventricular balloon in 
one of the lateral ventricles.  The peaks were timed with the systolic pulse and 2-hour periods of 
this intervention on alternate days up to a maximum of 26 hours were delivered.  Ventricular 
dilatation occurred rapidly and the histological changes of the ependyma and periventricular 
tissues included denuding of the ependymal layer with pallor of the periventricular tissues 
associated with demyelination (Di Rocco, 1984).  These findings are similar to those found in 
patients with NPH.  It remains unclear, however, which feature of ICP is the crucial pathological 
factor and ICP monitoring is invasive and requires expertise.  These problems of interpretation 
and data ascertainment unfortunately confine this technique to being a research tool for the time 
being. 
Hakim and Adams (1973) described this syndrome after observing a clinical 
improvement after removal of CSF.  A positive ―tap test‖ is where 20 to 30 mls of CSF removed 
at lumbar puncture is associated with a rapid improvement of gait and or mentation within 
minutes to hours.  A positive tap test suggests that recovery occurs due to mechanical release 
from pathology such as a release of hydrostatic pressure on stretched axons post procedure and 
therefore supports a stretching hypothesis associated with ballooning of the ventricles.  It is not 
clear, however, how pressure effects or stretching of neural pathways causes dysfunction of 
neural transmission which is as rapidly reversible as is suggested by the marked improvement in 
function patients can get with the tap test.  If stretching or pressure on neural pathways was the 
operative mechanism in NPH a correlation between ventricular size and disability would be 
expected and recovery post shunting would correlate with reduction in ventricular volume.  In 
fact neither the first nor the second condition is consistently observed.  If stretching is an 
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important mechanism how can the striking phenomenon of asymptomatic ventriculomegaly be 
explained?  In a study of 45 patients with iNPH ventricular size did not correlate with response 
(Petersen, Mokri, Laws, et al, 1985).  
Intriguingly, the tap test procedure is associated with a high false negative rate (Vanneste, 
1994) and a different mechanism must account for symptoms in patients with negative tap tests 
that respond to shunting, such as remyelination.  An alternative explanation of the positive tap 
test is that ventricular dilatation may have an impact on the periventricular microcirculation.  If it 
is assumed that disruption of association pathways in the periventricular tissues is at the core of 
the pathology in NPH, it is probably not a co-incidence that white matter autoregulation of blood 
flow is significantly less efficient than that in grey matter (Symon, Pasztor, Dorsch et al, 1973) 
and that the anterior and posterior periventricular tissues occupy an arterial watershed area (De 
Reuck, 1971. Howard, Trend, Russell et al, 1987. Bladin and Chambers, 1993), a venous 
watershed (Andeweg, 1996) and an area of increased biomechanical stress in an expanding 
ventricle (Pena, Bolton, Whitehouse et al, 1999).  
2.2.2 Cerebrovascular factors 
 
2.2.2.1 Arterial considerations 
 
Cerebrovascular effects are thought to contribute to the clinical picture in iNPH.  
Proposed mechanisms include reversible ischaemia due to stretching of the anterior and or 
middle cerebral arteries, compression of vascular beds and to reduced cerebral blood flow and 
volumes (Greitz , Grepe , Kalmer et al, 1969. Mathew, Meyer, Hartmann et al, 1975. Ingvar, 
Risberg, Schwartz et al, 1975) and impaired autoregulation.  Patients with NPH have been shown 
to have more cardiovascular risk factors than age matched controls (Graff-Radford and 
53 
 
Godersky, 1987. Casmiro, D'Alessandro, Cacciatore et al, 1989. Krauss, Rege, Vach et al 1996). 
In one-study 14/19 (74%) patients with iNPH had systemic hypertension while 10 of the 14 
shunt responders had systemic hypertension (Graff-Radford and Godersky, 1987).  The best 
estimate of prevalence of hypertension, both treated and untreated for this age group in the USA 
was quoted at 35% for men and 34% for women aged 60 to 69 (Graff-Radford and Godersky, 
1987). In another study 17 patients with iNPH were compared with age and sex matched controls 
(Casmiro, D'Alessandro, Cacciatore et al, 1989).  In this study an odds ratio of 3.14 was 
calculated for hypertension in this condition and 4.2, and 6.0 for ischaemic heart disease and 
diabetes respectively.  In another study of 65 patients with iNPH a highly significant association 
with arterial hypertension was demonstrated with 83% of patients with iNPH suffering 
hypertension compared to 36% of controls (Krauss, Regel, Vach, et al 1996). Diabetes was also 
significantly associated with iNPH and was present in 49% of patients and 29% of controls. 
Evidence of reduced blood flow in different regions of the brain in patients with NPH has 
been demonstrated using single photon emission computed tomography (SPECT) (Mathew NT, 
Meyer JS, Hartmann, et al, 1975. Graff-Radford, Rezai, Godersky, et al 1987. Vorstrup, 
Christensen, Gjerris, et al 1987. Kimura, Tanaka, Yoshinaga et al, 1992. Waldemar, Schmidt, 
Delecluse, et al 1993. Larsson, Bergh, Bilting, et al, 1994. Kristensen, Malmo, Fagerland, et al, 
1996. Tanaka, Kimura, Nakayama et al, 1997). Fifteen patients with idiopathic (Vanneste, 
Augustijin, Dirven, et al 1992) and secondary (Gustafson and Hagberg. 1978) NPH had regional 
cerebral blood flow and regional cerebral blood volume measurements performed before and 
after CSF pressure was lowered at lumbar puncture (Mathew, Meyer, Hartmann et al, 1975).  
Maximal reductions in these haemodynamic variables was in the territory of the anterior cerebral 
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artery and CSF pressure reduction at lumbar puncture lead to a significant rise in these variables 
in contrast to a non hydrocephalic demented control group.   
Using a tomographic technique regional cerebral blood flow (rCBF) was measured in 22 
patients with NPH (Graff-Radford, Rezai, Godersky, et al 1987).  Pre-operative reductions in 
rCBF were most prominent in anterior regions and improved at 2 months post operatively.  It 
was not clear from this study how many patients were idiopathic and how many secondary.  An 
anterior to posterior ratio of blood flow (1.05) was used to correctly distinguish between good 
and poor outcome groups with the good outcome ratio being less than 1.05.  Interestingly the 
improvement in rCBF was not sustained at 6 months.   
In a further study of rCBF in a mixed group of 17 patients with NPH (14 idiopathic) a 
central low flow area was described which significantly reduced on shunting in 6 patients 
(Vorstrup, Christensen, Gjerris, et al 1987).  All six of these patients improved clinically.  A 
quantitative three-dimensional technique using xenon-enhanced computed tomography was 
applied to seven patients with NPH secondary to subarachnoid haemorrhage (Kimura, Tanaka, 
Yoshinaga, 1992).  Thalamic and frontal subcortex regions demonstrated the greatest reduction 
in rCBF (47.3% and 39.1% vs control) pre-operatively and shunting lead to recovery of rCBF 
most impressively in the frontal subcortex (95.7% of control values).  The improvement in rCBF 
correlated with reduction in ventricular size, resolution of periventricular lucency and clinical 
improvement.   
Subsequent studies using different techniques confirmed a sub-cortical low flow region 
(Waldemar, Schmidt, Delecluse, et al. 1993) or reduced frontal white matter rCBF (Larsson, 
Bergh, Bilting et al, 1994) pre-operatively which recovered after shunting.  In another study of 
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31 individuals with iNPH a significant reduction in subcortical white matter rCBF was 
demonstrated with SPECT (Kristensen, Malm, Fagerland et al, 1996), similar to that 
demonstrated by the Cambridge group in 2004. They showed maximal decrease in the 
ventricular
 
wall, with an increase in cerebral blood flow (CBF) as one moves laterally. Among
 
subjects with NPH, a more profound decrease in CBF followed the
 
induction of increased CSF 
pressure, in a U-shaped distribution, with the CBF shifting laterally from the ventricle by 
approximately 9 mm and normalizes as it moves toward the
 
cortex. Cerebral vascular 
autoregulation was also impaired among these subjects, suggesting less capacity to compensate 
for
 
increases in CSF pressure (Momjian, Owler, Czosnyka et al, 2004). If reduced cerebral blood 
flow was the only determinant in the disease process a correlation between severity of flow 
deficit and symptoms would be expected.  No such correlation has been demonstrated to date and 
attempts to use these techniques to predict outcome from surgery, have met with mixed success 
(Owler, Pickard, 2001).  This is probably because, although subcortical low flow regions are 
common in NPH and potentially important in the disease process, there is no straightforward link 
between low blood flow and clinical deterioration (Mamo, Meric, Ponsin et al, 1987). An 
additional consideration is that low CBF may be secondary to a primary metabolic impairment as 
has been the interpretation of results in positron emission tomography (PET) studies in 
Alzheimer‘s disease.  SPECT techniques have demonstrated focal reductions in rCBF in the 
posterior parietal and contiguous temporal and occipital regions in patients with Alzheimer‘s 
disease (Talbot, Lloyd, Snowden et al, 1998).   
PET studies investigating the rCBF in patients with NPH (Brooks, Beaney, Powell et al, 
1986. Klinge, Berding, Brinker et al, 1999) have demonstrated global white matter oligaemia 
pre-operatively.  One PET study found appropriate levels of oxygen extraction for the reduced 
56 
 
cortical blood flow in chronic hydrocephalus (Brooks, Beaney, Powell et al, 1986). This 
contrasted with the acute hydrocephalus group in which the reduced blood flow was 
accompanied by an elevated oxygen extraction value.  This suggested that the acute 
hydrocephalus group was compensating for the oligaemia whilst the chronic group was not able 
or did not need to compensate for oligaemia by increasing oxygen extraction.  Another study 
demonstrated a marked reduction in the white matter rCBF (40 ml/100ml/minute) in a group of 
10 patients with chronic hydrocephalus compared to 10 controls (61 ml/100ml/minute) (Klinge, 
Berding, Brinker et al, 1999).  The control group, however, in this study was much younger than 
the patient group (25 vs 67 yrs respectively). 
If low rCBF is not solely responsible for the clinical deterioration then reduced 
autoregulation may be partly responsible for the symptoms.  Autoregulation is the maintenance 
of rCBF despite variation in systemic arterial blood pressure between 50 and 150 mmHg 
provided the carbon dioxide (CO2) tension is normal (Strandgaard, Olesen, Skinhoj et al, 1973). 
Evidence for impaired autoregulation is provided by a number of studies which measured rCBF 
pre- and post- tap test (TT) (Mathew, Meyer, Hartmann et al, 1975. Mamo, Meric, Ponsin et al, 
1987. Meyer, Tachibana, Hardenberg et al, 1984) or shunting (Graff-Radford, Rezai, Godersky 
et al, 1987. Vorstrup, Christensen, Gjerris et al, 1987. Kimura, Tanaka, Yoshinaga, 1992. 
Waldemar, Schmidt, Delecluse, et al. 1993. Larsson, Bergh, Bilting et al, 1994. Tanaka, Kimura, 
Nakayama et al, 1997) and found an increase in rCBF after CSF diversion.  Only two studies 
failed to show changes in CBF post-TT (Kristensen, Malm, Fagerland et al, 1996. Kushner, 
Younkin, Weinberger et al, 1984). Both rCBF and rCBV increased after tap testing.  Xenon 
inhalation was then used to demonstrate an increase in blood flow in frontal and temporal grey 
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matter in 11 patients with NPH following CSF pressure reduction at lumbar puncture (Meyer, 
Tachibana, Hardenberg, et al. 1984 
In a further 25 patients with NPH (18 idiopathic) intravenous Xenon and gamma camera 
were used to demonstrate an improvement in hemispheric blood flow 3 hours after removal of 20 
to 30 mls of CSF at lumbar puncture (Mamo, Meric, Ponsin et al, 1987).  This contrasted with 
findings from a group of ―control‖ patients with senile and ―pre-senile‖ dementia who underwent 
blood flow measurement before and after CSF removal and in whom the hemispheric blood flow 
reduced or remained unchanged.   
There was a positive correlation between reduction in ventricular size and increase in 
blood flow in a study but changes in blood flow did not correlate with changes in function 
(Vorstrup, Christensen, Gjerris et al, 1987).  
Klinge, Berding, Brinker, et al. 1999 demonstrated in a PET study of patients pre and 
post-operatively where the patients who responded to shunting also improved their 
cerebrovascular reserve to 52% at 7 days. There was no difference in cerebrovascular reserve 
between good and poor outcome groups prior to surgery and the poor outcome group was 
characterized by a post-operative reduction in cerebrovascular reserve.   
Much of the discrepancy between studies can be accounted for by heterogeneous group 
selection, differing techniques and poor white matter resolution.  The techniques discussed above 
are biased by, if not wholly dependent on, cortical signal.  It is also worth bearing in mind that 
various essential neuronal functions are tightly coupled to thresholds of cerebral blood flow 
(Astrup. 1982) and that patients with iNPH may have impaired autoregulation and white matter 
circulation.  This may make patients with iNPH more susceptible to abnormal ICP fluctuations 
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which may have an exaggerated impact on the already oligaemic white matter microcirculation 
resulting in intermittent ischaemia.  This dual pathology model may provide the extra element 
required to explain the paradox that the white matter is oligaemic in iNPH but the level of 
oligaemia is not predictive of outcome from surgery.  If there is obligate marginal perfusion in 
the background of iNPH other active processes may be required to embarrass perfusion to 
ischaemic levels such as abnormal ICP peaks and/or CSF absorption.  These processes could 
theoretically be independently or collectively active in each case of NPH.   
2.2.2.2. Venous hypotheses 
The periventricular tissues are supplied by long medullary arteries and drained 
exclusively by the deep venous systems, which terminate in the straight sinus.   The centrum 
semiovale occupies an area within the venous watershed, which has been demonstrated between 
the territories of the deep and the superficial venous systems (Andeweg, 1999). The importance 
of this venous watershed is that there are no anastamoses between deep and superficial systems 
and that differential involvement of each system may play a part in the pathophysiology of 
different conditions ranging from NPH and Alzheimer‘s disease to benign intracranial 
hypertension (Bateman, 2003). It has been argued that as a consequence of the watershed area 
differential effects on the compliance of each system can result in intraparenchymal pressure 
gradients leading to ventricular enlargement in NPH and ventricular compression in benign 
intracranial pressure (Bateman, 2003).  A reduction in vascular compliance in the superficial 
venous system in 10 patients with NPH (Bateman, 2000) has been demonstrated using magnetic 
resonance flow quantification of the cerebral vessels.  This impaired superficial compliance, a 
consequence of CSF pulsation on subarachnoid veins, leads to increased resistance to venous 
flow and therefore pressure in these vessels.  This in turn would lead to increased capillary 
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pressures and therefore production of interstitial fluid which would communicate with the CSF 
via the perivascular spaces.  Bulk flow would transport CSF and therefore isotope in scintigraphy 
studies from the vertex to the ventricles where the compliance of the deep system remained 
normal.  Because there is little interaction between CSF and venous outflow at the vein of Galen 
the pressure in the deep system is invariably lower than CSF pressure.  This leads to a 
transependymal pressure gradient and ventricular enlargement.  This neatly explains the 
commonly observed discrepancy between cortical and ventricular dilatation in NPH.   
2.2.3. Metabolic dysfunction in hydrocephalus 
Haemodynamic compromise may be expected to result in metabolic disruption.  
Ischaemia results in mitochondrial dysfunction and cellular damage and repair may result in 
lasting metabolic changes.  This area has not been studied in patients with iNPH to any great 
extent.  Most of the work that has been done on hydrocephalus has been done in acute 
hydrocephalus, in children, and animal models of acute hydrocephalus.  This is now reviewed. 
The main issues studied in animal models of acute hydrocephalus with magnetic 
resonance spectroscopy techniques concern changes in metabolite levels as a consequence of 
ischaemic processes or osmolyte compensatory change.  A comprehensive biochemical and 
physiological study used cats, rabbits and rats rendered hydrocephalic using kaolin injections 
(Higashi, Asahisa, Ueda et al, 1986).  In the acute and chronic (6-8 weeks) stages rCBF was 
globally reduced whilst CO2 reactivity of CBF was reduced only in the acute stages.  Water 
content of the periventricular tissues increased in the acute phase only and lactate was 
temporarily detected in the frontal tissues during the acute phase of the experiment.  Adenosine 
triphosphate (ATP) was reduced in all tissues in the acute phase.  There was recovery to pre-
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hydrocephalic levels and then another reduction in ATP levels in the chronic phase.  In addition 
cholesterol levels dipped after the acute phase and remained reduced in animals with the most 
severe hydrocephalus.  Catecholamine and monoamine metabolites were significantly increased 
in the chronic phase of the experiment in all tissues.  This change in neurotransmitter metabolites 
was attributed to an unexplained effect of hydrocephalus on the function of the major 
neurotransmitter pathways in this condition. 
Anaerobic glycolysis has been demonstrated in deep white matter in an acute model 
using an autoradiographic method in kittens (Chumas, Drake, Del Bigio et al, 1994).  Glucose 
utilization in the cortical grey matter regions remained unaffected.  These findings have been 
replicated and refined by further studies using magnetic resonance spectroscopy techniques.  
Phosphorus spectroscopy in a neonatal model of acute hydrocephalus confirmed the importance 
of acute ischaemic processes by demonstrating a reduced whole brain PCr/Pi and an increased 
Pi/ATP ratio (de Silva, Drake, Lemaire et al, 1994). These changes in high energy phosphate 
metabolites are characteristic of acute ischaemia.  There were no significant changes in 
intracellular pH either at one or three weeks post induction of hydrocephalus.  This was 
explained as indicating post-ischaemic metabolic change as opposed to acute ischaemia.  The 
same group used an autoradiographic method to document reduced periventricular rCBF and 
recovery with shunting using the same model (de Silva, Michowicz, Drake et al. 1995). This 
confirms the importance of the periventricular tissues as a site of active pathology in 
hydrocephalic processes.  Another study using both proton and phosphorus spectroscopy in a 
similar model found that lactate accumulated in whole brain and the PCr/Pi ratio was reduced 
acutely (Braun, Dijkhuizen, de Graaf et al, 1997).   Quantitative in-vitro spectroscopy studies 
using an inherited infantile hydrocephalus model in rats has confirmed and extended the 
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understanding of the effects of acute hydrocephalus on the developing brain.  Both high energy 
phosphorus and membrane phospholipid metabolites were reduced in acute hydrocephalus.  
Shunting early led to recovery of the energy metabolites (Harris, Plant, Briggs et al, 1996). 
Similarly, in vitro proton spectroscopy in the same model demonstrated a marked reduction in 
creatine (Cr), N-acetyl Aspartate (NAA) and choline (Cho) amongst other compounds consistent 
with neuronal atrophy rather than acute ischaemia (Harris, Plant, Inglis et al, 1997). Early 
shunting resulted in maintenance of the concentration of these compounds whereas a delay led to 
persistent reductions of NAA indicating a loss of neurons.   
A role for ischaemia in humans with NPH is further supported by a phosphorus 
spectroscopy study, which demonstrated metabolic dysfunction resulting in acidic periventricular 
tissues (Arnold, Shoubridge, and Villemure, 1988).  Similar findings were seen in a mixed group 
of 5 patients with obstructive and communicating hydrocephalus.  The acidic tissues reverted to 
normal after shunting in the two cases (both obstructive cases) studied post–shunting (Brooke, 
Ouwerkerk, Adams et al, 1992).   
A PET study investigated rCBF and oxygen extraction in patients with hydrocephalus 
(Brooks, Beaney, Powell et al, 1986).  A small number of chronic idiopathic hydrocephalic 
patients were studied and the baseline measurements were not significantly different from the 
control group and there was no change with surgery.  The acute hydrocephalic group, on the 
other hand, had inappropriately high oxygen extraction values for the reduction in CBF and this 
improved with shunting.  This is consistent with acute ischaemic process being active in the 
acute rather than chronic hydrocephalus. 
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CSF metabolites have also been studied in NPH.  Glial fibrillary acidic protein (GFAP) a 
marker of astrogliosis and neurofilament triplet protein (NFL) a marker of axonal damage, were 
found to be elevated in 65 (1/3 of whom were idiopathic) patients with NPH (Tullberg, 
Rosengren, Blomsterwall, et al. 1998).  There was a correlation between NFL, a structural 
component of neurons and a biochemical marker of neurodegeneration, and symptom severity.  
In addition, high CSF NFL concentrations were associated with high levels of gait and 
psychometric impairment, urinary incontinence and good outcome from surgery.  The same 
group was able to distinguish 43 patients (49% idiopathic) with NPH from 19 patients with 
subcortical arteriosclerotic encephalopathy (SAE) by using a marker of demyelination 
glycosphingolipid (sulfatide) (Tullberg, Mansson, Fredman et al, 2000).  Sulfatide was found to 
be 6 times higher than control in patients with SAE and normal range in patients with NPH 
suggesting that the pathological substrate of SAE is demyelination and axonal degeneration in 
NPH.  In this study, however, the NPH patients were a mixed group with both secondary and 
idiopathic patients represented and it is not clear whether ischaemic demyelination is more 
important in either the idiopathic group than the secondary group.  The histopathology data, 
however, suggests that ischaemic demyelination plays a prominent role in the pathological 
process in iNPH. 
A further study of 14 patients (13 idiopathic) with NPH investigated the changes in CSF 
levels of somatostatin (SOM), neuropeptide Y (NPY), and corticotrophin releasing factor (CRF) 
after surgery from pre-operative levels (Poca, Mataro, Sahuquillo et al, 2001). SOM is a 
neuropeptide found in cortical neurons and hypothalamic neurons, which have been shown, the 
author‘s state, to be selectively damaged in hydrocephalus and NPY and CRF are also 
neuropeptides associated with enhanced cognitive performance.  All three of these metabolites 
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were elevated post-operatively in all patients.  This was interpreted as restoration of metabolite 
levels in the CSF to pre-morbid levels as previous studies had demonstrated reduced levels of 
these metabolites in NPH.  There was no change in cognitive function, however, to parallel the 
restoration of neuropeptide levels.  The use of CSF metabolites to unravel the pathophysiology 
of NPH therefore remains uncertain. 
2.2.4 White matter hyperintensities and transependymal flow  
 
White matter hyperintensities (WMH) are areas of high signal change on T2 weighted 
MRI sequences.  They are common in the periventricular regions in NPH, in the normal elderly 
and in Subcortical Arteriosclerotic Encephalopathy (Bradley, Whittemore, Watanabe et al 1999).  
Leucoariosis is a term, which describes radiolucent areas of white matter on CT.  It is a term 
used interchangeably with WMH on magnetic resonance scanning.  WMHs have been 
demonstrated in about 25% of subjects over 65 years of age in a sample of 111 subjects from a 
large population based study (Breteler, van Swieten, Bots et al, 1994).  WMHs are a recognised 
association of hypertension where the cerebral vessels are found to have hyaline changes in their 
walls (Pantoni and Garcia, 1997).  The histopathological correlates of asymptomatic WMH on 
T2 weighted images are non-specific and include vascular ectasis, arteriosclerosis, dilated 
perivascular spaces, demyelination, hyalinosis, and small infarctions.   
Asymptomatic WMH (asymptomatic leucoariosis) are more common in subjects with 
cerebrovascular risk factors and abnormal microvascular function is thought to contribute to the 
genesis of these features on MRI (Meguro, Hatazawa, Yamaguchi et al, 1990).   
In iNPH WMH in the periventricular tissues are more common than would be expected 
for age (Krauss, Regel, Vach et al, 1997).  WMH have been credited with a pathogenic role in 
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this NPH (Bradley, Whittemore, Watanabe et al, 1999). In this study deep white matter 
hyperintensities were found in 58% of patients with iNPH compared to 24% in the control group.  
It was proposed that deep WMH result from ischaemic damage, which reduces the tensile 
strength of the brain parenchyma thereby setting up a hydrodynamic cycle, which results in 
ventriculomegaly. This contrasts with the negative correlation between ventricular dilatation and 
severity of WMH demonstrated above (Krauss, Regel, Vach et al, 1997).  It has been suggested 
that WMH at the horns of the ventricles that are commonly seen in patients with NPH may be an 
indication of ischaemic damage but that the relationship between vascular disease and NPH is 
non-causal (Krauss, Regel, Vach et al, 1997).   
WMH have been associated with a good response to shunting in some studies (Borgesen, 
Gjerris. 1982. Jack, Mokri, Laws, et al, 1987).  In a large early study 80 patients with NPH (40 
idiopathic) 16 patients had periventricular lucencies on CT.  All of these 16 patients improved 
post shunting (Borgesen and Gjerris, 1982).  In a further study designed to determine MR signs 
to distinguish between different dementia diagnoses 17 patients with NPH, 8 patients with 
obstructive hydrocephalus 8 patients with Alzheimer‘s disease and 21 with non-Alzheimer‘s 
dementia were studied (Jack, Jr., Mokri, Laws, et al, 1987).  There were no distinguishing 
features between the categories of dementia.  In addition, patients with more marked 
periventricular hyperintensity and less marked white matter hyperintensities tended to have a 
good outcome from shunting, confirming the importance of topographical location of WMH.   
Another study confirmed that the presence of moderate to severe white matter lucencies 
on CT was associated with poorer surgical outcome (Boon, Tans, Delwel et al, 1999). A final 
study used a more sophisticated semi quantitative scale which incorporated size and shape to 
quantify the extent of WMH in 34 patients with NPH (Tullberg, Jensen, Ekholm et al, 2001), 13 
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of whom had iNPH.  WMH extent did not correlate with outcome, but clinical improvement had 
a positive correlation with reduction in the periventricular hyperintensities post-operatively.  In 
addition, only the irregular periventricular hyperintensities at the frontal horns of the ventricles 
reduced post-operatively.  In practice, extensive WMH on imaging is associated with worse 
surgical outcomes but in itself should not be used as an absolute contraindication to surgery 
(Krauss, Droste, Vach, et al. 1996. Tullberg, Jensen, Ekholm et al, 2001).   
An alternative explanation that warrants consideration is that in NPH WMH may 
represent increased transependymal flow (Weller and Mitchell 1980. Sato, Ohya, Nojiri et al, 
1984. Tamaki, Shirakuni, Ehara et al, 1990).  This undoubtedly occurs in animal models of acute 
hydrocephalus but has not been demonstrated to be the main cause in the elderly patients with 
normal range CSF pressures.  If this was the primary mechanism, one might expect there to be a 
positive correlation with good outcome from shunting and resolution of WMH on shunting.  This 
has not been demonstrated (Tullberg, Jensen, Ekholm et al, 2001).  If WMH represented 
infarcted white matter or irreversible periventricular damage, on the other hand, the outcome 
would be expected to be less good the more infarcted tissue there was.  In keeping with this 
hypothesis there is, as mentioned above in fact, a negative correlation between severity of WMH 
and outcome (Krauss, Droste, Vach et al, 1996).  Patients with iNPH who had more extensive 
periventricular WMH had poorer outcomes than those with smaller volumes of WMH, although 
some patients with significant WMH volumes who were operated on also had good outcomes 
from surgery (Krauss, Droste, Vach et al, 1996 Tullberg, Jensen, Ekholm et al, 2001).   
The histopathological correlates of asymptomatic WMH on T2 weighted images are non-
specific and include vascular ectasis, arteriosclerosis, dilated perivascular spaces, demyelination, 
hyalinosis, and small infarctions.  This suggests that T2 weighted WMH in NPH reflect a 
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spectrum of disease ranging from reversible to irreversible which may therefore result from a 
spectrum ranging from microvascular disease to frank infraction.   
2.3 Summary  
The various hypothesis mentioned in this chapter explains the multifactorial complex 
nature of the disease. Understanding the natural history has helped us to identify factors that are 
more specific to NPH. Although various pathologies may co-exist identifying those symptoms 
that are treatable is essential. In the last 4 decades researchers have helped to identify specific 
tests that may differentiate the various pathologies that may be involved in the disease 
presentation. These tests are based on differentiating NPH from other conditions that mimic this 
group of patients. In the following chapter the aims and methods of trying to identify those 
patients who are more likely to suffer from NPH and may respond to shunt surgery is explained.  
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Chapter 3: Aims and Methods  
 
3.1. Introduction 
Despite the advances and our understanding of NPH identifying those who may respond 
to a shunt in a clinical setting is challenging because of the nature of presentation. Prognostic 
value of CT or MRI on their own is limited and other supplemental tests are necessary to 
increase the prognostic accuracy of identifying those who may respond to a shunt. Improvement 
in neuropsychological gait and urinary symptoms following drainage of fixed volume ―tap test‖ 
or continuous volume of CSF ―external lumbar drain‖ (ELD) can be one method of predicting a 
quick response. The methods used by researchers in differentiating and identifying those who 
would benefit from surgery can be complex. There is a large battery of tests available in the 
literature, all used for differentiating NPH from other conditions and also identifying the shunt 
responders. Some of these methods need specialist expertise and there are large costs involved. 
In this study a protocol has been derived from the literature that can be used in a clinical setting 
that is cost effective, simple and reproducible. The aims of this study are outlined in this section 
followed by an explanation of the methods chosen to investigate. There are several other aspects 
of NPH, which were also examined. 
3.2. Aims of Study 
The aims of this study are listed below; each of these aims will be discussed in the 
relevant sections in the results and discussion chapters.   
1. To compare the demographic and clinical characteristics of patients who are selected for 
shunting with those who are not. This may provide clearer criteria to distinguish patients 
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suffering from NPH from those who may be suffering from other disorders from their 
presentation. 
2. To evaluate the usefulness of the CT scan in identifying and preventing complications and 
predicting outcome at 1 year between the shunted and the non-shunted patients.  
3. To evaluate the baseline values of the screening, neuropsychological and gait tests at 
presentation to determine whether there were any significant differences between the 
shunted and the non-shunted patients.  
4. To evaluate the usefulness of Rcsf value as a criteria for shunting and analyse the outcome 
of the shunted patients. 
5. To determine whether the effects of external lumbar drain (ELD) on supplemental 
neuropsychological and gait tests in addition to urinary symptoms would identify those 
patients who would benefit from a shunt, and to determine if there was any correlation 
between the tests used to select patients for shunting at 1 year. 
6. To examine the effects of shunting to determine whether the symptoms of NPH improve 
following surgery. Where possible, a control group (those not receiving a shunt) were 
reassessed after the same time period to determine which factors alter over time. 
7. To compare the selection criteria including ELD, Rcsf values and outcome of the shunted 
patients who have responded well to surgery, with those who show little or no 
improvement. Within group analysis may assist in developing criteria, in the future, to 
select patients who are most likely to benefit from surgery. 
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8. To investigate if the neuropsychological and gait tests are able to predict surgical success or 
failure. 
9. To identify the complications occurring from external lumbar drain, shunt and use of 
anticoagulants. 
10. To identify the value of using the programmable shunts. 
3.3. Protocol 
In this section a review of the inclusion and exclusion criteria for those patients referred 
with a clinical and radiological suspicion of NPH is discussed. The management protocol used to 
investigate those who may benefit from a shunt operation is discussed.  
3.3.1. Eligibility criteria 
3.3.1.1. Inclusion criteria 
 
1. Clinical symptoms of Normal Pressure Hydrocephalus – Dementia, incontinence, gait 
and other disturbance. 
2. Radiological evidence of communicating hydrocephalus (CT or MRI).  
3. Both iNPH and sNPH patients were included. 
Patients with suspected NPH were admitted to the ward for evaluation accompanied by a 
family member or carer. They were sent an information leaflet (Appendix 1) giving an overview 
of what to expect during their stay in hospital. A covering letter was sent emphasising the 
presence of a family member where possible to provide a detailed history of the patient‘s 
symptoms. Patients and their relatives were involved in all decision making. Detailed discussion 
regarding the nature of their condition, difficulty with diagnosis, investigations, risks and 
benefits of shunt insertion were discussed. After obtaining a detailed history and completing a 
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physical examination, CT or MR imaging was reviewed with a radiologist. When there was a 
suspicion of a co-existing diagnosis the patient was referred to a specialist for an opinion or for 
further investigation. Those patients who were excluded from the study were further investigated 
as appropriate or referred to other specialists before reconsidering them. At this point some of the 
patients were excluded from the study. 
3.3.1.2. Exclusion criteria 
 
1. Severe co-morbid factors or contra indications for shunt surgery.  
2. Refusal to undergo investigation or surgery for any reason at the first consultation.  
3. Reduced life expectancy (malignancy or debilitating disease). 
4. Another identifiable cause, other than NPH for their symptoms.  
3.3.2. Study design 
Following a detail history of the patient‘s complaints and presentation they underwent a 
battery of neuropsychological and gait tests as listed in Table 3.1.  
Table 3.1: Neuropsychological and gait tests used in the study. 
Neuropsychological tests Gait tests 
Beck depression index (BDI) 10 metre walking time  
National adult reading test (NART) 10 metre walking steps 
Mini mental scoring examination (MMSE) 360 turn time 
Verbal fluency –FAS and animal 360 turn steps 
Clock drawing  
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CANTAB Test  
A senior physiotherapist in the neurosurgery department conducted the gait assessment. 
The time taken and number of steps taken to walk 10 metre (aided or unaided) and a 360-degree 
turn were recorded. If patients were on anticoagulants they were stopped before a lumbar 
puncture was performed. Informed consent was obtained from all patients and risk explained. 
Subsequently, all patients underwent a lumbar puncture to measure the opening CSF pressure 
and a constant infusion flow study was performed to calculate the resistance to CSF (Rcsf) as 
discussed in section 3.7.3. Following this procedure, an external lumbar drain (ELD) was 
inserted for 2 days and 100mls of CSF removed every 24hours. Neuropsychological tests and 
gait assessments were repeated and subjective improvement in their urinary symptoms was 
noted. After the results were compiled, specific criteria were used to recommend a shunt 
operation and further discussion with the patient and family was done, explained in chapter 3.3.3. 
A flow chart summarising this methodology is shown in figure 3.1.   
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Figure 3.1. Flow chart of the study protocol. 
                                                    Clinical signs and symptoms of NPH 
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 Yes 
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               Lumbar drain (100mls / 24hrs x 2 days) 
 
 
 
Repeat of tests 
   
 
 
 
 
 
 
Recommendation for shunt if 
     2 or more of the criteria met. 
 
 
 
 
 
 
 
 
 
 
 
 
Investigate as 
appropriate or 
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1. Neuropsychological 
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2. Gait assessment 
3. Urinary symptoms  
 
1. Neuropsychological 
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2. Gait assessment 
3. Urinary symptoms 
 
1. Improvement in Neuropsychological test  
2. Improvement in Gait  
3. Improvement in urinary symptoms 
4. Rcsf > 12 mmHg/ml/min 
 
 
 
5.  
Follow-up 
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3.3.3 Treatment selection criteria 
Following the ELD the following results in patients were noted: 
1. Rcsf value.  
2. Scores of various neuropsychological tests following ELD.   
3. Scores of various gait tests following ELD. 
4. Subjective reporting of improvement in urinary symptoms by patient, carer, relatives or 
nursing staff following ELD.  
The raw scores were used to calculate if patients improved, did not improve or worsened 
with each neuropsychological or gait test. Subjective statements were used to categorise the 
urinary symptoms. In the literature there was no clear indicator to classify the improvement 
scores. This may be due to the fact that this may be arbitrary. The values taken in this study to 
define improvement, no improvement and worsening was derived from studies related to 
dementia of AD (Han, Cole, Bellavance et al. 2000, O'Connor, Pollitt, Hyde et al, 1989, Spreen 
and Strauss. 1998) and NPH patients (Iddon, Pickard, Cross et al, 1999). The outcome scores in 
the gait tests were derived from studies with NPH patients (Boon, Tans, Delwel et al, 1997, 
Stolze, Kuhtz-Buschbeck, Drucke, et al, 2000) stroke patients (Wade, 1987) and traumatic brain 
injury patients (Watson, 2002). There was no consensus in the literature on the level of Rcsf 
above which patients should undergo shunt insertion. Because of these uncertainties 12 
mmHg/ml/min was used as a positive predictor for shunt insertion. This is detailed in chapter 
3.7.3.1. Table 3.2 shows how the outcomes following ELD were defined. 
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Table 3.2: Interpretation of the scores for all the tests 
Test Measure Improvement No 
Improvement 
Worse 
MMSE points Points >2 +2 to -2 <2 
VF-FAS Points >4 +4 to -4 <4 
VF-A Points >2 +2 to -2 <2 
Clocks Points >1 +1 to -1 <1 
RCSF  mmHg/ml/min >12 10-12 <9.9 
Gait-time 10 Seconds <4 +4 to -4 >4 
Gait –step10 Steps <4 +4 to -4 >4 
Gait –time360 Seconds <2 +2 to -2 >2 
Gait –step360 Steps <2 +2 to -2 >2 
Urinary Subjective Less/No 
incontinence 
Same as 
before 
Worse than 
before 
Based on the outcome from these tests patients were classified as possible, probable and 
unlikely (Table 3.3). This was used both following improvement with ELD and also to measure 
outcome of the patients during follow-up. These criteria are based upon current practice derived 
from the literature in large NPH series (Vanneste, Augustijn, Tan et al, 1993, Marmarou, 
Bergsneider, Kling et al, 2005). The patients in the ‗probable‘ category were shunted and the 
patients in the ‗unlikely‘ category were not shunted. Those patients in the ‗possible‘ criteria were 
given the option of shunting and if in doubt they were shunted. In this section these results are 
discussed in detail.  
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Table: 3.3. Classification of patients following external lumbar drain 
Score Memory Gait Urinary Rcsf 
mmHg/ml/min 
Treatment 
Probable Improvement in 2 
or more 
neuropsychological 
tests. 
Improvement 
in 2 or more 
gait tests. 
Improvement 
in urinary 
symptoms. 
> 12 Shunted 
Possible Improvement in 
less than 2 
neuropsychological 
tests.  
Improvement 
in less than 2 
gait tests. 
No 
improvement 
in urinary 
symptoms. 
10-12 Option to 
shunt 
Unlikely No improvement 
or worse than the 
baseline test. 
No 
improvement 
or worse 
compared to 
baseline test. 
Worse than 
the baseline 
urinary 
symptoms. 
<10 Not shunted 
3.3.4 Follow-up 
All patients irrespective of the shunt placement were assessed at 6 months and 1 year. 
Patients who were shunted were further reviewed between four and six weeks after surgery as a 
routine to perform a CT scan and check for any post operative complications and wound healing. 
CT scans were reviewed for ventricular catheter position and subdural collections. If they had 
any symptoms or signs of under drainage or over drainage their shunt settings were adjusted 
accordingly by 10-20 mm H20. Every time a shunt setting was changed they were reviewed in 
four weeks to check the effect of change. X-ray was done to check the change in the programme. 
CT scans were obtained at 4-6 weeks and 1 year in the shunted group and at 1 year only in the 
non-shunted group. The patients and their family or carers were interviewed on each follow-up. 
They were asked about their current symptoms and development of any new symptoms or 
neurological deterioration. Neuropsychological test except NART and BDI and gait tests were 
performed. The patients CT scans were then reviewed for a) Evans‘ index b) periventricular 
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changes and d) subdural collections or cerebral ischemia. Patients were then asked to grade their 
improvement in each of their three symptoms as improved, not improved and worse than before. 
Depending on their outcome the shunt was reset by 20-30 mm H2O if they had no improvement 
or worsening in the shunted group. If they showed satisfactory improvement the shunt setting 
was unchanged. In the non-shunted patients if there was significant deterioration they were given 
the option of repeating the study. The flow chart in Figure 3.2 explains the follow up. 
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Figure: 3.2. Flow chart of follow-up protocol. 
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3.4 Neuropsychological tests 
3.4.1 Introduction  
In chapter 1.3 the clinical features and presentations of dementia were discussed in detail. 
Deficits associated with NPH tend to be mild to moderate subcortical dementia which is best 
differentiated from cortical dementia by the absence of aphasia, apraxia and agnosia (Boon, 
Tans, Delwel et a, 1997). More specifically, neuropsychological alterations associated with NPH 
include impaired memory and ability to manipulate acquired knowledge, deficits in visuospatial 
function and spatial recognition, psychomotor slowing and decreased speed in processing 
complex information and poor executive function (particularly on initiation and perseveration 
tasks) (Iddon, Pickard, Cross, et al, 1999, Thomsen, Borgesen, Bruhn, et al, 1986, Vanneste. 
2000). Thus deficits are quite wide ranging indicating that a variety of neuropsychological tests 
should be employed, but there appears to be little consensus regarding which tests should be 
utilised.  
3.4.2 Neuropsychological tests chosen for this study 
The neuropsychological components of NPH are probably the most difficult to assess and 
differentiate from other forms of dementia. Dementia in NPH has traditionally been assessed 
using a brief screening tool such as the Mini Mental State Examination (MMSE) (Adams, Fisher, 
Hakim, et al.1965). This type of examination provides an overview of the cognitive functioning 
of patients allowing their degree of dementia to be determined, but it fails to provide details of 
patterns of specific impairment. A more detailed knowledge of the cognitive deficits shown by 
NPH patients would; (i) enable this disorder to be differentiated from dementia of the Alzheimer 
and other types (ii) allow assessment of cognitive improvement after surgery and (iii) may 
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provide some indication of those most likely to benefit from surgery. For these reasons MMSE 
cannot be used on its own to assess the type of neuropsychological deficit.  
Table 3.4 shows some of the tests that have been used in the literature in larger series. 
Only a few of these tests have been used more than once. Marmarou et al, 2005, used the MMSE 
and a series of neuropsychological tests. The other tests were used to test attention and 
concentration including, digital span forward and backward tasks. The Rey auditory verbal 
learning test was administered as a measurement of verbal fluency skills. Golomb et al, 2000 
realised that those who scored less in the neuropsychological tests had an increased gait and 
bladder function and were more likely to have concomitant Alzheimer‘s disease. Iddon et al, 
1999 proposed that early detection of NPH through clinical investigation and neuropsychological 
assessment would increase their likelihood of improvement from a shunt. They used the 
computerised battery of neuropsychological tests (CANTAB) described in the following 
chapters. Thomsen et al, 1986, gave their sample neuropsychology grades which equated to no 
impairment, slight impairment, moderate impairment, severe impairment and un-testable. 
Although there was no significant improvement found post-operatively, for the group of patients 
as a whole, 73% did improve with regards to their ―neuropsychological grade‖. The dementia 
caused by NPH did not completely reverse, but the patients did regain some of their abilities. The 
majority of tests however are designed to assess for dementia, which is subcortical. Boon et al, 
1997, in the Dutch NPH study, attempted to establish particular baseline characteristics of NPH. 
They used a battery of psychometric tests that found NPH patients to have memory deficits, 
diminished visuospatial abilities, inertia and psychomotor slowing. They proposed that the 
dementia was a mild to moderate subcortical type.  Gustafson and Hagberg, 1978, found NPH 
patients to have disturbances in their visuospacial abilities. Following shunt surgery only 39% 
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improved with regard to their cognitive ability. In contrast to the previous study, duration of 
illness was inversely correlated with improvement following surgery. Of those who improved, 
the mean duration of illness was 18.5 months in contrast to the unimproved who had a mean 
length of 57 months. Meir, 1999 found higher rates of improvement following shunt surgery, of 
65% at short term follow-up. A mild regression was noted at long term follow-up as only 54% 
remained improved.  
The literature review shows that NPH patients need to be assessed for information 
processing, memory, attention, conceptualisation and reasoning, visuospatial and constructional 
abilities, verbal and visual ability, remote language and executive processes. However, some of 
these patients may show quite severe dementia signs, many of the traditional neuropsychological 
tests may prove too difficult for them to complete. To avoid this problem, the MMSE is used as a 
short screening test, which provides information on attention, initiation/perseveration, 
construction, conceptualisation and memory in addition to an overall dementia. This has been 
widely used in most studies (Marmarou, Young, Aygok et al, 2005, Golomb, Wisoff, Miller et al, 
2000, Farina, Pomati and Mariani 1999, Iddon, Pickard, Cross et al, 1999). MMSE score has 
reasonable reliability and validity (Salmon, Thal, Butters et al, 1990). This is discussed later in 
section 3.4.4. 
Depressed patients often show a lack of interest or lack of motivation to complete tests. 
Hence, a depression-screening test, The Beck Depression Inventory (BDI) was used. BDI has not 
been used widely in NPH patients. There is a substantial variation in cognitive ability within 
populations and to compare an individual‘s performance with the population norm a National 
Adult Reading Test (NART) was used. There is impairment of both phonemic and semantic 
tasks associated with subcortical dementia; therefore a verbal fluency test was used to identify 
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this. Several studies have noted problems with visuospatial function in NPH (Thomsen, 
Borgesen, Bruhn et al, 1986). A quick way to assess this was by using the Clock drawing task.  
Together, these tests will provide a comprehensive assessment of cognitive deficits that 
occur as a result of NPH. This will enable a detailed assessment of the neuropsychological 
effects of shunt placement and may ultimately provide more information regarding the patient 
clinical symptoms that are most likely to respond to surgery. Patients with NPH are easily prone 
to fatigue and cannot tolerate multiple and complex tests (Miyoshi, Kazui, Ogino et al, 2005). 
Table 3.1 summarises the tests that were used in the study, these tests are well validated and 
documented further.   
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Table 3.4: Neuropsychological tests used in the literature 
 
 
 
 
 
MMSE – Mini Mental State Examination, CANTAB- Cambridge Neuropsychological Test Automated Battery. 
 
Study Tests Used / Advocated 
Marmarou et al., 
(2005) 
MMSE, Galveston Orientation and Amnesia Test, Controlled Oral Word Association Test and Benton Visual 
Retention Test–Revised, Digit Span Forward and Backward tasks, The Wechsler Memory Scale–Revised Logical 
Memory Test, The Rey Auditory Verbal, Learning Test. 
Golomb et al., 
(2000) 
MMSE, Global Deterioration Scale, Guild paragraph recall test, Digit symbol substitution test, Mefferd & Moran 
Perceptual Speed Test, Purdue Pegboard Test 
Vanneste (2000) Trial Making Tests B & C, Symbol Digit Memory Test, Stroop Test 
Boon et al., 
(1999) 
10 word Digit Span Forwards & Backwards, Trial Making, Finger Tapping 
Farina et al., 
(1999) 
MMSE, Digit Span Forward and Backward, Coris Block Tapping Test, Logical Memory Test, Verbal Fluency, 
Paired Associates Learning Test, Token Test, Rey- Osterrieth Complex Figure Copy & Recall, Revens Coloured 
Preogressive Matrics, Attentional Matrices  
Iddon et al., 
(1999) 
MMSE, Kendrick Objective Learning Test (KOLT), CANTAB (Visual recognition, Spacial recognition, ID/ED 
Attention Set Shifting Paradigm) 
Larsson et al., 
(1991) 
Bingley Memory Test, Ravens Matrices, Reaction Times, Cronholme-Molander test, 5 Item Memory Test, 
Identical Forms. 
Thomsen et al., 
(1986) 
Digit Span Forwards & Backwards, Ten Words Recall (>5min), Trial Making Tets A, Finger Tapping Test 
Gustafson & 
Hagberg (1978) 
Stroop Test, Reaction Time, Block Design, Word Definition Test, Paired Associates (Memory for Design & 
Visual Attention) 
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3.4.3 Screening Tests 
 
3.4.3.1 National Adult Reading Test (NART) 
The substantial variation in cognitive ability within populations can be standardised by a 
NART test to predict the premorbid IQ. This is important as IQ may determine performance on 
some tests.  The NART is a UK based test which is reported to accurately estimate the IQ by 
asking patients to read words with non-phonetic spelling (Nelson 1982). If the IQ was very low 
then this had a serious impact on the scores following ELD. 
Test administration: 
This is simply a list of 25 words that the patient was asked to read aloud (Appendix 3). This is 
the short version of the test as the full version contains 50 words. The examiner kept a list of the 
same to score their response. Correct pronunciations were adhered to, regional accents were 
allowed. To score the NART, all the correct response was added together. Since the short version 
(25 words) was used the score was converted to the full NART score using Table 3.5. The 
number of errors made on the test determined the NART score. To obtain the premorbid IQ the 
following equation was used:  
 
Premorbid IQ = 128 – 0.83 x NART error score.  
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Table 3.5: Conversion table for the prediction of the full NART Error score from the short 
NART score. 
 
Short NART correct score Conversion to full NART Error score 
0-11 As in full NART (50 minus correct) 
12 38 
13 36 
14 34 
15 33 
16 31 
17 30 
18 28 
19 26 
20 24 
21+ As in full NART (50 minus correct) 
 
3.4.3.2 Beck Depression Inventory (BDI) 
Depression causes sadness, inactivity, difficulty in thinking and concentration, feelings of 
hopelessness, and lack of motivation to complete tests. Many severely depressed patients will 
have some mental deficits including poor concentration and attention. When dementia and 
depression are present together, intellectual deterioration may be exaggerated. Depression, 
whether present alone or in combination with dementia, can be reversed with proper treatment. 
Without this measure, it may be assumed that the patients performed poorly for other reasons 
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(Beck, Ward, Mendelson, et al, 1961). The BDI is a 21 item self-report rating inventory 
measuring characteristic attitudes and symptoms of depression. It is a widely used questionnaire 
to screen patients for depression. Beck et al introduced the original version of the BDI, in 1961.  
The BDI was revised in 1971 and has been developed in different forms including several 
computerized forms, a card form the 13-item short form and the more recent BDI-11 form. The 
reliability of internal consistency for the BDI ranges from 0.73 to 0.92 with a mean of 0.86 
(Beck, Steer and Garbin. 1988). Beck suggested that if the BDI was re-administered within a 
short interval then scores could be spuriously inflated due to memory factors. In one series re-test 
reliabilities ranged from 0.48 to 0.86 (Groth-Marnat, 2
nd
 Edition, 1990). BDI has a high content 
validity, and validity in differentiating between depressed and non-depressed people. 
Table 3.6: Depression scores 
Score Level of depression 
05 – 09 These ups and downs are considered normal 
10 – 18 Mild to moderate depression 
19 – 29 Moderate to severe depression 
30 – 63  Severe depression 
The BDI is scored by adding up the scores for each of the twenty-one questions to obtain 
the total score. The highest score for each of the twenty-one questions is three and the highest 
possible total for the whole test is sixty-three. The lowest possible score for the whole test is 
zero. The depression scores are interpreted as in Table 3.6.  
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Test administration: 
The BDI takes approximately10 minutes to complete. Patients were requested to read 
each group of statements carefully, and then pick out the one statement in each group that best 
describes the way they have been feeling during the past two weeks, including the day of the test. 
They were not allowed to choose more than one statement for any group and if they did the 
highest score are taken. A sample of the questionnaire is attached in Appendix 4.  
Those patients who were severely depressed were referred to a psychiatrist and treated if 
necessary before further tests were carried out.  
3.4.4 Mini Mental State Examination (MMSE) 
The MMSE is a brief, quantitative measure to screen for cognitive impairment, to 
estimate the severity of cognitive impairment at a given point in time to follow the course of 
cognitive changes in an individual over time, and to document an individual‘s response to 
treatment. Folstein first described MMSE in 1975 (Folstein, Folstein and McHugh. 1975) that 
suggested a cut-off score of 23/30 or less, for the presence of dementia in persons with at least 8 
years of education. It was called "mini" because it did not test for mood and thought disorders, 
which are included in the full mental test. Some screening tests are unable to detect mild 
impairments and underestimate the level of subcortical dementia (Vanneste. 2000). 
Cognitive performance measured by the MMSE varies within the population by age and 
educational level. The normative data for different ages and educational levels are presented in 
the table 3.7. The NART scores give us an approximate level of the patient‘s education and 
premorbid IQ. There is an inverse relationship between MMSE scores and age.  
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Table 3.7: Mini mental state examination normative data for age and education level*  
 Age 
Education 65-69 70-74 75-79 80-84 >84 
4
th
 grade 22 22 21 20 19 
8
th
 grade 26 25 25 25 23 
High school 28 27 27 25 26 
College  29 28 28 27 27 
* Crum, Anthony, Bassett, et al, 1993.  
MMSE has been used extensively in the assessing patients with dementia. O'Connor, 
Pollitt, Hyde et al, 1989, found a sensitivity of 86% and a specificity of 92% when a cut-off of 
23-24/30 was used. The benefits of the MMSE include its brevity (5-10 minutes to administer), 
and the fact that it is a global assessment of many domains including: orientation to time and 
place (10 points), registration of 3 words (3 points), attention and calculation (5 points), recall of 
three words (3 points), language (8 points) and visual construction (1 point). It is an 11-question 
measure that includes assessments of personal orientation, immediate and delayed memory 
recall, attention and calculation, language, reading writing and copying skills. The maximum 
score is 30. In addition, when used repeatedly the instrument is able to measure changes in 
cognitive status that may benefit from intervention. 
The dementing range is 0-23; non-dementing range is 24-30 (Iddon, Pickard, Cross et al. 
1999). A recent meta-analysis of 37 longitudinal studies where the MMSE was used to follow 
patients with Alzheimer Disease over a 10 year period found an average ARC (annual rate of 
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change score) of 3.3 MMSE points (Han, Cole, Bellavance et al, 2000). Scores range from 25-30 
for normal, 21-24 for mild, 14-20 for moderate, and less than 13 in severe for patients with AD.  
Studies, which have utilised such screening tests, have found patients with NPH have 
moderately impaired MMSE score although the specific aspects of impairment cannot be 
identified. Hence, it does not replace a complete clinical assessment of mental status. In addition, 
the instrument relies heavily on verbal response, reading and writing. Therefore, patients with 
hearing and visually impaired have low English literacy, or those with other communication 
disorders may perform poorly even when cognitively intact. Since there is a risk of 
underestimation of the extent of the sub cortical dementia other tests are required. 
Test Administration: 
The patients were asked to perform a variety of verbal, nonverbal and paper and pencil 
tasks in a quiet setting. During the examination the patients were given explanation more than 
once if they did not understand a command. Appendix 5 shows a typical MMSE form used. The 
total score was marked out of 30.   
3.4.5 Verbal Fluency 
 
The purpose of this test was to evaluate the spontaneous production of words beginning 
with a given letter or of a given class within a limited time. There are two parts to this test. The 
first part assesses how many words the patient can think of in one minute beginning with the 
letters F, A or S. Patients with frontal lobe damage (as in NPH) often have difficulty doing this 
and repeat the same words. The second part of the test asks participants to think of as many 
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objects as possible belonging to a certain category (e.g. animals). This part of the test in 
relatively insensitive to frontal lobe damage but is impaired in AD. Therefore this test may help 
to distinguish patients with Alzheimer‘s from those with NPH (Spreen and Strauss. 1998). 
3.4.5.1 Verbal fluency - FAS 
 
Test administration:  
A stopwatch was needed and the instructions were given clearly and if necessary repeated 
as these patients can take longer to understand. The patient was given one minute to name as 
many words as possible beginning with the letters F, A and S. No proper nouns were allowed 
and local slang words were accepted. An example with any word was given where necessary 
(Appendix 6.1). 
The scores were the sum of all administered words for the three letters. Slang terms and 
foreign words that are part of Standard English were accepted. The results were compared to 
those in the Table 3.8 to judge how well the patient performed at different points. For statistical 
calculation raw scores rather than the percentile scores were used.  
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Table 3.8: Percentile conversion of verbal fluency - FAS scores 
 Age 60-79 Age 80-95 
Number of words Number of words 
Percentile 0-8 9-12 13-21 0-8 9-12 13-21 
90 39 54 59 33 42 56 
80 36 47 53 29 38 47 
70 31 43 49 26 34 43 
60 27 39 45 24 31 39 
50 25 35 41 22 29 36 
40 22 32 38 21 27 33 
30 20 28 36 19 24 30 
20 17 24 34 17 22 28 
10 13 21 27 13 18 23 
Mean 25.3 35.6 42 22.4 29.8 37 
 
3.4.5.2 Verbal Fluency - Animals 
 
Test administration: 
In exactly a similar method, instructions were given to the patients for the verbal fluency 
animals test. Appendix 6.2 gives instructions used for the test. The scores are the sum of all 
administered words for animals.  The results were compared to those in the Table 3.9. For 
statistical calculation we have used the raw scores rather than the percentile scores.  
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Table 3.9: Percentile conversion score for verbal fluency animal scores.  
 Age  60-79 
 
Age  80-95 
Number of words 
 
Number of words 
Percentile 0-8 9-12 13-21 0-8 9-12 13-21 
90 20 22 25 18 19 24 
70 17 19 22 16 17 20 
50 14 17 19 13 14 16 
30 12 14 16 11 12 14 
10 11 12 13 9 11 12 
Mean 14.4 16.4 18.2 13.1 13.9 16.3 
3.4.6 Clock drawing 
The purpose of this test is a clinical screening task for visuospatial and constructional 
disabilities as well as general dementia (Spreen and Strauss 1998), particularly sensitive to 
temperoparietal regions.  The simple free-hand drawing of a clock face has been part of the brief 
mental status examination in neurology for a long time (Battersby, Bender, Pollack et al, 1956, 
Critchley, 1953, Goodglass and Kaplan. 1972). In contrast to the primarily verbal content of 
most dementia scales, clock drawing relies on visuospatial, constructional, as well as higher-
order cognitive abilities. The test requires merely a sheet of paper and a pencil and can be given 
as part of a bedside examination, or in other instances when lengthy neuropsychological testing 
is not possible. The Clock Test (Tuokko, Hadjistavropoulos, Miller et al, 1995) uses three tasks: 
clock drawing (with pre drawn circles), clock reading, and clock setting.  
Discriminant validity of the test has been investigated in differentiating groups of normal 
elderly subjects and patient groups with AD, multi-infarct dementia, and depression (Wolf-Klein, 
Silverstone, Levy et al, 1989), with a mean age of 76 years. Correct classification in normal 
subjects was 97 percent, for AD patients 87 percent, for multi-infarct dementia 62 percent, and 
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for depression 97 percent. Tuokko, Hadjistavropoulos, Miller et al. 1992 report a correct 
classification rate of 86 percent for Alzheimer‘s disease and of 92 percent for normal elderly 
controls. O‘Rourke, Tuokko, Hayden et al 1997 also found good predictive validity; sensitivity 
was 91 percent at time of first testing for persons diagnosed with AD, and specificity was 95 
percent. (Kozora and McCullum. 1994) reported a mean score of 6.61 (range 2-10) in AD 
patients as compared to 9.59 for normal age-matched control subjects. Libon, Wenson, Barnoski 
et al, 1993 found, however, that the test does not discriminate between AD and vascular 
dementia patients and the authors found that in a similar condition, patients with cerebrovascular 
dementia performed worse than patients with AD. A second study (Libon, Malaniut, Swenson et 
al, 1996) with a different population of 31 AD and 27 cerebrovascular dementia patients 
confirmed this result. While the test may be useful in the diagnosis of AD and other forms of 
dementia, it should be noted that this test serves many purposes. Basically, it provides an 
estimate of visuospatial as well as cognitive skills and hence can be altered in patients with 
visual pathway defects. In NPH this test is very useful in differentiating cortical from subcortical 
dementia.  
Test administration 
An unlined letter-size sheet of paper and a pencil was placed in front of the patient and 
the instructions are given to draw a clock face and mark 20 minutes to 4 o‘clock on the clock. 
Instructions were repeated or rephrased if the patient did not understand, but no other help was 
given. The time taken to complete the task may be noted although this has not been used in this 
study. Pre-drawn circles were not used as part of the standard administration, but may be used if 
the patient fails to make a connected drawing (score of three or less according to the scoring 
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criteria below) in order to explore specific aspects of number placements and hand settings. 
Approximate time for administration was usually 5 minutes. A 10-point scoring system, adapted 
from Sunderland, Hill, Mellow et al, 1989 and Wolf-Klein, Silverstone, Levy et al, 1989 is was 
as in Table 3.10. Roman numerals are acceptable. Appendix 6.3 gives a sample instruction.  
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Table 3.10 Scoring of the clock drawing tests 
Score Description 
10 Normal drawing, numbers and hands in approximately correct positions, hour hand 
distinctly different from minute hand and approaching 4 o'clock. 
9 Slight errors in placement of hands (not exactly on 8 and 4, but not on one of the 
adjoining numbers) or one missing number on clock face. 
8 More noticeable errors in placement of hour and minute hand (off by one number); 
number spacing shows a gap. 
7 Placement of hands significantly off course (more than one number); very 
inappropriate spacing of numbers (e.g., all on one side) 
6 Inappropriate use of clock hands (use of digital display or circling of numbers despite 
repeated instructions); crowding of numbers at one end of the clock or reversal of 
numbers. 
5 Perseverated or otherwise inappropriate arrangement of numbers (e.g., numbers 
indicated by dots). Hands may be represented, but do not clearly point at a number. 
4 Numbers absent, written outside of clock or in distorted sequence. Integrity of the 
clock faces missing. Hands not clearly represented or drawn outside of clock face. 
3 Numbers and clock face no longer connected in the drawing. Hands not recognizably 
present. 
2 Drawing reveals some evidence of instructions received, but representation of clock is 
only vague; inappropriate spatial arrangement of numbers. 
1 Irrelevant, uninterruptible figure or no attempt. 
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3.4.7 Cambridge Neuropsychological Test Automated Battery (CANTAB) 
CANTAB is a series of computerised tests completed by the patient via a touch screen on 
a portable computer. CANTAB has been shown to be useful in early detection of different forms 
of dementia. It was found to be sensitive enough to detect alterations in cognitive ability pre and 
post shunt in patients with NPH (Iddon, Pickard, Cross et al, 1999). In addition, this battery was 
also able to differentiate between patients with mild dementia of Alzheimer‘s type and NPH. 
Tests include those for reaction time, frontal lobe (executive) function, visuospatial ability & 
memory. An advantage of this battery of tests is that it can be administered at the patient‘s 
bedside or at home, as the system is portable. In addition all data is held on the computer and can 
instantly be compared to that of age matched normal subjects (Iddon, Pickard, Cross et al, 1999). 
In this study patients were divided into two categories dependent on whether they scored within 
or outside of the dementing range on the MMSE. They suggest that although these patients were 
able to complete the MMSE, it is not sensitive enough to detect mild dementia caused by NPH. 
When assessed by way of the CANTAB, these patients were found to have deficits in verbal 
fluency, but were not found to be significantly impaired on tasks of semantic fluency i.e. naming 
animals. They were impaired preoperatively in comparison to controls on tasks of intra 
dimentional / extra dimentional (ID/ED) attention shift. This task requires the patient to shift 
their attention on the basis of feedback given by the computer. It is particularly sensitive to 
frontal lobe damage. Spatial span and pattern recognition were found to be unimpaired. In 
contrast, Alzheimer's patients were impaired on pattern and spatial recognition, but were 
unaffected on the ID/ED attention set shifting task. Thus, incorporating these tests into a 
patient‘s initial assessment could be beneficial when attempting to make a differential diagnosis 
of NPH or Alzheimer's and thus provide early intervention. They suggest that early intervention 
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will result in early CSF drain and shunt surgery thereby preventing further deterioration of 
cognitive functioning. 
 3.5 Gait tests 
3.5.1 Introduction 
Gait disturbance is usually the initial sign and most important symptom. Meier, Zeilinger 
and Kintzel, 1999, found gait disturbance to be present in 92% of their sample who were in the 
early stages of NPH and present in 90% in the late stage. Boon, Tans, Delwel et al., 1997 found 
that of the 101 patients assessed only 68 were able to walk unassisted. They also noted that the 
gait in NPH was characterised by a decreased number of steps per minute and smaller foot - floor 
clearance. Stolze, Kuhtz-Buschbeck, Drucke et al, 2000 found that draining 30mls of CSF 
increased the stride lengths and walking velocity by approximately 23%. Various objective 
computerised analyses have also been carried out which look into gait velocity; stride length, 
reduced foot to floor clearance and postural dysfunction. A variety of gait assessment tools from 
a simple 10 metre walking test to video recorded assessment and complex gait mats have been 
used to look for improvement following an ELD or shunt. In a clinical setting a 10 metre walking 
test assesses the patients walking before and after ELD and during follow up. Patients with NPH 
are known to have disturbance of dynamic equilibrium, reduced stride length and festinating gait. 
This can be assessed by asking them to perform a 360 degree turn after completing their 10 
metre walking test. In this section the two gait tests adopted in the study, and their administration 
is described. 
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3.5.2 10 metre walking test 
Some methods of gait analysis are complex and difficult to use. Gait analysis laboratories 
are at the complex end of the spectrum in this respect. They tend to be of limited availability, 
require much costly and sophisticated equipment, and can be highly complicated to operate. 
Thus they are fairly unlikely to be used in everyday clinical practice. The ten-metre walking test 
is a frequently used outcome measure and provides objective means of following changes in 
patient function over time. In 1987 Wade et al first described and documented the specific use of 
a ten metre-walking test to monitor recovery of gait following stroke. In many cases, 
improvement (increase) in walking speed was accompanied by an improvement in functional 
performance (i.e. degree of help and instruction needed, and the type of walking aid required if 
needed). More recently still, a timed walk over six metres now forms one component of the 
Elderly Mobility Scale (Smith, 1994). This has become a very popular assessment tool in 
UK-based elderly rehabilitation. Two raters tested 28 normal subjects (14 men, 14 women) in the 
manner already described. This was a convenience sample of healthy volunteer undergraduate 
students readily available to the testers. This resulted in 84 (3 x 28) potential pairs of timed trials, 
of which 82 pairs were recorded (one pair by each rater). The percentage agreement between 
testers for this was 96.8%. Using the procedure, acceptable levels of inter-rater reliability were 
found, with a 95% CI for agreement of -0.38 to +0.38 seconds for normal young subjects and 
-0.36 to +0.49 seconds for traumatic brain injured subjects (Watson, 2002). This suggests the 
very good inter-rater reliability for the 10 metre walking test.  
Though several studies have used 10 metres as a standard measure, specific discussion as 
to why this distance has been chosen is difficult to find, its practicality is understandable. Ten 
metres is probably the minimum functionally significant distance in the recovery of independent 
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walking. It is also probably a typical distance in clinical gait remediation, in terms of the free 
length of treatment areas and/or parallel walking bars. Ten metres is thus both a practical and 
meaningful distance to use. 
Test administration:  
The test required a standard electronic stopwatch and a 12-metre distance of free floor 
space. The corridor in the ward was used and had a start and finish line marked on the floor. It 
was found useful to identify a ‗target‘, which is a metre or more beyond the finish line. In 
practice this was a chair. Subjects were asked to walk towards this target. This method was found 
to be effective in distracting the subjects' attention from the finish line and prevented them from 
decelerating as they approached it. Where necessary they were given the walking aid they 
normally used or the physical support of a nurse or physiotherapist not involved in scoring the 
test. For timing, the tester followed the subjects as they walked. This allows for observation of 
step-count and time, and had the added advantage that physical help was available if required. 
Additionally, a subjective assessment of their walking pattern and steadiness was made. No 
inter-rater reliability was performed for this test. The gait pattern was also noted routinely. 
Mostly the same physiotherapist performed the pre and post drainage walking tests although the 
tester varied on a few occasions, but standard instructions were given 
3.5.3. 360 degree turn test 
The 360-degree test was a good measure of the patient‘s posture and balance as this can 
be affected in NPH patients. The patients were asked to make a full turn back after they 
completed walking 10 metres without using any support if possible. The same physiotherapist 
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performed the tests and most often they demonstrated the procedure before administering. 
During the test the time taken to make the turn and the number of foot steps used were 
calculated.  
3.6. Subjective analysis of urinary symptoms 
3.6.1. Introduction 
Urinary symptoms tend to occur at the later stages of this condition. Several methods of 
quantitative analysis of improved urinary function have been mentioned, which include 
urodynamic studies of bladder function and special scanning techniques that require specialist 
expertise. Such methods have not been used in this study but subjective improvement in 
symptoms was identified.  
3.6.2 Subjective reporting 
The family and or nursing staff were asked to report any improvement of urinary 
symptoms before and after the lumbar drain. It was a subjective score of improvement. The 
symptoms were graded as ‗worse‘ than before, ‗no improvement‘ or ‗improved‘. The urinary 
symptoms were recorded from the time of admission to discharge.  The same method was used 
during follow-up reviews.  
3.7 CSF hydrodynamic 
3.7.1 Introduction 
Stasis and absorption of cerebrospinal fluid is disturbed in NPH. Tests revolved around 
temporary CSF drainage and dynamic measurements of CSF circulation have been the main stay 
of investigation in these patients since the 1960s. The most widely used methods involve a 
standardised CSF ―tap test‖ introduced by Wikkelso, Andersson, Blamstrand et al, 1982 and 
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1986, although the first report of a tap test was by Adams et al, 1965 in their first paper 
describing the condition. The test involves removing large volumes of CSF (40-50 mls) by a 
lumbar puncture. A 40ml tap on 49 patients showed 26% sensitivity and 100% specificity 
(Walechenbach, Geiger, Thomeer et al, 2002). Thirty-five patients with iNPH showed a 33% 
specificity to tap test in another series (Malm, Kristensen, Karlsson et al, 1995). Both of these 
studies provide evidence to suggest that NPH patients cannot be excluded from shunting based 
on negative tap test. Other tests involve evaluation of CSF resistance to outflow
 
based upon the 
original lumbar infusion test described by Katzman
 
and Hussey in 1970 and Hussey, Schanzer 
and Katzman in 1970. Many investigators have used measurement of the resistance to outflow of 
cerebrospinal fluid (Rcsf) in selecting patients for shunt placement.  There are different dynamic 
testing techniques described, including perfusion study, infusion test, bolus testing and constant 
infusion testing. The constant flow lumbar infusion test was used in the study to calculate the 
Rcsf followed by insertion of a lumbar drain to remove 100mls of CSF over 24 hours for 2 
consecutive days.  
3.7.2 Lumbar infusion study  
The resistance to CSF absorption by the arachnoid villi can be measured and helps to 
predict shunt response. The lumbar infusion study was performed using a modification of 
Ekstedt‘s constant-pressure infusion technique (Ekstedt, 1978). The patients were placed in a left 
lateral position. Under aseptic conditions and local anaesthetic cover, a 16 G epidural needle was 
inserted into the thecal sac at the level of L3/L4 or L4/5. A 3-way tap was then connected and a 
pressure transducer was calibrated to atmospheric pressure at the level of the spinous processes 
of the vertebrae. The pressure transducer was connected to a monitor and opening pressure was 
measured after a 3-5 minute latent period before any CSF was lost. An infusion pump with 
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50mls of sterile 0.9% normal saline set at an infusion rate of 1.5mls/min was connected to the 3-
way tap. Saline was infused through the 3-way tap from the infusion pump, till a constant plateau 
pressure was obtained or a pressure of 50 mm Hg was reached. The pressure change was plotted 
on a graph manually. The advantages of this technique are that it is simple, quick, reliable and 
reproducible with a low risk of complications despite being an invasive technique.  
3.7.3 Rcsf 
3.7.3.1 Rcsf value used to measure outcome 
The infusion method of measuring the Rcsf in young volunteers showed the upper limit 
of normal was 10 mmHg/ml/min, with mean values of 9 mmHg/ml/min (Boon, Tans, Delwel et 
al, 1997). The observed range of Rcsf correlated with good outcomes range from 10 to 24 
mmHg/ml/min. Various investigators have used 8 (Børgesen and Gjerris, 1982), 10 (Ekstedt, 
1978. Graff-Radford, Godersky, Jones et al, 1989), 12 (Delwel, de Jong, Avezaat et al, 1989), 13 
(Tans and Poortvliet, 1985) and 15 (Price, 1989) mm Hg/ml/min as a threshold. If all the patients 
recieved a shunt irrespective of the Rcsf value, then it might be possible to predict the threshold 
level accurately. However this is not feasible for reasons discussed elsewhere. Using 
12.5mmHg/ml/min as a cut off value, Borgesen and Gjerris 1982, reported a positive predictive 
value of 84% and a negative predictive value of 100%. These good results are due to the fact that 
those with an Rcsf of less than 8.3 were not shunted. Although most authors have predicted 
measurement of Rcsf values as a positive predictor of shunt surgery some have found it not as 
reliable and others have found measuring Rcsf not useful in the selection of patients for a shunt 
(Boon, Tans, Delwel et al, 1997). A large prospective series from the Dutch group showed 
higher positive predictive values when the cutoff for the Rcsf was more than 18 mmHg/ml/min. 
Price, 1989, showed with a increasing Rcsf there was a increase in the number of patients who 
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improved following a shunt surgery. There is no consensus in the literature on the level of Rcsf 
above which patients should undergo shunt insertion. Because of these uncertainties an Rcsf of 
12 mmHg/ml/min has been used as a positive predictor for shunt insertion as values 12 and 
greater has consistently showed a better response to shunt surgery. Patients with lower Rcsf were 
also shunted if they showed improvement in other criteria as discussed in chapter 3.3.3.  
3.7.3.2 Calculation of Rcsf 
  During the study the CSF opening pressure at rest was measured at the beginning before 
infusion. The opening pressure in iNPH is normally between 3-18 mmHg. Lumbar pressure 
reading at every minute was plotted on a graph with the X-axis pressure and time on the Y-axis.  
The test was stopped if the patient developed symptoms of raised intracranial pressure or the 
plateau pressure reached 50 mm Hg or after 45 minutes of infusion. The resistance (Rcsf) to CSF 
absorption can be calculated using an Ohm‘s Law analogy:  
Rcsf = Pp-Po/1.5 mmHg/ml/min 
Pp – Plateau pressure  
Po – Opening pressure  
1.5ml/min – rate of infusion of saline. 
The Rcsf in normal individuals ranges from 6 to 10 mm Hg/ml/min. It increases in the elderly.  
 
3.7.4 External Lumbar Drain (ELD) 
After the infusion study an epidural catheter was inserted into the lumbar space and 
secured with tapes and connect to a bag via a 3-way tap. The patients were kept in bed rest for 
most of the 48 hour period of CSF collection, but were allowed to mobilise to the toilet and sit up 
for meals after which the 3-way tap was closed. CSF was drained only in lying or semi-sitting 
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position. 100mls of CSF was drained every 24 hours and after 48 hours the drain was removed. 
Patients were encouraged to drink plenty of fluids and keep well hydrated during the drainage. 
The ELD was then removed at 48 hours time and within two hours the neuropsychological and 
gait tests were repeated.  
3.7.5 Cerebrospinal Fluid Collection 
The patients were asked to remain in lying position on bed most of time allowing for 
brief breaks for meal and toilet use. They were instructed to call for nursing help to move out of 
bed. In this way, we could ensure that the valve was closed to drainage when the patient was 
upright. At the end of two days when the required amount of CSF was collected the tests were 
repeated within two hours after the drain was removed.  
3.7.6. Shunting criteria 
After all the tests were repeated the outcome of ELD was discussed with the patients and 
their family and carers. This was discussed in section 3.3.3.   
3.8 Treatment 
3.8.1 Introduction 
There is less scientific evidence on the appropriate surgical management compared to the 
diagnostic phase of the NPH. Although we have used specific criteria based on response to CSF 
drainage, when offering surgery to patients other factors such as co-morbidity and coagulation 
status are taken into consideration for individual patients. There is insufficient data on patients 
managed conservatively and the natural history of the disease. There are no published reports 
demonstrating returning to normality without surgery or progression if left untreated 
(Bergsneider, Black, Klinge et al, 2005) 
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Any form of CSF diversion procedure in this group of patients comes with significant 
risks that may be directly related to the surgery and postoperative complication. This was 
explained to patients and relatives before informed consent was obtained. The expectations of the 
patient and the family was considered and discussed in detail although there were several grey 
areas that could not be answered appropriately e.g., measure of improvement expected and 
sustained if there was improvement. In this section the co-morbid factors which influence 
surgical option of CSF diversion, the selection of type of shunt and the associated complications 
of shunt surgery have been discussed briefly.  
3.8.2 Surgical management 
 
3.8.2.1 CSF diversion procedures 
 
The most common method of permanent CSF diversion is a shunt. The shunt is a device 
that channels CSF from the ventricle to a distant site usually the peritoneum called Ventriculo-
Peritoneal Shunt (VPS) Figure 3.3. Other sites used in NPH are the right atrium of the heart 
(ventriculo-atrial shunt or VA shunt) or pleura (ventriculo-pleural shunt) when there is a 
contraindication for a VPS, although VA shunts have been used extensively in some series. 
Another type of shunt is a Lumbo-peritoneal shunt (LP shunt), which is CSF diversion, from the 
lumbar CSF space to the peritoneum and these are more prone to blockage and hence not popular 
in NPH. It is important to realise that each of these shunt procedures have potential advantages 
and disadvantages.  Endoscopic third ventriculostomy (ETV) has been performed for people with 
iNPH and aqueductal stenosis. This is performed by passing an endoscope into the lateral 
ventricle and perforating the floor of the third ventricle, thus diverting the CSF from the ventricle 
into the basal cisterns. It has proven efficacy in iNPH patients with aqueductal narrowing on 
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MRI flow scans (Meier, Zeilinger, Schonherr B et al, 2000. Mitchell and Mathew, 1999) but has 
failed to show success in patients with communicating NPH (Longatti, Fiorindi, Martinuzzi et al, 
2004). In elderly population this method of treatment may have better compliance but in 
communicating iNPH shunts are still the preferred option. Further studies comparing the two 
treatment modalities may provide a definitive answer.  
3.8.2.2 Ventriculo-Peritoneal Shunt (VPS) 
 
The VPS is performed under a general anaesthetic. A burr hole is performed in the skull 
and the shunt tubing is tunnelled underneath the skin from the head and placed into the peritoneal 
cavity as shown in Figure 3.3.  The shunt valve is the critical component of the shunt system. 
The design that has been used the longest is a fixed differential pressure valve which opens if the 
fluid pressure at the inlet of the valve exceeds the pressure at the outlet by a certain pressure. 
Traditionally, these come in low, medium and high pressure, each representing a fixed opening 
pressure. Most valves work with a ball and cone mechanism but other types are also available 
(figure 3.4). An anitisiphon device is inserted at the end of the valve to prevent the siphoning 
effect of gravity when the patient sits or stands. The operation was carried out usually within a 
few weeks after their initial admission or occasionally during the same admission.  
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Figure 3.3: Ventriculo-Peritoneal shunt position. (www.lifenph.com/about.asp. Webpage 
accessed on  20.10.2007)  
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3.8.2.3 Adjustable Valves 
In most large studies medium-pressure shunts were used and others used low-pressure 
(McQuarrie, Saint-Louis, Scherer, 1984) or high-pressure (Larsson, Jensen, Bilting et al, 1992. 
Benzel, Pelletier, Levy et al, 1990) valves. Vanneste, Augustijn, Dirven et al, 1992, did not find 
any differences between the various working pressures. The Dutch study randomized low and 
medium pressure valves and found low pressure with better outcomes but no statistical 
significance.  
A CSF shunt valve with an adjustable opening pressure level was originally proposed in 
1973 by Hakim. A differential pressure valve opens and begins to drain CSF at a certain 
pressure. Figure 3.4 shows the ball and cone mechanism of the shunt with the differential 
pressure across the two chambers. Because of the uncertainty of having to assume the optimal 
opening pressure in NPH patients (Boon, Tans, Delwel et al, 1998) adjustable valves have been 
used. These valves allow non invasive method of changing the pressure settings after 
implantation. Most of the existing literature on adjustable valves is in favour with benefit to 
patient‘s clinical outcomes (Black, Hakim, Bailey et al, 1994. Carmel, Albright, Adelson et al, 
1999. Mori, 2001. Zemack and Romner, 2000 and Goran Zemack, Bertil Romne et al, 2002).  
Although catheter-related complications and shunt-related infections are the major causes of 
shunt failure, adjustable valves are very useful in managing over drainage and under drainage 
problems in accordance with clinical or radiological findings in the postoperative period. After 
procedure the subdural haematoma is a major cause of morbidity and mortality in NPH patients. 
This complication requires surgical treatment of the collection by burr hole drainage and ligation 
of the shunt or revision to a higher-pressure valve to prevent further accumulation of blood. This 
suggests that use of programmable valves potentially makes revision operations unnecessary.  
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Figure 3.4: Ball and cone valve mechanism of shunt. (With permission from Codman, Johnson 
and Johnson) 
                               P 
 
CODMAN® HAKIM™ Programmable Valve (CHPV) was used in this study. CHPV is 
the same size as a fixed differential pressure valve and is implanted in exactly the same way. It 
gives the added choice of 18 different programmable pressure settings (30 mm H2O and 200 mm 
H2O) using a programming device. The opening pressure of the valve is changed through the use 
of an externally applied, codified magnetic field (Fig 3.5a). The spring in the ball-spring 
mechanism of the valve sits on top a rotating spiral cam which contains a stepper motor (Fig 
3.5b). Applying a specific magnetic field to the stepper motor will cause the cam to turn slightly, 
increasing or decreasing the tension on the spring, and changing the opening pressure of the 
valve (Fig 3.5c).  
 
 
CSF CSF 
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Figure 3.5 (a-c): Programmable shunt components. (With permission from Codman, Johnson and 
Johnson) 
 
–  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5a 
Figure 3.5c 
Figure 3.5b 
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The following figure shows the ball and cone mechanism of the shunt. Figure 3.6 shows 
the red ruby ball, which is closed, and in Figure 3.7 the ruby ball lifts up when the intracranial 
pressure exceeds the opening pressure of the programmable valve to allow the flow of CSF.  
Figure 3.6: Lateral view of a programmable shunt. (With permission from Codman, Johnson and 
Johnson) 
 
 
 
Figure 3.7: CSF flow through the valve. (With permission for Codman, Johnson and Johnson) 
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Figure 3.8: Photograph of a programmable valve. (With permission from Codman, Johnson and 
Johnson) 
 
    
 
3.8.2.4. Valve adjustment strategies. 
 
In the initial part of the study the opening pressure of the valve was set at the opening 
pressure during a lumbar puncture. Table 3.11 shows the corresponding pressure at which they 
were set. The valve pressure was adjusted when a) clinical symptoms worsened b) subdural 
hygromas or haematomas that could be managed conservatively developed and c) following an 
MRI scan when the magnetic field alters the settings. In the later part of the study the opening 
pressure of the valve was placed high at 130mm H2O and gradually reduced by 20-30mm H2O 
until clinical improvement was seen.   
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Table 3.11: Opening pressure and corresponding initial valve pressure setting.  
 
Opening pressure at LP 
mm Hg 
Conversion to mm H O 
Opening pressure of the 
valve.  
3 40 
60 mm H2O 4 54 
5 68 
6 81 
90 mm H2O 7 95 
8 109 
9 122 
120 mm H2O 10 136 
11 150 
12 163 
140mm H20 13 177 
14 190 
15 204 
140mm H20 16 218 
17 231 
 
3.9 Outcome measurement 
All patients, irrespective of their treatment outcome, were followed up until 1 year. The 
outcome measurements were kept standard throughout this study during follow-up at 6 months 
and 1 year. These measurements were 2 fold to assess the clinical and radiological outcomes. 
Firstly the outcome of the neuropsychological and gait tests along with improvement in the 
urinary symptoms at 6 months and 1 year, and secondly the changes on CT scans in the shunted 
and non-shunted patients at 1 year. During the visit at 6 months and 1 year patients were 
subjected to a full physical neurological examination to rule out any deficits. Chapter 3.3.4 
explains in detail the follow-up of patients after treatment. The reason the same 
neuropsychological and gait tests were used was to report a consistency in outcome over time 
and to look for a change. This proved useful to detect those who improved following shunting. 
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Unfortunately no specific standard NPH outcome measures or general quality of life measures 
were used. The disadvantages of this are described more in detail is the discussion chapter 5.11. 
The outcome was measured quantitatively as described in Table 3.2. The patients were 
classified into 3 groups improved, not improved and worse based on their scores. This 
classification was useful to measure the outcome over a period of time and to consider any 
intervention ie. Shunt adjustment or re-test depending on the results.  
3.10 Statistical analysis 
 
All data used in this study were ordinal (categorical) or continuous. Examples of ordinal 
data are the results of MMSE testing and categories of patients based on probable, possible and 
unlikely. Examples of continuous data are age and the results of 10 metre walking tests. All 
descriptive statistics were analyzed and summarized using commercially available software for 
Windows (SPSS, version 14 and higher; SPSS, Inc., Chicago, IL). The mean (M) and standard 
deviation (SD) was used to summarize the variables. The level of statistical significance of 
differences was p < 0.05.  
Parametric data involving differences between the means of two independent samples 
were analyzed with the aid of the Student paired t-test. Where there were non-parametric 
comparisons (because of skewed distributions or small group size) between two independent 
groups a Mann Whitney U test was used. This was used for assessing whether two independent 
samples of observations came from the same distribution. The baselines characteristics of the 
shunted and non-shunted patients were analysed using this method.  
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To determine whether a linear relationship existed between quantitative variables, the 
Pearson rank correlation coefficient was applied to normally distributed variables. The linear 
association between the neuropsychological and gait tests were assessed using this.  
Likelihood ratio shows us how much we should shift our suspicion for a particular test 
result. This was used in assessing the usefulness of the Rcsf values for selecting patients for 
shunting. Others tests in assessing the Rcsf value significance were the pre-test odd which shows 
that the patient has the target disorder before the test was carried out. Post test odds shows that 
the patient has the target disease after the test was carried out. The post-test probability shows 
the proportion of patients with that particular test result who have the target disorder.  
To examine the effects of shunting and to determine whether the symptoms of NPH 
improve following surgery, a two way mixed analysis of variance (ANOVA) was conducted with 
treatment (shunt, no shunt) and post shunt assessment (six months, one year) as factors for each 
of the measures taken. To examine the characteristics of patients who have improved from shunt 
surgery, with those who showed little improvement, a two way mixed analysis of variance 
(ANOVA) was conducted with surgery (Improved, not-improved) and post shunt assessment (six 
months, one year) as factors. Differences between groups may assist in developing criteria, in the 
future, to select patients who are most likely to benefit from surgery. To investigate if any of the 
tests are able to predict surgical success or failure from the baseline tests a multiple regression 
analysis at one year was performed.  
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3.11 Ethical approval (Ref: 2003.1.x) 
Ethics commitee approval for this research was submitted on the 30
th
 January 2003 to the 
Preston, Choley and South Ribble Local Research Ethics Committee (LREC), Trust 
Headquarters, Chorley and South Ribble District General Hospital, Chorley, PR7 1PP and the 
Research and Development Directorate, Lancashire Teaching Hospital, NHS trust. Details of the 
protocol, patient information leaflet and consent forms were produced.  
The committee had raised several questions regarding the appropriateness of the research 
title, sample size, statistical design, consent forms modification and finally regarding the 
research degree that I had submitted for. A letter and a personal representation in the LREC 
meeting clarified these questions.  
Since most of the patients in this group were elderly and suffered from dementia the 
consent form was modified to include the signature of the next of kin before any research was 
carried out. In order to make this process more effective patients and their carers were sent 
information leaflets even before they were seen in the hospital and it was an absolute 
requirement for a carer, member of family or next of kin to attend with the patient during the first 
visit on the advice of the committee.  
The information sheet was modified twice on the advice of the committee. The first three 
pages of the consent described the details about the condition, how to treat NPH and why 
patients required further investigation. The last page of the consent form described specifically 
about the various tests used in the study and how these tests would be performed. Care was taken 
to make it simple and in lay terms (Appendix 1).  
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A report from the hospital statistician and the supervisor from the University of Central 
Lancashire (UCLAN) were requested to discuss the sample size, statistical methods and analysis 
of outcome. The supervising consultant at the Lancashire teaching hospital was also consulted. 
The initial funding requirement was to purchase a computer called the Cambridge 
Neuropsychological Test Automated Battery (CANTAB) to perform the Neuropsychological 
tests. A report from the funding body, The Sydney Driscoll foundation, was requested.  
The modified aims, methods, statistical analysis, patient information leaflet and consent 
were resubmitted. After several communications with the LREC and the research and 
development directorate the ethics committee approval was granted on the 8
th
 April 2003. There 
were several conditions applied and part of this was to submit a 3000-word progress report at the 
end of year one. This was submitted and reviewed by 2 independent observers at the hospital and 
university. This was a requirement to proceed with the research and it was met. A final report 
was submitted to the research and development directorate at the hospital shortly after submitting 
this thesis. A copy of the ethics approval letter (Ref: 2003.1.x) is attached in the appendix. 
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Chapter 4: Results 
4.1 Introduction 
In this chapter each aim of the study is considered. Results are presented and 
summarised.  
4.2 Demographics and clinical presentation 
4.2.1 Aim 1 
To compare the demographic and clinical characteristics of patients who were selected 
for shunting with those who were not. This may provide clearer criteria to distinguish patients 
suffering from NPH from those who may be suffering from other disorders with similar 
presentation and evaluate the outcome between the shunted and non-shunted patients.  
4.2.2 Results 
 
4.2.2.1 Inclusion and Exclusion criteria 
The total numbers of patients referred to the study were 44 of which 40 met our research 
criteria as mentioned in chapter 3.3.1. Four patients who were excluded from the study are 
described in Table 4.1.  
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Table 4.1: Patients excluded from the study 
Age Presentation Reason for exclusion Action 
57 Memory and urinary 
incontinence 
Severe dementia MMSE <10. 
Significant cerebral atrophy 
for age. Possible Huntington‘s 
disease.  
Referred to 
Neurologist for 
further 
investigation. 
62 Gait problems only. On 
examination had 
cervical myelopathic.  
Ventriculomegaly and MRI 
cervical spine showed 
significant stenosis with 
myelomalacia changes. 
Had posterior 
cervical 
decompression with 
some improvement 
in gait symptoms. 
78 Memory, gait and 
urinary symptoms. 
Refused investigation and 
surgery. 
No follow-up. 
81 Memory and some gait 
problems. 
Severe dementia MMSE<10. 
Possible Alzheimer‘s.  
Referred to 
neurologist and 
started on treatment 
for AD. 
 
4.2.2.2 Age 
The total number of patients included in the study was 40, with an age range from 45-89 
years. The mean age of the sample was 76.4 years (SD=7.47). There was one male patient aged 
45 years and the mean age was similar even when this patient was excluded. Six patients were 
below the age of 65 years with a mean age of 57.8 years, 85% were above. iNPH patients 
generally present above the age of 65 years and the majority of those below this age are thought 
to have a secondary cause (sNPH). Table 4.7 shows the age and etiology of the patients with 
NPH. The 34 (85%) patients with idiopathic NPH had a mean age at presentation of 75.6 years 
(SD=7.7) and six (15%) with sNPH with a mean age of 71.6 years (SD=16.2).   
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4.2.2.3 Gender 
Of the 40 patients 15 (37.5%) were male and 25 (62.5%) were female with a mean age of 
76.5 and 74.76 years respectively. This is shown in Table 4.2 below. 
Table 4.2: Gender and age range of all patients 
 
Gender 
Age in years 
Minimum Maximum Mean (SD) 
Male 
(N=15) (37.5%) 
45 84 76.27 (9.72) 
Female 
(N=25) (62.5%) 
58 89 74.28 (8.45) 
 
The age range and gender of the patients who were shunted and not shunted are described 
in the table 4.4.  In the shunted patients 44% were male and 56% were female and in the non-
shunted group, 35% were male and 65% were females. The mean ages between the two groups 
were similar. There was no difference in age between the shunted and the non-shunted groups or 
males and females. There were more female patients in both iNPH and sNPH groups (Table 4.3). 
Table 4.3: Age range of the shunted and non-shunted patients 
 
 
 
N = count 
Gender Shunted 
(N=23) 
Non-Shunted 
(N=17) 
Male 
N=15 
N 9 6 
Mean age 77.33 74.67 
Female 
N=25 
N 14 11 
Mean age 73.86 74.82 
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4.2.2.4 Etiology 
Of the 40 patients in the study 34 (85%) had primary or idiopathic NPH (iNPH) and 6 
(15%) had secondary NPH (sNPH).  Table 4.6 and 4.7 show the two groups of patients.  
Table 4.4: Etiology, gender and age of patients  
Type of NPH No. of Patients 
(Percentage) 
Male : Female 
ratio 
Mean age in 
years (SD)  
Age range  
years 
Idiopathic 34 (85%) 13 : 21 75.6 (7.7) 58-89 
Secondary 6 (15%) 2 : 4 71.6 (16.2) 45-84 
Total 40 (100%) 15 : 25 75.6 (8.9) 45-89 
Table 4.5 Etiology of the shunted and non-shunted patients 
 
 
 
The mean ages between the two groups were not statistically significant although the 
secondary NPH patients were slightly younger (71.6 years compared to 75.6 years). Of the six 
sNPH patients four of them had previous cranial surgery and only two were shunted. More 
details of the patients are shown in Table 4.8. 
 
Treatment groups Shunted   
Male : Female ratio 
Non-Shunted   
Male : Female ratio 
Total N = 40 9 : 14 
 
6 : 11 
 
Idiopathic N = 34 9 : 12 
 
4 : 9 
 
Secondary N = 6 0 : 2 
 
2 : 2 
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Table 4.6: Details of secondary NPH patients 
Age Cause Treatment Latent Period 
45 Right parietal 
AVM 
Craniotomy for excision of AVM 18 year 
58 Head Injury 9 weeks coma, conservative 
treatment 
12 years 
80 SAH Conservative management Approx 10 
years 
81 Meningioma Craniotomy and excision of tumour  4 years 
82 SAH Craniotomy for MCA aneurysm 
clipping 
8 years 
84 SAH Craniotomy for AComA aneurysm 
clipping 
24 years 
 
AVM – Arterio-venous malformation, SAH – Subarachnoid haemorrhage, 
MCA – Middle cerebral artery, ACom A – Anterior communicating artery. 
 
 
4.2.2.5 Clinical symptoms 
 
During presentation the triad of gait, memory and urinary symptoms was present in 32 
patients (80%) with gait being the first symptom in 34 patients (85%). Memory occurred as the 
second most common symptom in at least 57% of the patients and urinary problems as the final 
symptom to be noticed in 13 patients (32%). Eight patients (20%) noticed all three symptoms of 
the triad to have started around the same time. Gait and memory symptoms were present in 38 
patients (95%), gait and urinary symptoms in 34 patients (85%) and memory and urinary 
symptoms in 32 patients (80%) of the total. These results are summarised in Table 4.7 and 4.8. 
Gait was the predominant symptom in all patients, memory and urinary symptoms in 95% and 
85% of patients respectively. Urinary symptoms were not present in 15% of patients. 
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Table 4.7: Frequency of NPH symptoms. 
 
Symptoms in months Number of patients Percentage 
Triad – gait, memory and urinary.  32 80% 
Gait and memory 38 95% 
Gait and urinary 34 85% 
Memory and urinary 32 80% 
 
Patient‘s duration of symptoms at presentation were compared between those shunted 
and not shunted. Twenty-three patients (57.5%) were shunted and 17 (42.5%) were not shunted 
in this study. No difference was found in the duration of symptoms between the shunted and the 
non-shunted patients in their memory and urinary symptoms but a marginally not statistically 
significant difference for gait with the shunted group having the longer duration of symptoms 
was noted (Table 4.8). This could partly be due to the fact that three patients had gait problems 
for more than five years while the others had a mean of 21.4 and 15.7 months of symptom 
duration in the shunted and non-shunted groups respectively.  
Table 4.8: Details of the symptoms characteristics in the shunted and non-shunted patients 
 
 Total  
Mean (SD) 
Shunted 
Mean (SD) 
Non-Shunted 
Mean (SD) 
 
p values 
N 40 23 17  
Gender  Male = 15 
Female = 25 
Male = 9 
Female = 14 
Male = 6 
Females = 11 
 
 
Symptoms 
in months 
means(SD) 
Gait 22.68 (16.3) 25.9 (17.53) 17.25 (13.35) 0.076 
Memory 15.20 (11.23) 15.8 (12.23) 14.56 (10.37) 0.354 
Urinary 7.29  (7.84) 6.1 (8.28) 9 (7.35) 0.147 
The mean duration of symptoms was 22.68 months for gait, 15.20 months for memory 
and 7 months for urinary symptoms. In the shunted group, 78% of the patients showed 
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improvement in memory, 83% of the patients showed improvement in their gait and 26% of the 
patients improved in their urinary symptoms at 1 year. Table 4.9 shows the outcome of shunted 
patients in percentage.  
 Table 4.9: Outcome of shunted patients 
 
 
 
  
 
 
 
Outcome at 6 months 
 
Outcome at 1 year 
 
Count Symptoms Improved 
Not 
Improved 
Improved 
Not 
Improved 
Shunted 
Patients 
(23) 
Memory 39% 61% 78% 22% 
Gait 52% 48% 83% 17% 
Urinary 39% 61% 26% 74% 
Overall 43% 57% 74% 26% 
 
Of those patients who had the triad of symptoms 70% showed improvement at 1 year and 
30% did not show any improvement. Patients presenting with only two symptoms showed a 
higher percentage (83%) of improvement compared to the patients having the classical triad 
(Table 4.10). 
Table 4.10: Symptoms and outcome of shunted patients at 1 year 
 Improved Not improved Total 
Triad 
present 
12 (70%) 5 (30%) 17 
Only 2 
symptoms 
5 (83%) 1 (17%) 6 
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4.2.2.6 Co-morbidity 
Co-morbidity plays a significant role when making a decision to offer shunt surgery and 
patients with significant cerebrovascular disease respond poorly to shunt placement. Table 4.11 
shows a detailed analysis of the co-morbid factors in the shunted and non-shunted groups. These 
factors are represented as events and some of these events can be present in the same patient. 
There was no difference in the co-morbid risk factors between the two groups of patients.   
Table 4.11: Co-morbidity of NPH patients.  
Co-morbidity Shunted group Non-Shunted group 
Cerebrovascular disease 5 4 
Hypertension 7 8 
Ischemic heart disease 4 4 
Myocardial infarction/IHD 3 2 
Diabetes Mellitus 2 1 
Prostate symptoms 2 1 
Depression 2 4 
Osteoporosis/osteoarthritis 2 2 
Hypercholesterolemia 1 2 
IHD – Ischemic Heart disease 
4.2.3 Summary  
Age, gender, etiology and marginally duration of symptoms were not associated with any 
difference in the outcome between the shunted and the non-shunted patients. It was not possible 
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to predict the outcome of the shunted patients based on their clinical presentation. Co-morbidity 
did not influence the selection or outcome of shunting.   
4.3 Radiology Evaluation 
4.3.1 Introduction 
 
CT scans not only help in diagnosing and differentiating NPH from other conditions; it is 
also used to evaluate the prognosis of the condition following treatment. In the shunted patients 
CT scans were performed at intervals to identify the position of the shunt catheter, assess the size 
of the ventricles and detect postoperative complications like subdural collections. In the non-
shunted patients CT scans help as a prognosticator of the disease process. Section 1.4.2 explains 
the CT scan characteristics used in differentiating other conditions and various measurements 
that can be used to evaluate the size of the ventricles following a shunt. The prognostic value of a 
CT scan on its own is limited.  
4.3.2 Aim 2 
To evaluate the usefulness of the CT scan in identifying and preventing complications 
and predicting outcome at one year between the shunted and the non-shunted patients.  
4.3.3 Results 
Ventriculomegaly was determined based on an Evans‘ index equal to or greater than 
0.30. Other parameters that were noted are CT scan evidence of previous cerebral infarcts and 
peri-ventricular lucency. The Evans‘ index is defined as the maximal width of the frontal horns 
measured at their extreme to the maximal biparietal diameter (figure 1.2). In the shunted patients 
scans were performed 4-6 weeks after their operation to identify any complications. After this 
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they had a further scan at one year. The non-shunted patients had only one scan at the one-year 
follow-up. 
A reduction in the Evans‘ index of more than 0.12 was defined as a clear or significant 
reduction in the ventricular volume, whereas a reduction of at least 0.06 to 0.11 was classified as 
a moderate improvement and a differential of 0.05 was regarded as no reduction in ventricular 
volume.    
Evans‘ index scores:    0.00 – 0.05 = No reduction in ventricular volume 
   0.06 – 0.11 = Moderate reduction in ventricular size 
   0.12 – 0.18 = Significant reduction in ventricular size 
4.3.3.1. Baseline radiological findings 
The baseline radiological variables noted were Evans‘ index, periventricular edema and 
evidence of cerebral infarcts. The mean Evans‘ index of all patients was 0.43 (SD = 0.097). The 
mean of the shunted patients was 0.422 (SD = 0.077) and the non-shunted patients were 0.443 
(SD = 0.120). There was no significant difference between the groups in the baseline Evans‘ 
index. Nine (22.5%) patients showed periventricular changes on the CT scan and six (15%) 
patients showed evidence of previous infarcts. Of the nine patients with periventricular changes 
five were shunted and only two out of six patients with previous infarcts were shunted. These 
patients were reviewed at a one-year scan for changes. 
4.3.3.2. Radiology finding at 4-6 weeks  
The CT scans performed at 4-6 weeks were to rule out shunt related complications like 
subdural hygromas or haematomas and mal-position of the ventricular catheter. The Evans‘ 
index was not reviewed at 4-6 weeks. Three patients developed a subdural hygroma on CT which 
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was managed conservatively and two other patients developed subdural haematoma, one of them 
requiring surgery for evacuation of the haematoma. One patient had a suboptimal position of the 
shunt requiring a revision surgery (Table 4.12). There was reduction in the complications in the 
later part of the study when the opening pressure was set at 130 mm H2O and gradually reduced.  
Table 4.12: Complication of shunt at 4-6 weeks 
Type of complication Initial part of 
study (13 
patients) 
Later part of 
study (10 
patients) 
 
Total 
(23 
patients) 
Outcome 
Suboptimal proximal end of VPS 0 1 (4 %) 1 Revision of 
shunt 
Subdural Hygroma (SDHy) 3 (13 %) 0 3 Conservatively 
managed 
Subdural haematoma (SDH) 2 (8.7 %) 0 2 One patient 
needed an 
operation 
The two patients who had a repeat surgery for their complication were reviewed again 
after four weeks with CT scans. The shunt position was satisfactory and the subdural collection 
was stable with less midline shift and the weakness had improved. The patients with SDHy and 
SDH were managed conservatively by increasing their valve pressure to 130 mm H2O, they 
remained stable without any increase in the size of their collection and one of them required a 
further raise in their pressure by 20 mmHg. The pressure was then gradually reduced over a 
period of time. Every time they had a change in their pressure setting they were reviewed 4 
weeks later.  
4.3.3.3 Radiology outcome at 1 year  
CT studies were compared between baseline and one year in all 40 patients. In shunted 
patients (N=23) the mean difference between the baseline (m=0.422, SD=0.077) and one-year 
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Evans‘ index (M=0.359, SD=0.085) showed a moderate reduction in the size of the ventricle 
(M=0.063). A related samples t-test revealed a significant difference between the baseline and 
one-year Evans‘ index in the shunted patients (p <0.001, CI=0.044-0.82). In the non-shunted 
patients the mean difference between the baseline (M=0.443, SD=0.120) and one-year 
(M=0.437, SD=0.113) Evans‘ index did not show a reduction in the size of the ventricles 
(M=0.006). A related samples t-test showed non-significant difference between the baseline and 
one-year Evans‘ index (p=0.32, CI=-0.21-0.33) between the shunted and the non-shunted 
patients (Table 4.13).  
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Figure 4.1: Association of Evans‘ index and clinical outcome at 1 year in the shunted patients.  
 
Of the shunted patients 43.5% did not have any reduction in their ventricular size but all patients 
showed clinical improvement. Amongst the 52.5% patients who showed moderate reduction in 
their ventricular size 50% showed clinical improvement, 33% showed no improvement and 
16.6% showed worsening of their symptoms. Only one patient had a significant reduction in his 
ventricular size with clinical improvement (Fig 4.1).  
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Table 4.13: Evans‘ index in the shunted and non-shunted patients. 
 
 
Shunted 
 
Non-Shunted 
 
Baseline EI 
Mean (SD) 
1 year EI 
Mean (SD) 
p-value 
Baseline EI 
Mean (SD) 
1 year EI 
Mean (SD) 
p-value 
Evans‘ 
index 
0.422 
(0.077) 
0.359 
(0.085) 
0.001 
0.443 
(0.120) 
0.437 
(0.113) 
0.32 
At 1 year a patient showed evidence of subdural haematoma that required evacuation of 
the collection surgically and another patient with an SDHy was managed conservatively. The 
other CT features that were compared at one year were the periventricular changes and cerebral 
infarcts. Of the 9 patients who had periventricular changes at presentation, 5 were shunted. The 
periventricular changes improved in 4 and remained the same in one. The periventricular 
changes in the 4 non-shunted patients were unchanged at one year. Six patients had cerebral 
infarcts and ischemic changes at presentation. Two patients were shunted and neither improved 
following shunting. There were 4 more patients who showed new ischemic lesions or infarcts on 
the CT at one year, two of them following a shunt.  Of the four patients with periventricular 
changes who were not shunted, one patient developed a stroke with a cerebral infarct but 
clinically recovered fully. The remaining three were stable clinically and radiologically.  
4.3.4 Summary 
A CT scan performed during the postoperative period (4-6weeks) was very useful in 
identifying the early complications and position of the catheter. This helped in the programming 
of the valve during subsequent follow-up. At one year the Evans‘ index showed a significant 
reduction (p=0.001) in the size of the ventricle in the shunted group. Periventricular changes 
improved in the majority of those who were shunted.  
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4.4 Baseline neuropsychological and gait tests 
4.4.1 Aim 3 
To evaluate the baseline values of the screening, neuropsychological and gait tests at 
presentation to determine whether there were any significant differences between the shunted 
and the non-shunted patients.  
4.4.2 Results 
 
4.4.2.1 NART 
Premorbid IQ of patients varies within the population and it reflects on the performance 
of other tests. The patients in both groups were within the normal range of IQ for their age 
(Table 4.14). A Mann-Whitney U test failed to show any significant differences between the 
shunted (M=110.78, SD=7.2) and the non-shunted (M=108.76, SD=8.3) groups (U = 166.50, Z = 
-0.798, p = 0.212). 
Table 4.14: Range of IQ between the shunted and non-shunted patients. 
IQ range Classification Shunt (23) No Shunt (17) 
120 and over Very superior intelligence 0 1 
110-120 Superior intelligence 3 5 
90-110 Normal to average 18 10 
80-90 Dullness 2 1 
Below 70 Borderline to severe deficiency 0 0 
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4.4.2.2 Beck Depression Index 
Depression could affect the performance in the neuropsychological tests; severely 
depressed patients were referred to the psychiatrist for investigation and treatment. In total, 
82.5% of the patients in the shunted (m=14.09, SD=7.6) and the non-shunted (M=14.18, 
SD=8.2) group were within the normal to mild range of depression (Table 4.15). One of the 
patients in each group had severe depression. They were both treated for their depression with 
anti-depressants in the first instance before any tests were performed. A Mann-Whitney test 
failed to show any significant differences between the shunted and non-shunted groups (U = 
188.0, Z = -0.206, p = 0.85). 
Table 4.15 Beck Depression Index – scores of their depression status.  
 
 Shunted Non-shunted Total (percent)  
Normal (5-9) 7 4 11 (27.5%) 
Mild (10-18) 12 10 22 (55%)  
Moderate (19-29) 3 2 5 (12.5%) 
Severe (30-63) 1 1 2 (5%) 
Total 23 17 40 (100%) 
 
4.4.2.3 Mini Mental Score Examination 
 
Thirty-one patients (77.5%) had normal to moderate level of cognitive scores and nine 
patients (22.5 %) had severe cognitive deficits as described in most studies (Table 4.16). The 
mean ages of the nine patients who had severe cognitive deficits MMSE (<13 points) were 74.8 
years for the shunted and 83 years for those who were not shunted. Three of the five patients 
showed improvement at one year following shunting. 
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Table 4.16: Mini mental scores in the shunted and non-shunted patients. 
 
 
 
 
 
 
 
 
 
 
 
4.4.2.4 CANTAB test 
Unfortunately this test was abandoned after a set of 4 patients had been administered 
during the initial part of the study due to a variety of reasons, namely (i) difficulty to administer 
by the researcher due to time constrains, as each setting took more than an hour and had to be 
performed before and after drainage, (ii) availability of neuropsychologist with expertise in this 
tool, (iii) patients were not very co-operative to perform the test as some of them have never used 
a computer or even seen one, which again took a considerable amount of time to familiarise. 
Data from the 4 patients were not analysed due to the likely inaccuracy of obtaining the data.  
This will not be discussed further in this thesis. In future this valuable computer equipment could 
be used in selected patients with appropriate trained persons.  
4.4.2.5 Baseline tests 
The baselines values of the various tests at presentation were analysed using a Mann-
Whitney U-test. This is used to compare two independent groups of sampled data. Although the 
Range MMSE range Shunt No-shunt Total (percentage) 
Normal 25-30 6 5 11   (27.5%) 
Mild 
impairment 
21-24 4 3 7     (17.5%) 
Moderate 
impairment 
14-20 8 5 13   (32.5%) 
Severe 
impairment 
<13 5 4 9     (22.5%) 
 Total 23 17 40   (100%) 
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mean values for the shunted and non-shunted patients were different, a Mann-Whitney U-test 
failed to show any significant difference between the groups (Table 4.17).  
Table 4.17: Mann-Whitney U-test results of baseline tests.  
 
Test Shunt No Shunt 
U Z P value  Baseline 
Mean (SD) 
Baseline 
Mean (SD) 
MMSE 19.57  (6.48) 19.41 (7.09) 193.50 -0.55 0.48 
VF-FAS 21.61 (11.51) 28.82 (24.34) 181.00 -0.397 0.35 
VF animal 9.26   (6.11) 8.18   (5.96) 178.50 -0.467 0.32 
Clocks 5.09   (2.73) 5.53   (3.11) 174.50 -0.579 0.28 
Gait 10 metre time 22.09 (17.66) 30.59 (21.4) 145.50 -1.375 0.08 
Gait 10 metre steps 33.65 (28.26) 35.41 (28.32) 191.00 -0.124 0.45 
360 deg turn time 6.74   (6.21) 8.06   (8.63) 191.00 -0.125 0.45 
360 deg turn steps 8.61   (8.36) 7.41   (6.76) 181.00 -0.404 0.34 
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Table 4.18: Pearson Correlation coefficients for the neuropsychological and gait tests of all 
participants 
Variable  MMSE  VF  
VFanim
al  
Clock 
drawing  
Time to 
walk 10 
metre  
No of 
steps to 
walk 10 
metre  
Time 
taken to 
turn 360 
degree  
No of 
steps to 
turn 360 
degree  
MMSE  1 .583** .739** .608** .140 .270 -.093 .009 
  - .000 .000 .000 .388 .092 .569 .956 
VF  - 1 .540** .400* .223 .225 -.005 .228 
  - - .000 .011 .167 .163 .975 .157 
VFanimal  - - 1 .574** .293 .246 -.173 -.137 
  - - - .000 .066 .126 .287 .399 
Clock drawing  - - - 1 .212 .207 .027 .222 
  - - - - .188 .200 .870 .169 
Time to walk 10 metre - - - - 1 .780** .507** .377* 
  - - - - - .000 .001 .017 
No of steps to walk 
10 metre  
- - - - - 1 .513** .444** 
  - - - - - - .001 .004 
Time taken to turn 
360 degree 
- - - - - - 1 .598** 
  - - - - - - - .000 
No of steps to turn 
360 degree  
- - - - - - - 1 
  - - - - - - - - 
 
 
 
**  Correlation is significant at the 0.01 level (2-tailed). 
*  Correlation is significant at the 0.05 level (2-tailed). 
 
Table 4.18 tabulates the Pearson correlation for the neuropsychological and gait tests. 
This was to measure the strength or degree of a supposed linear association between two 
variables. It can be concluded from this data that the correlation coefficients were significant 
between all the neuropsychological tests with 2-tailed p-values less than 0.01 and between the 
gaits tests with 2 tailed p-values less than 0.01. However there was no correlation between the 
neuropsychological and gait tests.  
136 
 
4.4.3 Summary 
The screening tests and baseline tests used in the study did not discriminate between the 
shunted and non-shunted groups and there was no correlation between the neuropsychological 
and gait tests.  
4.5 CSF hydrodynamic studies  
4.5.1 Introduction 
During an infusion study the opening pressure of CSF and plateau pressure were 
measured to calculate the Rcsf. An external lumbar drain was inserted for 2 days following the 
infusion study. Neuropsychological and gait tests were repeated after drainage. An Rcsf of 
>12mmHg/ml/min was used as a positive criteria for shunting. In this section the results of the 
lumbar infusion studies are analysed. 
4.5.2 Aim 4 
To evaluate the usefulness of Rcsf value as a criteria for shunting and to analyse the 
outcome of the shunted patients with an Rcsf of 12mmHg/ml/min or more.  
4.5.3 Results 
 
4.5.3.1 Opening and Plateau pressure 
The average opening and plateau pressures measured in shunted and non-shunted patients 
are summarised in Table 4.19. There was no difference in the opening pressure between the two 
groups of patients. The average opening pressures for iNPH and sNPH patients were 9.38mmHg 
(range 3-17mmHg) and 10.33 mmHg (7-14 mmHg) respectively.  
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Table 4.19: Opening and plateau pressures in the shunted and non-shunted patients.  
 
 Shunt 
(mm Hg) 
No Shunt 
(mm Hg) 
 Mean (SD) Range Mean (SD) Range 
Opening 
Pressure 
9.22 (3.4) 3-17 9.94 (3.9) 3-17 
Plateau 
Pressure 
31.43 (9.8) 14-55 27.29 (11.5) 6-50 
 
4.5.3.2 Rcsf 
Following the infusion studies, the Rcsf was calculated. An Rcsf of 12mmHg/ml/min was 
used as positive criteria for shunting. The average Rcsf values in the shunted and non-shunted 
group are shown in Table 4.20; Table 4.21 shows the number of patients with different ranges of 
Rcsf in mmHg/ml/min (<11.9, 12-17.9, >18). The majority of patients in the shunted group had 
an Rcsf of more than 18mmHg/ml/min (43.5%). Seven patients with Rcsf of less than 12 
mmHg/mil/min were also shunted and 8 patients of those with an Rcsf of more than 12 
mmHg/mil/min were not shunted. Considering an Rcsf of 12mmHg/ml/min as a cut off, 60% of 
the patients showed improvement in the neuropsychological and gait tests following an ELD 
(Figure 4.2). This clearly shows that Rcsf should not be used on its own as a criterion for 
shunting in this study. 
Table 4.20: Rcsf values in the shunted and non-shunted patients 
Treatment (n=40) Rcsf in mmHg/ml/min- 
Mean (SD) 
Range mmHg/ml/min 
Shunted (n=23) 14.9 (5.43) 4 - 27.3 
Non-Shunted (n=17) 9.7 (6.4) -1.30 – 24 
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Table 4.21: Range of Rcsf in shunted and non-shunted patients. 
 
Rcsf : mmHg/ml/min Total Shunted Non-Shunted 
< 11.9 16 7 30.5% 9 53% 
12-17.9 10 6 26% 4 23.5% 
>18 14 10 43.5% 4 23.5% 
Total 40  23 100% 17 100% 
 
 
 
Figure 4.2: Box plot of Rcsf values in shunted and non-shunted patients. 
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As predicted the mean Rcsf of the shunted (n=23, M = 14.9, SD = 5.43) patients was 
higher than the non-shunted (n = 17, M = 9.7, SD = 6.4). The difference is significant beyond the 
0.05 level: t (38) = 2.30; p = 0.014. The 95% confidence interval on the difference between 
means is (0.529, 8.268). Table 4.22 shows that 63% of patients showed improvement at 1 year 
when an Rcsf of 12 mmHg/ml/min or more was used. Four percent did not improve and 13% had 
a worse outcome. Forty two percent of patients showed improvement with an Rcsf of 18 
mmHg/ml/min. An Rcsf of 18 mm Hg/ml/min was used as an example to calculate this in the 
shunted group of patients (Table 4.23). The positive and negative predictive values of Rcsf were 
investigated by means of efficacy analysis.  
Table 4.22: Rcsf and outcome of the shunted patients. 
Shunted patients 
 
Outcome at 1 year Total 
Improved Not-improved Worse   
 
 
Rcsf 
  
  
>18 
8(42%) 0 2(9%) 10 
12-18 
4(21%) 1(4%) 1(4%) 6 
<12 
7(37%) 0 0 7 
Total 
19 (83%) 1 (4%) 3 (13%) 23 
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Table 4.23: Efficacy analysis at Rcsf of 18 mmHg/ml/min 
 
Rcsf : 
>18mmHg/ml/m
in 
Shunt 
responsive 
Shunt Non 
responsive 
 
Total 
Test Positive 8    (a) 2   (b) 10 
Test Negative 9     (c) 4    (d) 13 
Total 17 6 23 
 
 
1. Sensitivity =  a/(a+c) = 8/17   =  47% 
 
2. Specificity = d/(b+d) = 4/6  =  66% 
 
3. Likelihood ratio of positive result = Sensitivity/(1-specificity) =0 .47/1-0.66= 1.38 
 
4. Positive predictive value = a/(a+b) = 8/10    =  80% 
 
5. Negative predictive value = d/(c+d) = 4/13  = 31% 
 
6. Prevalence of shunt responsive (SR) hydrocephalus = (arc)/(a+b+c+d) = 17/ 23 = 74% 
 
7. Pre-test odds of having SR hydrocephalus = Prevalence / (1-prevalence) = 0.74/(1-0.74) 
= 2.8 
 
8. Post-test odds of having SR hydrocephalus = pre-test odds x likelihood ratio = 2.8 x 1.38  
=  3.86 
 
9. Post test probability of having SR hydrocephalus = post test odds/(post test odds+1) = 
3.86 / 4.86  =  79% 
 
The specificity was 83% and sensitivity was 17% if the Rcsf was raised to 
20mmHg/ml/min with a positive predictive value of 75% and the likelihood ratio was 1.0. The 
specificity and positive predictive ratio was 100% if the Rcsf was raised to 24mmHg/ml/min. 
Because of the considerable number of patients who improved despite a negative test, the 
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negative predictive values were low. In Table 4.24, sensitivity decreased and specificity 
increased with rising Rcsf values. The highest likelihood ratio (sensitivity/100 - specificity) was 
by far was found at an Rcsf cutoff of 18 mm Hg/ml/minute with a positive predictive value of 
80%. If there was a big change in the pre-test to post-test odds then it would be more clinically 
useful but this was not noticed. The post-test probability of having a shunt response was 68%. 
Table 4.24: Diagnostic testing of Rcsf values.  
Rcsf 
mm > = 
Hg/ml/min 
Sensitivity 
(%) 
Specificity 
(%) 
Likelihood 
Ratio 
Positive 
predictive 
value (%) 
Negative 
predictive 
value (%) 
12 64 16 0.76 68 14 
18 47 66 1.38 80 31 
20 17 83 1.0 75 26 
24 5 100 ∞ 100 27 
 
Although Rcsf was only part of the criteria for shunting, at 1 year a paired samples t-test 
showed a significant difference between the shunted and the non-shunted groups in all the 
neuropsychological tests and some of the gait tests with p values < 0.05. The results are 
summarised in Table 4.25.         
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Table 4.25: Outcome at 1 year with an Rcsf above and below 12mmHg/ml/min in the shunted 
and non shunted patients.  
                                                                                                                                         
Rcsf >/= 12 mmHg/ml/min 
 
Rcsf < 12 mmHg/ml/min 
Drainage Baseline 
Mean (SD) 
1 year 
Mean (SD) 
 
p-value 
Baseline 
Mean (SD) 
1 year 
Mean (SD) 
 
p-value 
MMSE 17.21 (6.26) 19.38 (5.97) 0.004* 22.94(5.85) 23.81(5.67) 0.138 
VF FAS 19 (11.43) 22.21 
(12.79) 
0.006* 33.19(23.05) 29.81(19.3) 0.056 
VF 
animal 
7.13 (4.0) 9.08 (5.32) 0.005* 10.50(7.04) 11.31(6.18) 0.151 
Clocks 4.67 (3.05) 5.29 (3.13) 0.05* 6.19(2.4) 6.31(2.15) 0.379 
10 metre 
time 
23.50(20.6) 23.33(22.43) 0.487 29.0(17.96) 28.50(12.96) 0.45 
10 metre 
Steps 
29.71(25.97) 23.67(18.71) 0.045* 41.44(30.12) 31.75(21.45) 0.655 
360° turn 
time 
8.21(7.59) 9.25(9.48) 0.256 5.94(6.76) 6.31(5.21) 0.434 
360° turn 
steps 
8.13(6.89) 5.33(4.59) 0.002* 8.06(8.91) 9.56(6.83) 0.108 
* p < 0.05 
4.5.4 Summary 
At an Rcsf value of 12 mmHg/ml/minute positive predictive values for improvement 
were approximately 68% with a specificity of 16% and sensitivity 64%. At one year there was a 
significant difference between the shunted and the non-shunted patients in majority of the 
supplementary tests used with 63% patients showing improvement.   
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4.6. Effects of ELD on patient selection 
4.6.1. Introduction 
All patients included in the study had a lumbar puncture and CSF studies as mentioned in 
the previous chapter. Following this, an ELD was placed for 2 days. Neuropsychological tests, 
gait tests, subjective improvement in the urinary symptoms and Rcsf results were used to classify 
patients into 3 categories: probable, possible and unlikely. Table 3.3 shows how these categories 
were derived.  The patients in the probable category were shunted, those in the possible category 
were given the option of a shunt and the patients in the unlikely category were not shunted. In 
this section we will discuss these results in detail.   
4.6.2 Aim 5 
To determine whether the effects of external lumbar drain (ELD) on supplemental 
neuropsychological and gait tests along with urinary symptoms and to determine if there is any 
correlation between the tests which are used to select patients for shunting at 1 year. 
4.6.3 Outcome of ELD selection 
Twelve out of 40 patients with NPH improved (30%) following ELD. Nineteen patients 
(48%) showed some improvement. These groups of patients have also been referred to as 
borderline improvement groups in some series. Nine patients (22%) did not improve in the 
majority of the tests and none of them had a shunt (Table 4.26). These patients were classed as 
probable, possible and unlikely. Of the 12 (30%) patients in the probable group 11 (92%) were 
shunted and one patient refused a shunt as he did not want to take the risks of the operation. 
Twelve (63%) patients were shunted in the possible group and seven (37%) refused a shunt 
operation. All of the nine patients who were unlikely to improve were not shunted.  
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Table 4.26: Outcome of ELD.  
*Patient refused a shunt operation.  
4.6.4 Effect of ELD on neuropsychological and gait tests  
From the short-term drainage the mean difference values for the various tests were 
significant in the shunted patients for most of the neuropsychological and gait tests. A related-
samples t-test showed significance beyond the 0.05 level for all of the neuropsychological tests 
and most of the gait tests except the 10 metre walking time and 360 degree turning time. These 
results are shown in Table 4.27. The non-shunted patients did not show any significant difference 
in any of the tests. This confirms that the patients were selected based on the significant 
improvement in the various tests and the high predictive value of ELD in the probable and 
possible groups.  
 
 
 
ELD outcome Total Shunt No shunt 
Probable 12 (30%) 11 92% 1* 8% 
Possible 19 (48%) 12 63% 7 37% 
Unlikely 9 (22%) 0 0% 9 100% 
Total 40 (100%) 23 - 17 - 
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Table 4.27: Outcome of all the tests in the shunted and non-shunted group    
                                                                                                                                         
Shunted 
 
Non-Shunted 
Drainage Pre drainage 
Mean (SD) 
Post 
drainage 
Mean (SD) 
 
p-value 
Pre drainage 
Mean (SD) 
Post drainage 
Mean (SD) 
 
p-value 
MMSE 19.57 (6.48) 21.83 (6.44) 0.0001 19.41(7.09) 19.59(8.25) 0.442 
VF FAS 21.61(11.51) 25.87(13.31) 0.0025 28.82 
(24.34) 
23.71 (22.0) 0.019 
VF 
animal 
8.09 (5.42) 9.26 ( 6.11) 0.054 9.0 (5.96) 8.18(4.94) 0.188 
Clocks 5.09 (2.75) 5.91 (2.73) 0.01 5.53 (3.11) 5.65 (3.30) 0.415 
10 metre 
time 
22.09(17.66) 19.70(15.94) 0.191 30.59(21.4) 34.59(48.64) 0.34 
10 metre 
Steps 
33.65(28.26) 26.35(20.34) 0.049 35.41(28.32) 36.65(35.31) 0.394 
360° turn 
time 
6.74 (6.22) 6.48 (6.89) 0.423 8.06(8.63) 7.35(10.94) 0.36 
360° turn 
steps 
8.61 (8.36) 6.04 (5.73) 0.026 7.41(6.76) 6.41(6.33) 0.159 
The pre and post drainage clock drawing tests were compared for inter-rater reliability. A 
second observer scored the clock tests and Pearson correlation coefficient between observer 
scores was positive at 0.95. The linear scatter plot in Figure 4.3 shows a deviation to the right 
with narrow elliptical clouding of the points and was significant (p=0.001) 
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Figure 4.3: Inter-rater reliability in clock drawing tests pre and post drainage.  
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4.6.5 Outcome of shunted and non-shunted ELD positive patients at 1 year  
 
 4.6.5.1 Shunted patients 
 
Table 4.28: Outcome at 1 year for the shunted patients with probable and possible improvement 
 
 
 
 
 
 
 
 
 
Eleven patients (48%) were classified in the probable improvement category of which 8 
(35%) had improvement at 1 year. Of the 12 (52%) in the possible class 9 (39%) improved at 1 
year. The remaining 4 (17%) did not improve but were no worse than their presentation and 2 
(9%) worsened after shunting (4.28).  
4.6.5.2 Non-shunted patients 
 
It is interesting to review the non-shunted patients in a similar way. One patient as 
mentioned earlier refused a shunt showing improvement following ELD. This patient did not get 
worse but remained symptomatic. Of the 7 patients (42%) in the possible group 5 of them 
worsened (71%) and only 1 (14%) showed some improvement despite not being shunted. Sixty 
seven percent of those in the unlikely class worsened and 3 (33%) remained symptomatic (4.29). 
 
 
 
 
 
Total 
shunted 
Improved 
Not 
improved 
Worse 
Probable 11 (48%) 8 2 1 
Possible 12 (52%) 9 2 1 
Unlikely 0 0 0 0 
Total 23 (100%) 17 (74%) 4(17%) 2(9%) 
148 
 
Table 4.29:  Outcome at 1 year for the non-shunted patients 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
It cannot be proved if the non-shunted patients who also had a reliable clinical and 
radiological presentation would have benefited from a shunt but clearly they showed no 
improvement from conservative management except one patient (5%). NPH is not a progressive 
disease and not self-limiting. The likelihood of these patients showing any improvement with a 
shunt despite having a negative test is unlikely.  
4.6.5.3 ELD re-testing in non-shunted patients 
There is no evidence in the literature if retesting is useful or essential before the patients 
can be declined a shunt treatment. In this study 14 non-shunted patients were worse at 6 months. 
Only 2 patients were retested and 12 patients declined for various reasons. This could partly be 
due to the reason that they have accepted the fact that no treatment will change the outcome and 
also from the experience of having the lumbar puncture and other tests in hospital they preferred 
not to have the same repeated. The 2 patients who were retested showed no improvement in their 
symptoms and they were followed up.  
 
 
Total 
Improved 
Not 
improved 
Worse 
Probable 1 (5%) 0 1 0 
Possible 7 (42%) 1 1 5 
Unlikely 9 (53%) 0 3 6 
Total 17 (100%) 1(5%) 5(29%) 11(66%) 
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4.6.5.4 Summary 
ELD was a good predictor of which NPH patients may have benefited from a shunt. 
Following ELD testing, categorising patients into probable, possible and unlikely seemed to be 
the best method to study the groups and to compare the within group analysis.  
4.7 Outcome at 6 months and 1 year  
4.7.1 Introduction 
 
 In this study the patients have been followed up at 6 months and 1 year. A further follow 
up of the outcome of all patients is proposed at 2 and 5 year intervals.   
4.7.2 Aim 6 
To examine the effects of shunting to determine whether the symptoms of NPH improve 
following surgery. The control group (those not receiving a shunt) were reassessed after the same 
time period to determine which factors alter over time. 
4.7.3 Results 
All patients were followed up for a period of 1 year. Those who were not shunted were 
used as a control group (Table 4.30). This allowed the determination of those factors that altered 
over time. Data were analysed using a 2 (treatment: shunt, no shunt) x 3 (assessment time 1, time 
2 & time 3) mixed analysis of variance (ANOVA) for between and within subjects factors for 
each of the measures used. Time 1-3 were outcome points post-drain, at 6 months and at 1 year.  
This test allows the examination of the effects of shunting and determines whether the symptoms 
of NPH improve following surgery. 
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Table 4.30: Clinical outcome at 6 month and 1 year 
  
 
Outcome at 6 months Outcome at 1 year 
 
Improved 
(%) 
Not 
Improved 
(%) 
Worse (%) 
Improved 
(%) 
Non 
Improved 
(%) 
Worse 
(%) 
Shunted 10 (43) 11 (48) 2 (9) 17 (74) 4 (17) 2 (9) 
Non-
shunted 
1 (6) 2 (12) 14 (82) 1 (6) 5 (29) 11 (65) 
 
The mean scores for the patients selected for shunt and those not selected differed 
significantly in all the neuropsychological tests: MMSE (F (1, 38) = 4.53, p=0.04); verbal 
fluency-FAS (F (1, 38) = 26.27, p<0.0001); verbal fluency – animals (F (1, 38) = 14.63, 
p<0.0001); clock drawing (F (1, 38) = 4.53, p=0.04). Similarly there was significant differences 
between these two groups of patients on the 360 degree step count (F(1,38) = 4.42, p=0.04); but 
the other gait tests did not show any significant differences between the shunted and the non-
shunted patients, time for 10 metre walk (F(1,38) = 2.69, p=0.109); steps in 10 metre walk 
(F(1,38) = 0.793, p=0.379) and time taken to turn 360degrees (F(1,38)=0.182, p=0.672) (Table 
4.37).
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*P <0.05, CI 95% 
Table 4.31: Outcome of the supplemental tests over time in all patients.   
   
Post Drainage 
 
6 months 
 
12 months 
  Shunted 
Mean(SD) 
No-Shunt 
Mean(SD) 
P (CI) Shunted 
Mean(SD) 
No-Shunt 
Mean(SD) 
P (CI) Shunted 
Mean(SD) 
No-Shunt 
Mean(SD) 
P (CI) 
Memory  
Tests 
MMSE 2.26 
(2.58) 
0.18 
(4.90) 
0.089 
(-0.37,4.51) 
2.70 
(3.28) 
0.47 
(3.24) 
0.04* 
(0.11,4.34) 
2.43 
(3.15) 
0.59 
(3.69)  
0.096 
(-0.35,4.04) 
VF 
(FAS) 
4.26 
(6.62) 
-5.12 
(9.31) 
0.001* 
(4.29,14.47) 
5.43 
(5.75) 
-4.47 
(8.63) 
0.0001* 
(5.30,14.51) 
4.61 
(5.20) 
-4.88 
(6.42)  
0.0001* 
(5.77,13.21) 
VF 
(animal) 
1.17 
(3.35) 
-0.82 
(3.73) 
0.084 
(-0.28,14.5) 
2.74 
(2.88) 
-0.24 
(2.84) 
0.002* 
(1.12,4.83) 
3.13 
(2.46) 
-0.71 
(2.87) 
0.0001* 
(2.13,5.54) 
Clocks 0.83 
(1.59) 
0.12 
(2.21) 
0.244 
(-0.5,1.92) 
0.96 
(1.69) 
0.35 
(1.54) 
0.254 
(-0.45,1.66) 
1.04 
(1.67) 
-0.41 
(1.42) 
0.006* 
(0.44,2.47) 
Gait 
tests 
10 
metre 
time 
6.39 
(11.31) 
-4.0 
(39.26) 
0.234 
(-7.02,27.8) 
11.48 
(17.31) 
4.71 
(20.61) 
0.266 
(-5.38,18.93) 
12.09 
(18.01) 
4.71 
(19.46) 
0.223 
(-4.6,19.45) 
10 
metre 
steps 
7.30 
(20.24) 
-1.24 
(18.59) 
0.180 
(-4.13,21.2) 
6.57 
(25.13) 
4.59 
(23.95) 
0.803 
(-
13.98,17.93) 
9.48 
(19.11) 
4.82 
(21.08) 
0.470 
(-8.3,17.58) 
360° 
turn 
time 
0.26 
(6.33) 
0.7 
(7.97) 
0.845 
(-5.02,4.13) 
-0.61 
(9.14) 
-4.47 
(9.99) 
0.212 
(-2.3,10.12) 
-1.09 
(7.75) 
-0.35 
(8.65) 
0.780 
(-6.0,4.54) 
360° 
turn 
steps 
2.57 
(6.0) 
1.0 
(4.0) 
0.357 
(-1.84,4.97) 
1.43 
(7.48) 
-3.24 
(5.29) 
0.034 
(0.37,8.97) 
2.52 
(5.32) 
-0.88 
(3.0) 
0.023* 
(0.5,6.3) 
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Table 4.32: Clinical improvement at 6 months and 1 year 
  Outcome at 6 months Outcome at 1 year 
  Improved 
Not 
Improved 
Worse Improved 
Not 
Improved 
Worse 
Shunted 
Memory 9 (39%) 9 (39%) 5(22%) 18 (78%) 4(18%) 1(4%) 
Gait 12(52%) 8(35%) 3(13%) 19 (83%) 3(13%) 1(4%) 
Urinary 9 (39%) 14(61%) 0(0%) 6 (26%) 16(70%) 1(4%) 
Not 
Shunted 
Memory 2(12%) 4(23%) 11(65%) 4(24%) 7(41%) 6(35%) 
Gait 2(12%) 3(18%) 12(70%) 6(35%) 7(41%) 4(24%) 
Urinary 0(0%) 13(77%) 4(23%) 0(0%) 14(82%) 3(18%) 
Maximum shunt setting alteration in the shunted patients was performed during their 
review at 6 months and after. This explains the clinical improvement seen at 1 year compared to 
6 months.  Maximum improvement was seen in their gait (83%) and memory (78%) symptoms 
and only 26% improved in urinary symptoms (Table 4.32). 
The non-shunted patients showed no improvement at 1 year although interestingly 6 
patients showed some improvement in their gait and memory symptoms. We are unable to 
explain this improvement despite the fact that these patients had no intervention. The numbers 
are too small to draw any conclusions.  
4.7.4 Summary 
At one year there were differences between the shunted and the non-shunted patients in 
all the neuropsychological tests, with statistically significant differences noted in the verbal 
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fluency test (p<0.0001) and clock drawing test. The gait tests did not show any significant 
differences except the 360 degrees turn (p=0.04). The non-shunted patients showed no 
improvement at 1 year. At 1 year 78% improved in their memory and 83% improved in their gait 
tests compared to 39% and 52% at 6 months. The improvement seen between 6 months and 1 
year can be explained by the change in the valve pressure settings when no clinical improvement 
was seen. Urinary symptoms slightly worsened at 1 year from 39% to 26%. Overall there was a 
very slight improvement in the non-shunted patients.  
4.8 Shunt responsive patients 
4.8.1 Introduction 
 Because CSF diversion carries a significant risk of mortality and morbidity it is 
important to analyse the patients who were shunted to see those who improved, to develop a set 
of standard tests. The methods chosen in this study to analyse this is the mixed analysis of 
variance and regression analysis within the shunted group of patients.  
4.8.2 Aim 7 
To compare the selection criteria including ELD, Rcsf values and outcome of the shunted 
patients who have responded well to surgery, with those who show little or no improvement. 
Within group analysis may assist in developing criteria, in the future, to select patients who are 
most likely to benefit from surgery. 
4.8.3 Results 
Data were analysed using a 2 (surgery: improved, not improved) x 3 (assessment time 1, 
time 2 & time 3) mixed analysis of variance (ANOVA) for between and within subjects factors 
for each of the measures used. Time 1-3 were outcome points post-drain, at 6 months and at 1 
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year. The mean scores for the patients who showed improvement with those who did not 
improve differed significantly in all the neuropsychological tests except the MMSE, (F (1, 38) = 
2.5, p=0.122); verbal fluency-FAS (F (1, 38) = 14.84, p<0.0001); verbal fluency – animals (F (1, 
38) = 13.7, p<0.001) clock drawing test (F (1, 38) = 5.35, p=0.026). Similarly there were 
significant differences between these two groups of patients on the 10 metre walking time 
(F(1,38) = 9.04, p=0.005); but the other gait tests did not show any significant differences 
between the shunted and the non-shunted patients, steps in 10 metre walk gait (F(1,38) = 0.19, 
p=0.665);  time taken to turn 360degrees (F(1,38)=0.71, p=0.406); number of steps to turn 
360degrees (F(1,38)=0.410, p=0.526) (Table 4.39).  
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*P < 0.05  
 
Table 4.33: Outcome of the supplemental tests over time in the shunted patients. 
   
Post Drainage 
 
6 months 
 
12 months 
  Improved 
Mean(SD) 
Not-
Improved 
Mean(SD) 
P (CI) Improved 
Mean(SD) 
Not-
Improved 
Mean(SD) 
P (CI) Improved 
Mean(SD) 
Not-
Improved 
Mean(SD) 
P (CI) 
Neuropsy. 
 
Tests 
MMSE 2.61 
(2.77) 
0.36 
(4.33) 
0.064 
(-0.14,4.64) 
2.56 
(3.55) 
1.09 
(3.22) 
0.18 
(-0.71,3.64) 
2.17 
(3.19) 
1.23 
(3.7) 
0.40 
(-1.3,3.18) 
VF 
(FAS) 
4.56 
(6.21) 
-3.23 
(9.65) 
0.0005* 
(2.45,13.12) 
5.89 
(4.83) 
-2.59 
(9.18) 
0.001* 
(3.62,13.34) 
4.67 
(5.13) 
-2.77 
(7.37) 
0.001* 
(3.28,11.6) 
VF 
(animal) 
1.72 
(3.39) 
-0.82 
(3.45) 
0.025* 
0.34,4.74) 
2.94 
(2.92) 
0.27 
(2.95) 
0.007* 
(0.78,4.56) 
3.33 
(2.17) 
0.00 
(3.22) 
0.001* 
(1.53,5.14) 
Clocks 0.78 
(1.40) 
0.32 
(2.21) 
0.449 
(-0.76,1.68) 
1.28 
(1.67) 
0.23 
(1.48) 
0.042* 
(0.041,2.06) 
1.22 
(1.67) 
-0.23 
(1.48) 
0.006* 
(0.44,2.47) 
Gait tests 10 metre 
time 
6.72 
(12.27) 
-1.91 
(34.66) 
0.322 
(-8.76,26.0) 
17.33 
(20.66) 
1.45 
(13.95) 
0.006* 
(4.76,26.99) 
18.33 
(22.96) 
1.27 
(9.48) 
0.003* 
(6.19,27.93) 
10 metre 
steps 
8.28 
(22.82) 
-0.09 
(16.48) 
0.187 
(-4.2,20.96) 
4.33 
(30.22) 
6.86 
(18.93) 
0.748 
(-18.38,13.3) 
8.39 
(23.23) 
6.77 
(17.12) 
0.801 
(-11.3,14.5) 
360° 
turn time 
-0.33 
(6.86) 
1.09 
(7.17) 
0.528 
(-5.95,3.1) 
-3.0 
(13.3) 
-1.64 
(5.67) 
0.660 
(-7.59,4.87) 
 
-2.11 
(9.06) 
0.32 
(7.13) 
0.349 
(-7.61,2.75) 
360° 
turn 
steps 
2.33 
(6.34) 
1.55 
(4.26) 
0.642 
(-2.62,4.2) 
-0.39 
(8.97) 
-0.68 
(4.99) 
0.897 
(-4.25,4.83) 
2.17 
(5.47) 
0.18 
(3.97) 
0.192 
(-1.04,5.01) 
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4.8.4 Summary 
 These results show that within the shunted group all but the MMSE 
neuropsychological tests and the 10 metreetre walking test were good predictors of surgical 
success with shunt. The MMSE as discussed in chapter 3.4.4 is a good screening test to estimate 
the severity of cognitive impairment at a given point in time and to follow the course of 
cognitive changes over time or response to treatment. These tests can be used in assessing future 
patients.  
4.9 Prediction of surgical success in shunted patients 
4.9.1 Aim 8 
To investigate if any of the neuropsychological or gait tests at baseline were able to 
predict surgical success or failure in the shunt improved patients at 1 year. 
4.9.2 Results 
A multiple regression analysis was conducted with outcome from presentation to 1 year 
as the dependent variable and MMSE, VF-FAS, VF-animals and clock drawing tests as the 
predictor variables. The model accounted for 15.3% of the variance. Only verbal fluency-FAS at 
baseline predicted improvement (β=0.403, p=0.047). Table 4.34 shows the standardized 
coefficients (β) and the p values of the other predictors.  
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Table 4.34: Regression analysis of the memory tests    
 
Predictors Standardized coefficients 
(β) 
P value (p) 
MMSE at admission -0.151 0.559 
VF-FAS at admission 0.403 0.047 
VF-animal at admission -0.197 0.421 
Clock drawing at admission 0.252 0.219 
  
Similarly a regression analysis for the various gait tests was performed with outcome 
from presentation to 1 year as the dependent variable and 10 metre time, 10 metre steps, 360 
degree turn time and number of steps to turn 360 degree tests as the predictor variables. The 
model accounted for 7.7%. There was no gait test that predicted improvement. The standardized 
coefficients (β) and the p values of the other predictor are shown in table 4.35. 
 
Table 4.41: Regression analysis of the gait tests    
Predictors 
(at admission) 
Standardized coefficients 
(β) 
P value (p) 
Time taken for 10 m 0.370 0.171 
No of steps for 10 m -0.365 0.186 
Time taken to turn 360 deg -0.003 0.990 
No of steps to turn 360 deg -0.112 0.593 
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4.9.3 Summary 
A multiple regression analysis of memory and gait tests at 1 year showed the VF-FAS 
test to be the only variable that predicted a better outcome. Similarly a multiple regression 
analysis conducted for the gait tests failed to show any variable that would predict improvement.  
4.10 Complication of ELD and shunt 
4.10.1 Introduction 
External lumbar drain and the shunt insertion are both invasive procedures and can have 
complications related to it. This significantly determines the outcome of the condition in this 
group of patients who may present with other medical co-morbidities. After the shunting 
procedure pressure change in the programmable valve can be associated with formation of 
subdural collection which may be serious enough to warrant further surgery to remove it. In this 
section complications from these procedures are reviewed. Anticoagulants cause serious risk of 
bleeding both at the time of lumbar puncture and surgery. There is a small increase in risk of 
bleeding when they develop subdural haematomas or hygromas.  
4.10.2 Aim 9 
To identify the complications occurring from external lumbar drain, shunt and use of 
anticoagulants. 
4.10.3 Results of complications of ELD  
Two patients (5%) developed symptoms of meningits, one had grown staphylococcus 
aureus and both were treated with antibiotics. Three patients (7.5%) had their lumbar drain 
idisconnected and had their ELD re-inserted. Two patients (5%) developed headaches and were 
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treated for their symptoms (Table 4.36). There were no bleeding complications related to the use 
of external lumbar drain.  
Table 4.36 Complication of external lumbar drain. 
 
 
 
 
 
 
4.10.4 Results of complication from the shunt  
Of the 23 patients who were shunted only one patient had a shunt revision 2 days 
following suboptimal position of the brain catheter. No shunt related infections were seen (Table 
4.37). The major complication following shunt in this group of patients was subdural collection.  
Table 4.37: Shunt related complications. 
Complication 
Number 
(percentage) 
Action 
Suboptimal position of 
ventricular catheter 
1/23 (4.3%) Revision surgery of shunt 
Subdural hygroma 4/23 (17%) 
Shunt pressure raised by 30 mm H2O. 
Conservative management only. 
Subdural haematoma 3/23 (13%) 
 2 patients - Burr-hole evacuation of 
subdural haematoma. 
1 patient – Shunt pressure raised  
Complication 
Number of 
patients 
Treatment 
Meningitis 2 (5%) Antibiotics 
Disconnection of drain 3 (7.5%) 
Re-insertion of 
drain 
Headaches 2 (5%) Analgesia only 
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4.10.5 Anticoagulants use in NPH patients 
The bleeding complications can be prevented by stopping anticoagulants before a lumbar 
puncture and shunt. The risk of developing serious subdural haematomas is significantly 
increased in those who are on anticoagulants. Shunt programming in these groups of patients 
should be taken with extreme care. Anticoagulants were stopped at least 10 days prior to lumbar 
puncture in the case of Aspirin and Clopidogrel and 5 days for those on Warfarin till the 
International Normalised Ratio (INR) was below 1.2. A small risk of bleeding was explained to 
the patients. Table 4.38 and 4.39 shows the number of patients on anticoagulants. None of the 
patients were refused investigation or surgery based on their anticoagulation status. One of the 
shunted patients on warfarin developed a subdural hematoma that did not require surgery and 
was managed with raising the shunt pressure. The INR control in this patient was good. There 
were no other complications related to the use of anticoagulants in this study. There was no 
evidence of intracerebral haematoma or shunt related infection.  
Table 4.38: Anticoagulant use in all patients 
 
 
Table 4.39: Type of anticoagulant used 
 
 
 
 
 
 
 Shunted 
n = 23 
Non-Shunted 
n = 17 
Total 
n = 40  
Anticoagulant 5 12.5% 3 7.5% 8  20% 
Anticoagulant  Shunted 
n = 23 
Non-Shunted 
n = 17 
Aspirin 3 2 
Warfarin 2 0 
Clopidogrel 0 1 
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4.10.6 Summary 
Of the 40 patients who had an ELD, 7 patients developed complication of meningitis, 
disconnection and low pressure post drainage headaches. They were all managed conservatively 
and recovered fully. There was no mortality with shunts and 17% patients developed SDHy and 
13% developed SDH. Surgical evacuation was needed in only 2 (8%) of patients. Use of 
anticoagulants did not increase morbidity when they were carefully managed.  
4.11 Value of programmable shunt 
4.11.1 Aim 10 
To identify the value of using the programmable shunts. 
4.11.2 Results of shunt programming 
During the intial part of the study, the pressure set at insertion of the shunt was based on 
the opening pressure at lumbar puncture during assessment. This accounted for 13 patients and 
the reminder of the 10 patients had their pressures set at 130 mm H2O and gradually reduced  
following surgery. Five patients (38%) developed subdural haematoma and hygroma, 3 of these 
patients developed a subdural hygroma on CT which was managed conservatively by raising 
their programmable pressure by 20 mmH2O. Of the 2 other patients who developed a subdural 
haematoma, one of them presented with a mild right sided weakness and a left sided subdural 
haematoma with some mass effect and midline shift requiring surgery for evacuation of the 
haematoma. The other patient was managed conservatively with increasing the shunt pressure to 
130 mm H2O. Table 4.40 shows the reasons for the pressure changes performed in the shunted 
patients. 
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Table 4.40: Reasons for adjusting the valve pressure  
Reasons for adjustment Initial part of study 
n = 13 
Later part of study 
n =10 
All patients 
n = 23 
Over drainage 2 0 2 
Under drainage 10 14 24 
Over drainage causing 
SDH or SDHy 
5 2 7 
Under drainage after SHD 
or SDHy 
3 1 4 
Altered by MRI 2 0 2 
Total 22 17 39 
In the later part of the study only 2 patients developed a subdural haematoma, 1 (10%) 
patient showed evidence of subdural haematoma with a minimal midline shift and another 
developed a subdural hygroma. Both were managed conservatively in the first instance, later, the 
patient with the subdural haematoma showed clinical deterioration and was operated with good 
results. One patient had a suboptimal position of the shunt and had to undergo a revision 
operation for repositioning the ventricular catheter.  
4.11.3 Summary  
Programmable shunts are useful in managing over and under drainage after insertion of a 
shunt.  There was a 28% reduction in the SDH formation following the change in the way the 
shunts were programmed.  
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Chapter 5 Discussion 
 
5.1 Introduction 
In this section each of the aims 1 to 10 of the study are discussed. The aims are repeated 
followed by discussion and a brief summary.  
5.2. Demographics and Clinical presentation 
5.2.1 Introduction 
The demographic and clinical characteristics of patients selected for shunting and those 
who were not plays a major role in determining the outcome as discussed in section 1.3. Clinical 
presentation influences the selection for shunting considering the risk:benefit ratio of shunt 
surgery.  Whether criteria can be developed to distinguish patients suffering from NPH from 
those who may be suffering from other disorders with similar presentation, and the relevance of 
clinical presentation and outcome between the shunted and non-shunted groups of patients is also 
discussed.  
5.2.2 Aim 1 
To compare the demographic and clinical characteristics of patients who are selected for 
shunting with those who are not. This may provide clearer criteria to distinguish patients 
suffering from NPH from those who may be suffering from other disorders from their 
presentation. 
5.2.3 Discussion 
 
Idiopathic NPH tends to occur in patients above 65 years of age as compared to those 
with secondary NPH who are younger. Response
 
to shunting seems to be worse (30–50%) for 
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patients with
 
the idiopathic form than for patients with a known cause of
 
communicating 
hydrocephalus (50–70%) (Vanneste, Augustijn, Dirven et al, 1992, Vanneste. 1994). Patients 
with the classical triad of symptoms respond better to shunting and gait symptoms generally 
improve more following shunting than memory followed by the urinary symptoms. These 
findings are consistent in this study.  
Over an 18 month period 44 patients were referred to the neurosurgical unit with a 
clinical and radiological suspicion of NPH. Of these four patients were excluded from the study 
as they did not have the features of normal pressure hydrocephalus and had another pathological 
cause for their presentation. The details of these patients are described in detail in section 4.2.2. 
The mean age of the 40 patients was 76 years, similar for male (N= 15, mean age 77 years) and 
female (N=25, mean age 75 years).  As compared to most other series there were more females 
(60%). In total 85% of patients were above the age of 65 years and 50% of the patients were 
between the ages of 76-85 years and 50% of these were shunted. Proportionately 10 patients 
(43%) between the ages of 65 and 75 years were shunted. The older the patients and the longer 
the duration of their symptoms coupled with co-morbid factors the less likely they improve. 
Patients with age above 65 showed improvement similar to those below 65 years in this study. In 
the present study no correlation was found between patient age and outcome following treatment 
at 1 year. The lack of a direct relationship between age and improvement after surgery in this 
study is consistent with other study data revealing no relationship between age and outcome 
(Black, 1980, Larsson, Wikkelso, Bilting, et al, 1991, Thomsen, Borgese, Bruhn, et al, 1986, 
Stambrook, Cardoso, Hawryluk, et al, 1988).  
Unlike iNPH, secondary normal pressure hydrocephalus can present at any age, usually 
younger age and they have a better outcome to shunting. The mean age was not very different, 
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75.6 years and 71.6 years for the iNPH and sNPH groups respectively. Thirty four patients (85%) 
had idiopathic and 6 patients (15%) had secondary NPH. Interestingly, only 2 (9%) sNPH 
patients were shunted and both were females. There was one patient who was found to be an 
outlier regarding age (45 years) who is discussed in this section. This patient had a large right 
parietal AVM, which was operated on twice when he was 27 years of age (18 years prior to 
presentation). After his second operation he was left with left sided weakness. He presented with 
a 12 to 24 months history of progressive worsening of power in his right leg along with memory 
and urinary symptoms. He also had a large bone defect on the right hand side from previous 
surgery. The scalp was sunken on that side although it became fuller over the course of 12 
months. He did not have any symptoms of raised intracranial pressure. His Rcsf was -
1mmHg/ml/min. With infusion of saline during the lumbar infusion test he had some headache 
and fullness of the defect. Although the value of Rcsf in his case may not be valuable because of 
the loss of integrity of the skull vault, he did not show any improvement with the lumbar 
drainage of CSF and he was not shunted.  
At presentation, 32 patients (80%) manifested with the complete clinical triad. All 
patients presented with gait symptoms, 85% as their first onset symptom and 57% with memory 
as their second symptom. Six patients (15%) did not have any urinary disturbances. Only 53% of 
those who presented with the classical triad were shunted of which 70% improved. There was a 
noticeable difference in the clock drawing (p<0.034) and 360-degree gait (p<0.027) tests 
between those who had the classical triad and those who didn‘t. Overall it was not possible to 
predict those who would do better with the shunt operation from the clinical presentation.   
An independent samples t-test showed no significant difference between the shunted and 
the non-shunted patients concerning the length of their symptoms. In the literature patients with 
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shorter duration of symptoms showed better improvement following shunting compared to those 
with longer duration of symptoms. Contrary to this view, gait symptoms were of longer duration 
in the shunted and non-shunted groups. Interestingly the classical triad was found in 80% of the 
patients and 95% had gait and cognitive symptoms. These symptoms were self-reported and 
family members were present during the interviews for reliability of information. 
Depression could affect the performance of the neuropsychological tests, and severely 
depressed patients were referred to the psychiatrist first for treatment. There was no difference 
between the shunted and non-shunted groups in their depression scores. There was one patient in 
each group who had medical treatment for depression before they were included in the study.  
Cerebrovascular disease (CVD) is an important predictor of poor outcome (Krauss, 
Droste, Vach, et al, 1996, Larsson, Wikkelsö, Bilting, et al, 1991). In the Dutch NPH study 
patients with CVD are mostly aged above 74 with a high prevalence of arterial hypertension, 
diabetes mellitus, cardiac disease and peripheral vascular disease (Boon, Tans, Delwel et al, 
1999). These risk factors were found significantly more often among patients with NPH than 
among controls (Casmiro, D‘Alessandro, Cacciatore, et al 1989, Krauss, Regel, Vach, et al 1996) 
and the evidence of cerebrovascular disease such as white matter hypodense lesions and infarcts 
on CT scanning were noted in this group of patients (Kristensen, Malm, Fagerlund, et al 1996). 
Both of these are unfavorable outcomes after shunting. The causal relationship between CVD 
and NPH is unresolved but a correlation with poor outcome is clear. The neurological decline 
sometimes seen a few years after shunting may be due to progression of these co-morbid factors. 
Malm, Kristensen, Stegmayr et al in 2000 noticed a decline from 63% to 26% at 3 years.  
However, patient selection for shunt surgery in our study has been in the same manner as for any 
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neurosurgical procedure considering age, related risks and benefits. There was no correlation 
between poor outcome and CVD or hypertension in this study.   
5.2.4 Summary 
A detailed assessment of the clinical features and demographics of the patients in the 
study failed to show any correlation between age, etiology, presentation, duration of symptoms, 
co-morbid factors and the outcome following shunting. There were more patients with the 
classical triad and they showed better improvement in the clock drawing and 360-degree turn test 
compared to those who did not have the classical triad.   
5.3 Radiological Evaluation 
5.3.1 Introduction 
Radiological evaluation not only helps in diagnosis but also in the differentiation from 
other conditions that may mimic NPH and to identify those who may be having evidence of 
cerebrovascular disease (CVD) and ischemia. In this section the usefulness of a CT scan in 
correlating the radiological improvement to clinical improvement is discussed.  
5.3.2 Aim 2 
To evaluate the usefulness of the CT scan in identifying and preventing complications 
and predicting outcome at 1 year between the shunted and the non-shunted patients.  
5.3.3 Discussion 
Radiological evaluation on its own has little significance, but coupled with classical 
clinical features it has a high prognostic index of surgical success. CT scans are used to evaluate 
the prognosis of the condition following treatment. The Evans‘ index is not an appropriate 
measure of changes in ventricular size among different individuals. Instead, determining the EI is 
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a proven method to monitor changes in the ventricular size following shunt placement in an 
individual patient, regardless of whether the size of the ventricles decreases or not. The reduction 
in the Evans‘ index was classified as significant (0.12), moderate improvement (0.06 to 0.11) and 
no reduction (0.05) in ventricular volume. There was no significant difference between the 
groups in the baseline Evans‘ index. Volumetric measurements may be helpful in clinical 
assessment postoperatively and in guiding programmable valve pressure settings (Anderson et al, 
2002). No study in the literature has shown evidence of a positive association with any of the 
imaging criteria with clinical improvement except a recent study by Marmarou, Young, Aygok et 
al. 2005. They showed a reduction in ventricular size at 1 year which was statistically significant 
(p<0.001).  
In this study, of the 23 patients who were shunted, the Evans‘ index was compared at 
base line and at 1-year post shunt. Of the 52.5% of those who showed moderate reduction in the 
ventricular size, 50% had clinical improvement, 33% did not improve and 16.6% had 
deteriorated. Amongst the 43.5% of patients who had no postoperative change in Evans‘ index 
all patients showed clinical improvement and only one (4%) patient showed significant reduction 
in the ventricular volume associated with clinical improvement at 1 year.  The mean changes at 
baseline and at 1 year were statistically significant (p<0.001), and better clinical outcomes were 
observed in patients in the shunted group with little or no alteration in ventricular size patients. 
Similar conclusion was reported by Meier, Paris, Grawe et al, 2003. Reduced compliance 
seemed to be the best predictor of rapid and marked reduction in ventricular size (Tans and 
Poortvlie, 1989). There was also a suggestion that reduction of ventricular size following CSF 
shunting is not exclusively related to CSF dynamics and more likely to depend upon the intrinsic 
elastic properties of the cerebral parenchyma, which vary with age and/or co-existing pathologies 
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in the brain (Tans and Poortvliet, 1988). Others argue that unless not assessed volumetrically, 
changes of the ventricles may go undetected, questioning any statement about the significance of 
ventricular changes after shunting observed in NPH patients (Kitagaki, Mori, Ishii et al, 1998). 
Comparing the periventricular changes at baseline and 1 year, 5 (55%) out of the 9 
patients who had periventricular changes were shunted. These changes improved significantly in 
4 patients. Although the correlation of periventricular changes with clinical outcome is not clear 
from the literature, our patients show good radiological and clinical improvement. Of the 6 
patients who had cerebral infarcts 2 patients were shunted and both did not show any clinical or 
radiological improvement. Two patients who were not shunted showed new periventricular 
changes and a further 2 developed ischemic changes at 1 year follow up. One of these 2 patients 
developed a left sided stoke which completely resolved clinically at 1 year. Those with previous 
cerebral infarcts can progress with shunting although this was seen in only 1 patient.  
Nevertheless, CT measurements of ventricular width and the ―so called‖ periventricular 
edema has shown a variable change after shunting (Tans and Poortvliet, 1988) and was not 
supposed to play any role for the clinical outcome, particularly in idiopathic NPH. Most crucial, 
however, is the accurate selection of those patients which may benefit from shunting based on 
both the clinical and imaging findings. In a retrospective analysis of imaging and clinical 
findings Vanneste, Augustijn, Tan et al, 1993, were the first to introduce a definition of NPH 
classified using the terms "probable", "possible" and "unlikely". This was based on an ordinal 
global scale derived from combined clinical and CT data, which predicted the clinical outcome 
in 112 patients shunted for presumed normal pressure hydrocephalus (NPH). Based on CT 
characteristics they achieved sensitivity values of 46% and specificity of 91% in the probable 
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shunt responder group of 17 patients. The best strategy was to shunt only patients with ―probable 
shunt-responsive NPH‖ providing ―typical CT and clinical findings‖ with a positive predictive 
value (PPV) of 65%. However, the positive predictive value of the possible shunt responders 
group was only 24%. Surprisingly, these data were supported by a more recent analysis made by 
Boon et al, 2000, suggesting that best predictive rates based on a combination of ―typical‖ 
clinical and imaging findings may not exceed 60%. This clearly shows that the prognostic value 
of CT is limited on its own. 
5.3.4 Summary 
At 1 year 50% of those who showed moderate reduction in the ventricular size (Evans‘ 
index) had shown clinically significant improvement.  Although the numbers are too small (5 
patients-55%), to do any statistical tests, it is clear that those who had periventricular changes 
prior to shunting showed both clinical and radiological improvement, whereas those with 
cerebral infarct (6 patients) were poor candidates for shunting.  An early CT scan at 4-6 weeks 
was useful to identify (a) the position of the catheter (b) patients who may need a re-operation 
for inappropriate catheter position and (c) those who are likely to need close observation for 
subdural haematomas and planning shunt reprogramming. At 1 year the Evans‘ index showed a 
significant reduction (p=0.001) in the size of the ventricle in the shunted group and the 
periventricluar lucency improved radiologically in 4 out of 5 patients.  
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5.4 Baseline tests 
5.4.1 Aim 3 
To evaluate the baseline values of the screening, neuropsychological and gait tests at 
presentation to determine whether there were any significant differences between the shunted 
and the non-shunted patients. This may help to identify those who may be suitable for shunting.  
5.4.2 Discussion 
Although the screening tests did not discriminate specific patterns of dementia they are 
able to exclude, and can be used to investigate the patients who may be severely demented or 
severely depressed, as assessed by MMSE or BDI respectively. Patients with a very low IQ can 
underperform in some of the tests and the NART scores were used to evaluate this. The NART 
and BDI were not performed during the follow-up reviews at 6 and 12 months. These screening 
tests are not diagnostic nor are they equivalent to a neurological examination or formal mental 
status testing. NART test for premorbid IQ showed similar means between the shunted and non-
shunted patients and more than 92.5% of the patients had normal intelligence. Five (12.5%) 
patients were moderately and two (5%) patients were severely depressed. Both patients with 
severe depression were treated with anti-depressants initially. One of them was shunted and 
showed improvement at 6 months but not at 1 year. This concurs with other studies where 
patients with severe depression were poor candidates for successful shunting.  
The dementia of NPH is thought to be sub cortical and mild to moderate with 78% of 
patients having a normal to moderate dementia. MMSE is not always sensitive in picking up 
early dementia. Cognitive performance varies by age and educational level and there is an 
inverse relationship between MMSE scores and age in this study. Once the limitations of the test 
are understood, it can be very helpful in both the diagnosis of dementia and in monitoring the 
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response to treatment. Some studies have shown poor outcome from shunting with patients with 
severe dementia. Nine patients had a MMSE score of less than 13 (severe cognitive deficits). 
Five of these patients were shunted, three showed improvement at 1 year and two of them had no 
improvement at all. Four of those who were not shunted did not show any improvement and two 
of them deteriorated at 1 year. This study does not confirm a worse outcome after shunting in 
those with severe dementia. 
Reports of neurocognitive response to shunting have been variable and studies that 
predict cognitive outcomes after shunting are limited. As NPH progresses, cognitive impairment 
may become more generalized and more refractory to treatment. Nevertheless, even patients with 
fairly advanced dementia may still respond positively to shunting as shown in this study with 3 
of the 5 patients shunted with severe dementia showing improvement. The baseline 
neuropsychological tests showed no significant differences between the shunted and the non-
shunted patients at presentation. The Pearson correlation did not show a relation between the 
neuropsychological and gait tests.  
5.4.3 Summary 
The screening tests used in the study did not discriminate between the shunted and non-
shunted patients. Both groups had a normal IQ on the NART tests and 82.5% patients had a mild 
to normal BDI. 77.5% patients had mild to moderate cognitive deficits in the MMSE scores. 
There was no difference in the baseline neuropsychological and gait tests between the two 
groups.  
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5.5 CSF hydrodynamics  
5.5.1 Aim 4 
To evaluate the usefulness of Rcsf value as a criterion for shunting and analyse the 
outcome of the patients shunted with an Rcsf of 12mmHg/ml/min or more.  
5.5.2 Discussion 
The constant pressure infusion methods generate more data during a given time period 
than by using a constant flow infusion. The disadvantages are the more invasive nature of the 
procedure (two punctures of the CSF space) and the more complicated equipment required. In 
this study the simple lumbar constant flow infusion with one infusion rate was used, which has 
proved to be a reliable and reproducible method. 
Both lumbar infusion studies and ELD predict a positive outcome of shunt operations. 
They are complimentary to each other and best used together for optimal patient selection. There 
is also the argument that merely recording the steady state plateau pressure during the constant 
lumbar infusion study as originally described by Katzman was more accurate than calculating the 
Rcsf values. This is because if a patient had a high opening pressure at LP, the difference 
between the plateau pressure and the opening pressure will be low and vice versa. This high 
opening pressure will tend to disqualify patients from shunt surgery and vice versa if low 
(Kohlon, Sundborg, Rehncrona. 2002). Although good-to-excellent results were obtained using 
Rcsf as a predictor of outcome (Børgesen and Gjerris, 1982, Hartmann and Alberti, 1977, Lamas 
and Lobato, 1979, Lundar and Nones, 1990, Nelson and Goodman, 1971, Price, 1989, Tans, 
1979,  Tans and Poortvliet, 1984,  Tans and Poortvliet, 1985, Boon, Tans, Delwel et al. 1997), an 
equal number of studies has shown a less favorable predictive value (Wolinsky, Barnes, 
Margolis et al, 1973, Stein, Langfitt et al, 1974, Malm, Kristensen, Fagerlund et al, 1995, Janny, 
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Colnet, Veyre et al, 1981, Kosteljanetz, Nehen, Kaalund et al, 1990, Graff-Radford, Godersky, 
Jones et al, 1989, Delwel, de Jong, Avezaat et al, 1989). Another limitation of this test is that it 
needs a dedicated specialist who is able to perform and interpret the results.  
Although an Rcsf of 12mmHg/ml/min was used as one of the positive predictors in this 
series, the objective was also to determine the positive and negative predictive values of different 
ranges of Rcsf. At cutoff value 12 mm Hg/ml/minute, positive predictive values for improvement 
were approximately 68%, but the likelihood ratios were low. The likelihood ratio rose to 1.38, 
with a positive predictive value of 80%, for an Rcsf of 18 mm Hg/ml/minute. The negative 
predictive values were disappointingly low for all levels of Rcsf.  In some studies (Delwel, de 
Jong, Avezaat et al, 1989) Rcsf was used as a criterion for the diagnosis of NPH. Price 
emphasized the importance of different cutoff levels of Rcsf in 1989. The proportion of his 
patients responding positively to shunt placement increased almost linearly with increasing Rcsf. 
In the shunted group 17.5% patients improved with Rcsf values less than 12 and all of these 
patients showed improvement following ELD. If we had used Rcsf of 18mmHg/ml/min as a 
cutoff criterion, 4 patients who improved with an Rcsf between 12 and 18 may have been left 
out. The explanation for those who improved with low Rcsf could be due to physiological 
variability and more importantly was the improvement following ELD.  Boon et al, 1997 
demonstrated that leakage around the needle during an infusion test could explain this, although 
we cannot confirm this in this study. More important are the patients who did not improve 
despite the high Rcsf values; this cannot be explained.   
At an Rcsf of >12mmHg/ml/min there were significant differences between the shunted 
and the non-shunted groups in all the neuropsychological tests and most of the gait tests except 
the 10 metre walking test.  
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5.5.3 Summary 
It can be concluded that the Rcsf value of 12mmHg/ml/min was valuable in shunt 
selection but it should not be used as a positive indicator by itself, but instead used in 
combination with clinical as well as radiological findings typical for NPH and improvement 
following ELD. This study cannot recommend that choosing a higher Rcsf as a cut off was more 
valuable than using an Rcsf of 12 mmHg/ml/min in shunt selection.  
5.6 Response to ELD 
5.6.1 Aim 5 
To determine whether the effects of external lumbar drain (ELD) on supplemental 
neuropsychological and gait tests in addition to urinary symptoms would identify those patients 
who would benefit from a shunt, and to determine if there was any correlation between the tests 
used to select patients for shunting at 1 year. 
5.6.2 Discussion 
5.6.2.1 Introduction of selection bias 
 
Based on the improvement following ELD patients were classified into probable, possible 
and unlikely groups. Significant improvements (p<0.05) were seen for all of the 
neuropsychological tests and most of the gait tests except the 10 metre walking time and 360 
degree turning time in the shunted patients. Clearly this approach introduces a selection bias at 
this stage. Patients are put in the respective categories based on their results and treatment is 
instituted on this basis. The alternative is to shunt all patients in the study irrespective of the ELD 
outcome as in the Dutch NPH study (Boon, Tans, Delwel et al, 1998), but there are ethical 
considerations to be taken into account with this approach. Since this bias is unavoidable in the 
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study more emphasis will be given to the group of patients who were shunted and to look at 
those who improved versus those who did not improve. This will be discussed more in detail in 
chapter 6.6.  
5.6.2.2 ELD outcome 
Studies by other investigators who used ELD vary in their results. Walechenbach, Geiger, 
Thomeer et al, 2002, reported a positive predictive accuracy of 87% with ELD and a negative 
predictive accuracy of 36% in 43 patients with iNPH and justified shunting patients who 
improved with ELD. They also concluded that those who did not improve should also be shunted 
given that 4 out of the 18 patients in their series improved despite negative ELD. This conclusion 
cannot be justified. Haan and Thomeer, 1988, in a retrospective study of 32 patients showed 10 
patients to improve with a lumbar tap test and the 22 patients who did not improve underwent 
ELD and all of them showed improvement and were shunted. They concluded that ELD was a 
safe and effective means of predicting improvement.  
5.6.2.3 Within shunted patient discussion  
It is very important to discuss the patients within the shunted group in the probable and 
possible category. Eleven out of 12 (30%) patients in the probable group were shunted and 
twelve of the 19 patients in the possible group were shunted.  Nine patients did not improve with 
ELD and none of them were shunted. There was a 74% improvement seen at 1 year in those 
patients who underwent shunting following improvement from ELD in the probable and possible 
group. Seventeen percent did not show any improvement and 9% worsened following shunting. 
In the probable group 73% improved, 18% did not improve and 9% were worse. The one patient 
who refused to have a shunt did not improve. In the possible group, of the 12 patients who were 
shunted 75% improved, 17% did not improve and 8% were worse. In the non-shunted group of 7 
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patients, 14% improved with no treatment, 14% did not improve and 72% worsened. Based on 
the patients in the possible group, if we used the 7 patients in this group who refused a shunt as 
controls, 72% of the non-shunted patients deteriorated with observation at 1 year. On the other 
hand those 75% of patients in the same group who were shunted had a significant improvement. 
We can conclude from this that the ELD was a significant test to assess the outcome of 
treatment.  
5.6.2.4 ELD retesting 
 The natural history of NPH shows that most patients will continue to get worse while a 
significant number will remain stable after a period of decline (Marmarou, Young, Aygok  et al, 
2005). There are no predicting factors to identify those who will remain stable or get worse. 
Some clues are the severity of dementia at presentation, associated co-morbidity and presence of 
Alzheimer‘s disease.  There are few factors that can provide false negative results on the ELD 
and Rcsf calculation including the position of catheter and patient co-operation during the tests. 
Other factors that may introduce false negative results are lower back pain and discomfort in 
performing the tests following the lumbar puncture, post drainage headache and unsteadiness and 
environmental factors. Repeating the ELD test on a separate occasion may alleviate these factors 
and give a true positive result. Those who continue to get worse can either be watched or 
retested. Although all 14 patients who deteriorated at 6 months were offered a retest only 2 
patients accepted this. There are several reasons for this. The majority of the patients did not 
want to undergo a further stay in hospital, receive a lumbar puncture and drain again and have all 
the tests repeated. Whether using a smaller LP needle could have changed the experience needs 
to be considered for future studies.  
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5.6.3 Summary 
Of the 31 (77.5%) patients (probable and possible group) who were candidates suitable 
for a shunt only 23 got shunted and at 1 year only 17 (74%) of these improved in their clinical 
symptoms. Nine of those who were not suitable following an ELD did not get shunted and as 
expected none of them improved after a 1-year period of conservative management. 
Supplemental tests used to identify the response to ELD were useful to categorise patients for 
shunt selection. These categories were able to identify a high percentage of patients who may 
respond to a shunt. Although the groups were highly selected from the criteria chosen, those 
patients who did not receive a shunt can be used as a control group to predict the natural history 
of the disease. Of those not responding to ELD 29% remained stable and 66% progressively 
deteriorated over a period of 1 year.  
5.7 Outcome of surgery at 6 months and 1 year 
5.7.1 Introduction 
In this section aims 6 to 8 are discussed. The outcomes of the shunted and non-shunted 
patients are discussed at 1 year. Tests that may help identify patients who may respond better to 
shunting are also discussed.   
5.7.2 Aims 6 to 8 
Aim 6 
To examine the effects of shunting to determine whether the symptoms of NPH improve 
following surgery. The control group (those not receiving a shunt) were reassessed after the same 
time period to determine which factors alter over time. 
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Aim 7 
To compare the selection criteria including ELD, Rcsf values and outcome of the shunted 
patients who have responded well to surgery, with those who show little or no improvement. 
Within group analysis may assist in developing criteria, in the future, to select patients who are 
most likely to benefit from surgery. 
Aim 8  
To investigate if any of the neuropsychological or gait tests at baseline were able to 
predict surgical success or failure in the shunt improved patients at 1 year. 
5.7.3 Discussion 
 Only a few papers report an extended follow-up of patients with NPH and the value of 
the supplemental tests. All patients were followed up to 1 year. The non-shunted controls were 
also followed up with clinical and radiological review.   
There were significant differences between the shunted and the non-shunted patients in 
all the neuropsychological and most gait tests at 1 year. The improvement was more marked at 1 
year compared to 6 months. Overall there was a 74% improvement in the shunted patients and 
9% got worse. In those who were not shunted, as expected, there was deterioration in about 65% 
of patients and about 30% remained stable. Over time 17% of non-shunted patients showed a 
slight improvement in their condition without any treatment. There were more patients who 
improved or remained stable than those who got worse in the non-treated group.  
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Gait is generally believed to improve most with treatment (Graff-Radford and Godersky, 
1987). Only 26% improved in their urinary symptoms. Some previous studies report that only a 
very small percentage of patients show improvement in cognitive function. In this study 83% of 
patients showed improvement in their gait symptoms and 78% of patients showed improvement 
in memory at 1 year as supported by Meier, Zeilinger and Kitzel, 1996, who found higher rates 
of improvement following shunt surgery, of 65% at short term follow up. Other studies have 
shown mild regression at long term follow-up with only 54% remaining improved (Thomas, 
McGirt, Woodworth et al, 2005). Only 26% of the patients improved in their urinary symptoms. 
No statistically significant association was found between symptom duration and outcome. The 
overall improvement of the shunted patients was 43% at 6 months and 74% at 1 year. The 
significant improvement at 1 year compared to 6 months is due to the change in the shunt 
pressure setting during this period.  
5.7.4 Shunted vs non-shunted patients 
Figure 5.4 shows the flow chart of the patients in the study. The chart explains at each 
stage the total number of patients involved following treatment. Of the 23 shunted patients 13 did 
not improve and they all had their shunt re-programmed. At 1 year review 7 of these 13 patients 
improved with shunt re-programming and 6 of them had no improvement. In the non-shunted 
patients at 6 months only 3 patients were static and 14 patients deteriorated. Retest was offered 
to all 14 patients but only 2 accepted. Unfortunately both did not improve and were continued to 
be followed up. At 1 year interestingly 3 more patients slightly improved in the non-shunted 
group. These details were discussed in the previous chapter 5.6.  
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Figure 5.4:  Flow chart of follow-up including number of patients.  
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Because the shunted and non-shunted patients are highly selected, the best way is to 
compare the two groups separately. Within the shunted group the patients who improved with 
surgery were compared with those who did not improve following a shunt to identify factors that 
help to guide selecting patients for shunting in the future. Assessment tools are both invasive 
(lumbar puncture and ELD) and non-invasive (Neuropsychological and gait tests). Invasive tests 
carry a small but serious risk of meningitis. If the non-invasive tests were able to predict better 
those who will respond to a shunt it will help avoid performing the invasive tests. But this is not 
possible as the baseline neuropsychological and gait tests failed to show a pattern to guide 
patient selection.  Hence a lumbar puncture to calculate the Rcsf and ELD is necessary to 
quantitatively assess improvement in the neuropsychological and gait tests. MMSE and the 10 
metre walking tests were good predictors of surgical success. MMSE is used as a screening test 
to assess various components of dementia and in clinical practice this is a quick way to assess 
improvement following a lumbar puncture. Regression analysis showed that the verbal fluency 
test for FAS was the only variable that was important.  
5.7.5 Rcsf as a selection criteria in shunted patients  
An Rcsf of 12mmHg/ml/min was used as a criterion for treatment. As discussed in Table 
4.21 seven patients with an Rcsf of < 12 mmHg/ml/min and 16 patients with an Rcsf > 12 
mmHg/ml/min were shunted. Six of these had an Rcsf of between 12 and 18 mmHg/ml/min and 
10 had an Rcsf of > 18 mmHg/ml/min. Of those shunted with an Rcsf of > 12 mmHg/ml/min, 
75% improved at 1 year. Interestingly all patients with an Rcsf of < 12 mmHg/ml/min (100%) 
improved with a shunt. This shows that although choosing an Rcsf cut-off value can be a positive 
prognostic indicator it should be supplemented with improvement following ELD. A similar 
conclusion about the usefulness of Rcsf values was drawn by several studies. (Malm, Kristensen, 
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Fagerlund et al, 1995, Janny, Colnet, Veyre et al, 1981, Kosteljanetz, Nehen and Kaalund, 1990, 
Graff-Radford, Godersky and Jones, 1989, Delwel, de Jong, Avezaat et al, 1989). 
5.7.6 ELD and outcome of shunted patients 
Following the criteria used in Table 3.3, 30% of patients in the ―probable‖ group 
improved following ELD. All but 1 patient was shunted. Of these patients 73% improved at 1 
year. Twelve patients out of 19 in the ―possible‖ group were shunted and 63% of these patients 
improved. None of the patients in the unlikely group were shunted. Considering the patients in 
the probable and possible group would improve with a shunt, 74% showed improvement at 1 
year, 17% showed no improvement and only 9% were worse. This confirms that classifying 
patients following ELD into ―probable‖, ―possible‖ and ―unlikely‖ has serious benefits in 
identifying those who are likely to benefit from a shunt.   
5.7.7 Summary 
At one year there was a statistically significant difference between the shunted and the 
non-shunted patients in their neuropsychological and gait tests. The improvement was noticed 
more in the gait than neuropsychological tests followed by a smaller improvement in the urinary 
symptoms. Except the urinary symptoms there was a sustained improvement in the clinical 
symptoms over time from 6 months to 1 year. The MMSE and 10 metre walking tests were good 
predictors of surgical success and a regression analysis showed VF to be a good prognosticator 
of outcome. Baseline tests could not differentiate those who will respond to a shunt and invasive 
tests (LP and ELD) will be needed to identify these patients. Using Rcsf on its own was not 
useful and classifying patients based in outcome from ELD was helpful in making a treatment 
decision.  
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5.8 Complications of ELD and shunting 
5.8.1 Aim 9 
To identify the complications occurring from external lumbar drain, shunt and use of 
anticoagulants. 
5.8.2 Discussion 
The complications following lumbar puncture and insertion of ELD were minimal. Two 
patients (5%) developed symptoms and signs of meningitis. One of these patients had grown 
staphylococcus aureus in the CSF culture and later on had a shunt insertion after 2 months, and 
the other did not qualify for shunting. In the literature, the risk of meningitis from a spinal 
catheter following neurosurgical post-operative drainage of CSF is 4 – 10%; however this may 
not reflect the rate in NPH population. Mortality is quoted at 1-2% in some series. Three patients 
(7.5%) had their lumbar drain disconnected from the lumbar CSF space and a repeat ELD 
insertion was performed. The way dressings were applied to secure the lumbar drain was 
modified during the later part of the study and this complication was avoided.  Two patients 
(5%) developed low pressure headaches and needed fluid hydration and pain killer for more than 
24 hours following ELD. No other complications were noted following the lumbar puncture and 
ELD.  
The incidence of co-morbidity plays a role in determining the risk to benefit ratio. 
Complications of shunting can occur at the time of shunt operation or after the procedure which 
may be immediate or delayed. The most common immediate complication reported is 
intracerebral haematoma, 3% in the Dutch series (Boon, Tans, Delwel et al, 1998). Delayed 
complications normally are infection, seizures, shunt malfunction, under and over drainage, 
headaches and most importantly subdural collections. The incidence of subdural collections 
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quoted in literature is 2-17% (Black, 1980) and 9.5% in iNPH and 1.4% of Secondary NPH 
(Zemack and Romner, 2002). In the Dutch Normal-Pressure Hydrocephalus Study routine CT 
screening after VPS insertion showed subdural effusions in 71% of patients with low-pressure 
valves and in only 34% of patients with medium-pressure shunt systems. The subdural 
collections can either be a simple effusion, which can be observed with close surveillance or a 
major haematoma requiring immediate drainage. Early drainage of asymptomatic subdural 
effusions has not shown any superior benefits than conservative management. Early CT scanning 
may pick up these collections from 4-6weeks following surgery. Adjustable valves are useful in 
the conservative management of subdural collections by increasing the opening pressure and 
prevent worsening. Mortality related directly to shunt insertion is very low but the risk increases 
gradually over time after shunting when complications arise (Malm, Kristensen, Stegmayr et al, 
2000). Patients on anticoagulants did not pose an excess risk of bleeding problems. There was no 
mortality in this study at 1 year follow up.  
5.8.3 Summary 
The risk of subdural haemaetoma and hygroma was significantly reduced in the later part 
of the study by the way in which the patient‘s shunts were programmed. The risk following ELD 
was minimal and the technique of securing the drain to avoid the displacement was modified. 
Recognized complications of shunt placement like inadequate position, over and under drainage 
related complications as reported in other series were seen. There was neither mortality nor shunt 
infection in our series.  
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5.9. Value of programmable shunt  
5.9.1 Aim 10 
To identify the value of using a programmable shunt. 
5.9.2 Discussion 
 
Various strategies for setting the opening pressure and making the adjustment have been 
mentioned. Some have used a high initial opening pressure that can be decreased until there is an 
improvement of symptoms (Pollack, Albrigh, Adelson et al, 1999) whereby others recommend a 
low opening pressure that is increased in the postoperative period (Turner and McGeachie, 
1988). A third option would be to start with a reasonably high setting at the time of shunt 
insertion, reduce the opening pressure to a level at which the brain parenchyma gives way to 
ventricular shrinkage, and then increase the pressure slightly once the clinical symptoms begin to 
improve to avoid complications of over drainage (Hakim, Hakim, Hakim et al, 2001). In the 
initial part of the study the shunt pressure was set at the opening pressure at lumbar puncture. It 
was found that 5 (38%) of the 7 patients who developed SDHy and SDH had shunt valve settings 
set between 60-90mm H2O. After these complications were encountered, during the later part of 
the study the opening pressure of the valve was set at 130 mm H2O and gradually reduced at 
their first visit if there was no evidence of SDHy or SDH. The incidence of SDHy and SDH 
significantly reduced, although 2 patients presented at 1 year with a SDHy and SDH not needing 
any surgical treatment.  
The first 13 patients had their shunt pressure set at the opening pressure during the 
lumbar puncture. There were 5 (38%) patients who developed complications of subdural 
haemetoma and hygroma. Two had a haemetoma and one needed a burrhole drainage of the 
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blood collection and the other was managed conservatively by raising the pressure to 130 mm 
H2O. It was found that they did not improve following the raise in pressure and their pressures 
were slowly lowered. Following this observation the policy of shunt programming was changed 
in the later part of the study and the pressure was set at 130 mm H2O and then lowered during 
their follow-up starting from 4-6 weeks. Of the 10 patients in this group 1 (10%) patient 
developed a subdural collection with a minimal pressure and the other patient develped a 
subdural hygroma. A burrhole evacuation of the clot was performed on the subdural patient. 
There was certainly a 28% reduction in the number of subdural formation following this change 
in pressure setting at the time of shunt insertion.  
Adjustments were performed mostly at the time of first review at 4-6 weeks; the valve 
was re-programmed by lowering the pressure by 20 mm H2O. If there were signs of overdrainage 
then the pressure was raised by 20 mm H2O. A check X-ray was taken to confirm every change. 
Everytime a patient had a change to their programme they were reviewed within 4 weeks to see 
the effect of change and further adjustments were made if necessary. The other reasons for the 
change in the pressure was performed when there was evidence of a subdural hygroma (SDHy) 
or subdural haematoma (SDH) on CT scans at 4-6 weeks post surgery. The patients were not 
seen on a regular basis as recommended in some series for change of pressure. The patient, 
family and carers were well instructed to contact us if there was either deterioration or no 
improvement in their clinical condition. The patients were given a card that described the 
pressure setting in their valve.  
5.9.3 Summary 
The results show that the best way to set the opening pressure of the programmable valve 
was to set at a higher pressure and then gradually reduce if the CT scan did not show any 
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evidence of SDHy and SDH. The incidence of SDH and SDHy reduced with this policy. The 
average change of the programmable shunt was less with the starting at a lower pressure than at a 
higher pressure, which brings the argument of using low pressure differential pressure valve. 
Radiological findings were not evaluated after each adjustment, because the change in 
ventricular size, in our experience, does not always correlate with the clinical outcome. 
Programmable valves help in adjusting the pressure of the shunt and also in treating patients with 
subdural conservatively.  
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Chapter 6: Conclusions  
 
6.1 Value of clinical and radiological criteria  
Analysis of the data in the literature shows some positive prognostic indicators with the 
complete clinical triad (Benzel, 1994,  Raftopoulos, Deleval, Chaskis  et al, 1994,  Black, 1980, 
Jacobs, Conti,  Kinkel WR et al, 1976), recent onset of symptoms (Caruso, Cervoni, Vitale et al, 
1997, Graff-Radford and Godersky, 1986, Larsson, Wikkelso, Bilting et al, 1991, Thomsen, 
Borgesen, Bruhn et al, 1986, Peterse, Mokri, Laws et al, 1985, Wood, Bartlet, James et al, 1974), 
a history of gait abnormality before dementia (Caruso, Cervoni, Vitale et al, 1997, Graff-Radford 
and Godersky, 1986, Graff-Radford, Godersky, Jones et al, 1989),  small cortical sulci (Benzel, 
1994, Black, 1980, Tans, 1979), enlarged temporal horns (Stambrook, Cardoso, Hawryluk et al, 
1988, Tans, 1979, Wikkelso, Andersson, Blomstrand et al, 1989), secondary  NPH (Larsson, 
Wikkelso, Bilting et al, 1991, Thomsen,  Borgesen, Bruhn et al, 1986) and the absence of other 
contributing causes of dementia.  
In this study age, etiology, presentation, duration of symptoms and presence of co-morbid 
factors were unrelated to outcome. Evans‘ index showed a significant reduction in the size of the 
ventricle in the shunted patients at 1 year.   
6.2 Value of supplemental tests  
 
After confirming a clinical and radiological diagnosis the decision to shunt a patient was 
based on responses to the supplemental tests. These tests can increase the predictive accuracy for 
prognosis to greater than 90% (Marmarou, Bergsneider, Klinge et al, 2005). Screening tests used 
in this study were able to differentiate patients with depression and severe dementia. From the 
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MMSE test, 77% of patients suffered mild to moderate dementia of NPH type. There were no 
significant differences between the shunted and the non-shunted patient‘s baseline 
neuropsychological or gait tests. A multiple regression analysis showed the verbal fluency-FAS 
to be the only test to predict a good outcome in the shunted patients at 1 year.  
Rcsf testing and improvement to ELD are known to correlate with good outcome in 
several series as mentioned previously. The range of better outcomes mentioned lies between 12 
and 18 mmHg/ml/min. Sixty three percent of patients had shown improvement at 1 year with an 
Rcsf of more than 12mmHg/ml/min. The post-test probability of having shunt response was 68% 
and the negative predictive value was 14% with a specificity 64% and sensitivity of 16%. The 
specificity increased with rising Rcsf values.   
Thirty one patients (77%) were likely to improve with shunting in this series (probable 
and possible group). Twenty three (74%) of these patients were shunted and 18 (58%) showed 
improvement at 1 year. The sensitivity of ELD was 100% and the specificity was 52% with a 
PPV of 74% and a NPV of 100%. This shows that both Rcsf testing and ELD enhance a positive 
predictive outcome of shunt operation. From this study the Rcsf cut off value recommended is 12 
mmHg/ml/min as 4 patients who showed improvement at 1 year may not have been shunted if 
the Rcsf cut off was raised to 18 mmHg/ml/min even though the specificity and PPV may rise.  
6.3 Value of shunting and pressure setting 
The Cochrane review concluded that ―there is no evidence to indicate whether placement 
of a shunt is effective in the management of NPH‖ (Esmonde and Cooke, 2002). Recent 
international guidelines recommend CSF diversion for iNPH patients in whom there is a 
favourable risk-benefit ratio (Marvin, Black, Klinge et al, 2005). The lack of a randomised 
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controlled trial gives rise to discrepancy in the views. There are approximately 162 different 
companies making valves in the world market as of 2006. Of these 137 are simple differential 
valves and 118 advanced technology valves (26 adjustable pressure valves). Unfortunately there 
no data comparing superiority of one valve over the other in NPH (Drake, Kestle, Milner et al, 
1998). Data from the UK shunt registry, over a period of 8 years, shows the 1-year revision rate 
for overdrainage to be 0.9 +/- 0.8% (SD) in NPH by using various shunts, almost invariably due 
to subdural collections. Hence, we can conclude that there was no significant difference between 
the valves systems, but, certainly the complications such as subdural haematomas and hygromas 
can be more readily managed with adjustable valves. Adjustable valves allow for raising or 
lowering the pressure differentials according to the clinical need and are now implanted as a 
matter of routine (Zemeck, Romner, 2002). Selecting a higher pressure at shunt implantation and 
gradual reduction over a period of time has reduced the complication of SDH and SDHy rates 
significantly. This also gives the opportunity to select the best response to pressure setting for 
that individual patient by repeated adjustments.  
6.4 Identifying the shunt responsive patients 
In this study it was found that the classification of patients into probable, possible, and 
unlikely categories following ELD was useful in determining the treatment. This was 
recommended by the recent international study group for NPH. (Relkin, Marmarou, Klinge et al 
2005). Hopefully these criteria will be widely applied in clinical practice and will promote 
greater consistency in patient selection in future clinical investigations involving NPH. Ideally, 
the best way to study the selection of patients with shunt responsive NPH would be a randomised 
control study or to shunt all patients in the three categories, but for ethical reasons this was not 
possible in this study. If the risks of shunting were small, this would be an appropriate approach; 
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however as that is not the case; we still need diagnostic methods to select those patients who are 
most likely to benefit from CSF diversion.  
All 23 patients who were shunted were positive to ELD, of which 17 (74%) showed 
improvement at 1 year. The CSF drain effectively mimics the effects of the shunt; therefore those 
who respond to this are most likely to respond to surgery. Those who show no improvement are 
less likely to benefit from a shunt. 
6.5 Awareness of NPH 
Current NPH research in the UK is isolated to very few dedicated centres. Even hospitals 
that have a dementia service do not have a multi-disciplinary team to deal with this entity. 
Patients without appropriate investigation may receive a shunt. These patients are not followed 
up long term to study the outcome. Those who are not deemed for a shunt are lost to follow up 
and review. Although there are several factors it is partly due to lack of awareness among the 
medical community in referring these patients to the appropriate physicians. Because the elderly 
patients have varied co-morbidity there is a lack of sub-specialist interest among surgeons to deal 
with these patients. Once patients are shunted, they are subject to shunt related complications 
which can be delayed after several years and hence they need long term follow up. Over drainage 
and under drainage problems can be under diagnosed and not treated appropriately.  
Because of the improved health care and increased longevity patients in their 70s and 80s 
are now seeking an improved quality of life and are willing to accept the risks of surgery. 
Evidence suggests that shorter duration of symptoms is related to better outcomes, although this 
was not the case in this study. In the UK, currently 700,000 or one person in every 88 has 
dementia, incurring a yearly cost of £17 bn. By 2051 it is estimated that the figure will rise to 
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1,735,087, an increase of 154% (BBC, February 2007).  It is estimated that about 5% of these 
patients may suffer from NPH. An increasing elderly population is seen in most developed 
countries and more needs to be done to increase the awareness of normal pressure 
hydrocephalus. This awareness needs to be targeted both at the public and the medical 
professionals in a well balanced manner as there will a large number of patients referred as a 
consequence. Increasing the awareness alone will be inadequate if we are not able to implement 
these tests systematically. The infrastructure within the NHS needs to be better developed to 
perform these tests as a routine in a larger scale in a multicenter setup. This will be an important 
aim of future work.  
6.6 Limitations of the study 
6.6.1 Methodological limitations 
Improvement following ELD was used in selecting patients for treatment. The selection 
bias introduced in assessing patients‘ following treatment is unavoidable for several reasons. 
There is no gold standard test to diagnose NPH and the treatment with VP shunt cannot be 
justified in those with only a suspicion of the diagnosis. VP shunt carries a serious risk. This is a 
serious limitation in the methodology and introduces a biased group of patients.  
The alternative methodological option is to shunt all the patients. Shunting all patients 
will give the opportunity to study those who were expected not to improve with shunt following 
failure to improve with ELD. This will answer the question as to why we should or shouldn‘t 
shunt those who are unlikely to improve. This method has serious ethical considerations and this 
approach may not be justified for the reasons discussed in the previous paragraph.  
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Another method would be to randomize whether patients receive a shunt. Because there 
is no clinical equipoise in treatment this will again be unjustifiable. There is also the risk of 
losing out on those who are likely to improve with ELD and may benefit from a shunt.  
Given these limitations the best option was to select patients who improved with an ELD 
and treat them with a shunt operation, with the intention that the majority of them have a better 
chance of improving from a shunt compared with those who do not show any improvement with 
an ELD.  
Patients in this study were assessed by the researcher. A multi disciplinary approach to 
patient assessment and treatment was a drawback of the study. This was partly due to the 
difficulty in setting up such a group in an NHS setting. In future this will be a serious 
requirement to effectively diagnose the condition.   
6.6.2 Limitation of outcome measurement 
The other limitations of the study are the outcome measures. There is no standard 
outcome measure for NPH patients like the Glasgow outcome scale (GOS) for head injury. In 
most studies improvement rates and outcomes after shunting have been combined. Various 
measures have been used in different studies, Black scale, Stein and Langfit scale for assessment 
of shunt outcome, Dutch NPH scale, Japanese NPH scale only to mention a few (Marmarou, 
Bergsneider, Klinge et al, 2005). These are not validated for the use in NPH patients. The 
outcome measurements need to focus on all three components of NPH and the general measures 
of quality of life. Assessment of the dementia component is difficult and symptoms may progress 
over time especially in the non-shunted patients. According to the international guidelines 
published in 2005 (Marmarou, Bergsneider, Klinge et al, 2005), outcome is measured by 
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―improvement‖, ―no improvement‖ and ―worse‖. In this study the same measures has been used 
through out. General QOL measurements have not been used in this study, which needs to be 
included in the future.  
6.7 Future Consideration 
6.7.1 Future consideration from this study 
 
The patients in this study were assessed and tested by the main researcher and the 
supervisory consultant in the hospital before a shunt was inserted. The differential diagnosis for 
NPH includes a large number that are relatively commonplace in the elderly population. 
Multidisciplinary approaches will be necessary in the future to assess these patients. A 
multidisciplinary team of specialists may consist of a neurologist, neurosurgeon, psychologist, 
physiotherapist and psychiatrist, where indicated. Because dementia of NPH is not easy to 
differentiate these patients must be seen by a clinical psychologist or a neurologist. A clinical 
physiotherapist assessed patients in this study. Following discussions with these professionals, a 
decision must be reached regarding treatment.  
A 16G epidural needle was used in this study. Larger bore needles can cause more 
discomfort to patients and there is a potential for fluid leak around the catheter during the 
infusion studies. A smaller gauge needle must be used in the future. The drainage of CSF was 
100ml over a period of 2 days. Recent study shows that better results are achieved with more 
drainage of CSF up to 250ml over a period of 3 days (Marmarou, Young, Aygok et al 2005). 
This gives a higher specificity and sensitivity for the post procedure analysis. 
Patient‘s life expectancy and co-morbidity should be taken into account as they determine 
the outcome. The current study is only a one-year follow up. This will not answer questions 
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regarding risk benefit ratios of shunt insertion, which are more significant after one year. A long-
term follow-up is necessary. These patients should be followed up for a period of 3-5 years. The 
patient‘s managed by observation should also be followed-up in a similar manner to understand 
the natural history.   
From this study adequate experience has been gained to recruit, organise and investigate 
large number of patients for appropriateness of shunting and long-term follow-up.  The study is 
being continued and expanded. Further assessments of Cine Phase MR CSF flow studies before 
and after ELD and shunting, assessment of CSF biochemical markers and measurement of 
lumbar pressure are being undertaken currently. It is proposed to follow up the patients in this 
study for a period of 3-5 years to predict long term outcome. The protocol used in this study has 
been modified to collect more data and additional investigation as mentioned above.  The 
experience gained and the scope of this study has expanded. It is hoped to collaborate with other 
centres in the North West of England and wider.  
6.7.2 Future considerations in a broader context. 
Since the disease is complex and there may not be a gold standard test to predict shunt 
response, future efforts should be directed towards better identification of the pathogenesis of 
idiopathic NPH.  A randomised controlled trial cannot be implemented for several reasons, but 
this would be ideal. With the advances in diagnostic tests and shunt design, the patients outcome 
is significantly better and doctors in the forefront are showing a renewed interest in treating NPH 
across the globe. In many ways we are doing better, thanks to the 40 years of clinical studies and 
new investigative technology. In identifying those who will respond best to a shunt, tests 
revolving around lumbar puncture, lumbar tap and drainage have been used as the standard 
methods when assessing improvement. These are invasive tests with minimal but serious risks. 
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Many CSF factors have been identified that can diagnose the disease and predict the outcome. 
MR CSF flow studies can predict shunt responders and PET scans have been used to detect 
periventricular blood flow improvement post shunt. Non-invasive methods of investigation and 
prediction of outcome is being increasingly recognised as a safe and quicker option, but these 
can be cost-intensive. Treatment has been challenged with endoscopic third ventriculostomy, 
although the effectiveness of this treatment is less known in iNPH.  Large numbers and longer 
follow-ups are necessary to answer some of the difficult issues surrounding this condition, but 
old age and co-morbidity will always limit this. 
6.8 Concluding comments 
Several guidelines have been derived from the literature in the last decade from different 
parts of the world. Although there is little variation in their recommendation we are in a better 
position to manage these patients from the information available. Although this study was not 
able to identify those who will respond to a shunt from their age, etiology, duration of symptoms 
and classical triad, it supports the literature that a typical clinical presentation and radiological 
diagnosis along with CSF hydrodynamic testing, including an ELD for improvement was able to 
produce a 73% good response to shunt at 1 year. An Rcsf of >12 mmHg/ml/min can be 
recommended as a cut off above which good surgical outcomes may be seen but this cannot be 
used on its own. The initial and late risk of shunting can be avoided by using a programmable 
shunt and performing an early scan a few weeks after surgery and a later scan to identify late 
subdural collections. The early complications of subdural collections can be avoided by setting 
the pressure between 110 and 130 mmH2O and gradually reducing over time. Overall a 
systematic approach to investigate these patients based on a protocol can identify shunt 
responsive patients with higher success rates, but we haven‘t identified any non-invasive tests 
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that will predict those who will benefit a shunt. The long term follow up of these patients is 
necessary to account for further clarification of this protocol. It is proposed to continue this work 
in its entirety along with some modifications and further non-invasive investigations in the future 
and collaborate to set up a multicenter study in the United Kingdom.    
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Appendix 
 
Appendix 1: Patient and Relative information leaflet 
 
Royal Preston Hospital 
Lancashire Teaching Hospital NHS Trust 
Department of Neurological Surgery 
Sharogreen Lane, Fulwood, Preston PR2 9HT 
 
Research Project: Normal Pressure Hydrocephalus - Identifying the most appropriate investigation in shunt 
responders. 
 
Welcome to the Royal Preston Hospital. You have been admitted to the hospital for evaluation of a condition called 
Normal Pressure Hydrocephalus (NPH), which you may be suffering from. It is characterised primarily by gait 
(walking) problems, dementia (memory problems), and urinary incontinence. You are invited to take part in a study 
as part of identifying the most appropriate investigation and measuring outcome following treatment in this group of 
patients. Before you decide, it is important for you to understand why the research is being done and what it will 
involve. Please take time to read the following information carefully and discuss it with your family and doctors to 
clarify any queries. 
 
What is Hydrocephalus? 
 
Hydrocephalus is an abnormal (excessive) accumulation of cerebrospinal fluid, commonly referred to as CSF in the 
head. The CSF is located and produced within cavities of the brain called ventricles. The function of CSF is to 
cushion the delicate brain and spinal cord tissue from injuries and maintain proper balance of nutrients around the 
central nervous system.   Every day your body produces a certain amount of CSF and that same amount of CSF is 
absorbed in the brain. When an imbalance occurs, an excess of CSF fluid builds and if left untreated, will create 
increased pressure in the head and may result in increased symptoms or brain damage.  
 
What is Normal Pressure Hydrocephalus? 
 
Normal pressure hydrocephalus (NPH) is a type of hydrocephalus, which normally occur, in older adults. NPH is an 
accumulation of CSF, which causes the ventricles of the brain to enlarge. The enlarged ventricles of an NPH patient 
may not cause increased intracranial pressure, as is the case with most types of hydrocephalus. The abnormal 
accumulation of CSF, causing enlarged ventricles, is thought to stretch the nerve tissue of the brain causing a 
various symptoms. NPH normally occurs in adults 60-years and older, and in as many as 10% of all patients with 
symptoms of dementia. Some patients with some of the same symptoms as dementia, Alzheimer's, or Parkinson's 
may actually have NPH. Unfortunately, NPH can be difficult to diagnose and many times goes untreated. 
 
 
What causes it? 
 
For most patients the cause of NPH cannot be determined. In some cases, history of previous brain injury or surgery 
can result in hydrocephalus. In other cases, the imbalance in the production or absorption of CSF causes the 
hydrocephalus. Diagnosis of NPH is often difficult due to the symptoms being similar to other disorders like mild 
dementia, Alzheimer's, Parkinson's or simply old age factors.  
 
What are the symptoms of NPH? 
 
Characterized by three primary symptoms, a triad of gait disturbance (difficulty in walking), dementia, and urinary 
incontinence. Gait disturbances range in severity, from mild imbalance to the inability to stand or walk at all. The 
gait is wide-based, short, slow and shuffling and may have trouble picking up their feet, making stairs and kerbs 
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difficult and frequently resulting in falls. Mild dementia can be described as a loss of interest in daily activities, 
forgetfulness, difficulty dealing with routine tasks and short-term memory loss.  People do not usually loose 
language skills, but they may deny that there are any problems. Impairment in bladder control is usually 
characterized by urinary frequency and urgency in mild cases, whereas a complete loss of bladder control (urinary 
incontinence) can occur in more severe cases. However, not all symptoms are always apparent. Because these three 
symptoms are often associated with the aging process in general, and a majority of the NPH population is older than 
60 years, people often assume that they must live with the problems or adapt to the changes occurring within their 
bodies.  Symptoms can be present for months or even years before a person sees a doctor. The symptoms of NPH 
seem to progress with time and the rate of progress is variable. As a general rule, the earlier the diagnosis, the better 
the chance for successful treatment, but some people experiencing symptoms for years can improve with treatment. 
 
How is it diagnosed? 
 
Once the diagnosis of NPH is suspected there is no single perfect test to determine if a patient will respond to 
treatment. The most common diagnostic tools are doing a scan of the head CT or MRI, which you may have already 
had. To make a more precise diagnosis one or more of these tests may have to be performed which include Magnetic 
resonance imaging (MRI), lumbar puncture, measurement of cerebrospinal fluid outflow resistance, continuous 
lumbar CSF drainage, walking tests and neuropsychological testing. Please find attached on a separate piece of 
paper, details of each investigation. 
 
What is the treatment for NPH? 
 
The treatment of choice for NPH patients who show a positive response to diagnostic testing is the 
placement of a VP (ventricular peritoneal) shunt.  A shunt is an implantable device designed to drain CSF 
which has two components:  a catheter, the tubing that transports and diverts the CSF from the ventricles to the 
abdominal cavity where it is easily absorbed, and a one-way valve that regulates the pressure or flow of CSF 
away from the ventricles of the brain, thereby allowing the enlarged ventricles to return to a normal state. 
This requires a surgery under general anaesthesia the details will be explained including the risks when a 
decision is made. This technique is very effective in improving the troubling symptoms of NPH. There are 
two types of shunts a traditional fixed pressure valve shunt or a pressure programmable shunt. The 
choice depends on each individual case. You will generally need to stay in the hospital on an average between 
three to seven days following an operation.   
 
Will this treatment work? 
 
If the cause of NPH is known, success rates can be as high as 80 percent. In cases in which a cause is not known, the 
success rate varies from 25 to 74 percent. The higher success rates, however, have been reported from centres using 
the more demanding diagnostic tests, as you will undergo in our study. Your symptoms may improve within days of 
shunt surgery which ranges from mild to dramatic, or may take weeks to months to abate. However, there is no way 
to predict how fast, or to what extent, this improvement will occur. It is also not possible to make general predictions 
of how long the improvement will last, as the course of clinical improvement varies for each patient. Unfortunately, 
there are no guarantees. 
  
Are there any restrictions to life after the surgery? 
 
Generally, there are no restrictions to daily activities, except those involving great physical exertion. We will discuss 
with you any restrictions that may be needed. Most patients with hydrocephalus can look forward to a normal future. 
Shunts are expected to perform reliably over a long period of time. Follow-up visits will be necessary to check post-
operative status and resolution of symptoms.  
 
Do I have to undergo these tests and who will do them? 
 
You are only suspected to have this condition and in order for us to diagnose and decide the appropriate treatment 
you will have to undergo the tests mentioned. The tests are simple and straightforward but carry very small risks, 
which will be, explained. The tests will be carried out in a systematic manner by one of the doctors. You will also 
meet a physiotherapist and nurse who may also perform some tests.  
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Will my family be involved in the decision-making? 
 
Yes, feedback from family and friends especially during the period of investigation will guide us in decision-
making. They can take part in the various discussions and feel free to ask any questions on your behalf. 
 
Conclusion: 
 
These are some of the facts about normal pressure hydrocephalous. If you did not understand any of the information 
feel free to ask any questions to Mr.G.Balamurali, one of the doctor, who will be responsible for conducting your 
investigations. The consultant looking after you will make the final decision.  
 
Investigations for Normal Pressure Hydrocephalus 
 
A brief description of the various tests, and their significance, which you will be undergoing has been explained. 
Various personnel‘s including a radiographer, physiotherapist, nurse and a doctor will perform these tests. Tests may 
be repeated. Please do ask us if you do not understand. 
 
MRI flow scan:  
Is safe and painless, and will take approximately 30 minutes or longer.  MRI uses radio signals and a very powerful 
magnet to create a picture of the brain.  It will be possible to detect if the ventricles are enlarged as well as evaluate 
how fast CSF moves through a particular part of the brain called the cerebral aqueduct, which may provide 
information about the surrounding brain tissues. Patients with cardiac pacemakers or certain other metallic implants 
cannot have MRI scans because of potential interference with the pacemaker. This machine can be claustrophobic 
and you will need to lie down still for about 30 minutes. 
 
Walking tests: 
You will be asked to walk a fixed distance usually 10 metreeters. Your pattern of walking, speed and time will be 
noted. This test will be repeated after a spinal tap to look for any improvement.  
 
Neuropsychological Tests and CANTAB: 
This testing involves asking a series of questions used to determine if there is a loss of brain function due to 
hydrocephalus. You will also undergo some tests on a touch screen computer. Tests will be repeated after a lumbar 
puncture.  
 
Lumbar Puncture or spinal tap: 
This allows an estimation of CSF pressure and analysis of the fluid. Under local anesthetic, a thin needle is passed 
into the spinal fluid space of the low back. This test may be slightly uncomfortable but is a very valuable diagnostic 
tool. Following a spinal tap CSF outflow and drainage tests can be performed. 
 
Measuring CSF outflow resistance:   
This is a more sophisticated test done during a spinal tap. It requires the simultaneous infusion of artificial spinal 
fluid and measurement of CSF pressure.  In essence, this test assesses the degree of blockage to CSF absorption 
back into the bloodstream. If the calculated resistance value is abnormally high, then there is a very good chance that 
the patient will improve with shunt surgery. 
 
Lumbar catheter insertion:  
This is a variation of the lumbar puncture or usually done after a spinal tap, a thin, flexible tube (catheter) is passed 
into the spinal fluid and the needle is removed. The lumbar catheter allows continuous removal of spinal fluid over 
two days imitating the effect that a shunt would have.  You will not feel any pain but will feel its presence. It will be 
removed after two days and some of the tests repeated. Patients who respond dramatically to such spinal fluid 
drainage are likely to respond to shunt surgery.  
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Appendix 2: Consent form 
 
Royal Preston Hospital. 
Lancashire Teaching Hospital NHS Trust 
Department of Neurological Surgery 
 
Title of Project:  Normal Pressure Hydrocephalous - Identifying the most appropriate 
investigation in shunt responsive patients. 
 
Name of Researcher: Mr G Balamurali 
                                                                                                          Please initial box 
 
1. I confirm that I have read and understand the information 
 Sheet dated …………. (NPH03 version 2) for the above                 
 study and have had the opportunity to ask questions. 
 
2. I understand that my participation is voluntary and that I 
 am free to withdraw at any time, without giving any reason,          
 without my medical care or legal rights being affected. 
 
3. I understand that sections of any of my medical notes may 
 be looked at by responsible individuals from regulatory 
authorities where it is relevant to my taking part in research. 
 I give permission for these individuals to have access to 
 my records. 
  
4. I agree to take part in the above study.                                          
 
 
 
_________________________      ________________     _________________________    
Name of patient                                   Date                                 Signature  
 
 
_________________________      ________________     _________________________    
Name of Next of Kin/Carer               Date                                 Signature    
(If patient not competent to give consent) 
 
_________________________      ________________     _________________________    
Name of researcher                            Date                                 Signature  
 
 
1 copy for patient; 1 copy for researcher; 1 copy to be kept with hospital notes. 
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Appendix 3: National Adult reading Test 
 
(Abbreviated version) 
Hazel E. Nelson 
 
Please read aloud the following words 
 
 
 
CHORD      NAIVE 
 
ACHE       CATACOMB 
 
            DEPOT      GAOLED 
 
AISLE      THYME 
  
BOUQUET      HEIR 
 
PSALM      RADIX 
 
CAPON      ASSIGNATE 
 
DENY       HIATUS 
 
NAUSEA      SUBTLE 
 
DEBT       PROCREATE 
 
COURTEOUS     GIST 
 
RAREFY      GOUGE 
 
EQUIVOCAL 
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Appendix 4: Beck Depression Inventory 
 
Please read each group of statements carefully, and then pick out the one statement in each group 
that best describes the way you have been feeling during the past two weeks, including today. Do 
not choose more than one statement for any group. 
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Appendix 5: Mini Mental scoring Test (MMSE) 
 
1. Orientation        Scores 
Year  
 
Month Day Date Season (1-5) 
Country 
 
County Town Hospital  Ward (1-5) 
 
2. Registration 
Name three objects 
 
(0-1) 
Repeat 
 
(0-1) 
Repeat three times 
 
(0-1) 
 
3. Attention 
Serial numbers 7s :100,93,86,79 
or 
(1-5) 
Word backwards: CARPET=t,e,p,r,a,c… 
 
 
 
4. Recall 
Recall the three objects 
 
(1-3) 
 
5. Language 
Name objects shown by examiner: pencil, tie, watch… 
 
(1-2) 
Repeat (No if ands, buts…) 
 
(0-1) 
3-Stage command ( take this piece of paper in your right hand, fold it 
in half and place it in the chair next to you) 
 
(1-3) 
Obey written command 
 
(0-1) 
Write a senence 
 
(0-1) 
 
Copying (Copy the figure below)     (0-1) 
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Appendix 6: Instruction to patient 
Appendix 6.1: Instruction for Verbal fluency FAS test 
 ―I will say a letter of the alphabet. Then I want you to give me as many words that begin 
with that letter as quickly as you can. For instance, if I say ―B‖ you might want to give me ―bad, 
battle, bed…..‖etc. I do not want you to use words which are proper names such as ―Blackpool, 
Bob or Brylcream‖. Also do not use the same word again with a different ending such as ―eat‖ 
and ―eating‖. Any questions please? Begin when I say the letter. The first letter is F. You may go 
ahead. Now begin timing. The three letters F, A and S are given continuously one after the other. 
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Appendix 6.2: Instruction for verbal fluency – Animal test 
―I am going to tell you the names of some things you can find in the kitchen: spoons, 
knives, forks, plates etc. Can you think of other things in the kitchen?‖ Allow the patient to name 
a few things and correct if they produce incorrect responses, explaining the task again. Then say: 
―now tell me the names of as many animals as you can.‖ Allow 1 minute. If the patient 
discontinues before the end, encourage them to produce more names. Repeat the basic 
instructions and give a starting word like ―dog‖ if there‘s a pause of 15 seconds or more. Allow 
extra time if you gave them repeat instructions. 
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Appendix 6.3: Clock drawing test 
"I want you to draw the face of a clock with all the numbers on it. Make it large." After 
completion of the clock face, instruct as follows: "Now, draw the hands pointing at 20 to 
4".Instructions may be repeated or rephrased if the patient does not understand, but no other help 
should be given. The time taken to complete the task may be noted although this has not been 
used in this study. 
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Appendix 6.4: 10 metre walking test  
 The instruction given to the patients for the walking test was, ―You see that chair over there, 
please walk towards it, at your usual speed. Please start walking when you are ready‖. Total 
number of steps and time taken to walk a distance of 10 metres was noted.  
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Appendix 7: Copy of Ethical Approval  
 
 
 
 
 
 
 
 
 
